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Abstract 
 Monoterpenes are liquid hydrocarbons that can serve as light component 
precursors for drop-in jet fuels. Fermentative production of monoterpene products in 
engineered microorganisms, such as Saccharomyces cerevisiae, has gained attention as 
a potential route to deliver these next-generation fuels from renewable biomass. However, 
end product toxicity presents a formidable problem for microbial synthesis. Due to their 
hydrophobicity, monoterpene inhibition has long been attributed to membrane interference 
but the molecular mechanism remains largely unsolved. This thesis applied tools in 
biochemical engineering, evolution engineering and systems and synthetic biology to: (1) 
gain a better understanding of the mechanism behind monoterpene inhibition and (2) detail 
specific strategies to overcome toxicity restraints for improved production.  
 Contrary to the accepted mechanism of membrane deterioration, these data 
demonstrate that the plasma membrane is not a target for monoterpene inhibition. 
Hallmark molecular inhibitory effects, such as increased membrane fluidity and changes in 
fatty acid content, were not observed during limonene exposure. Analysis of the global 
transcriptional response to limonene revealed a compensatory reaction to cell wall 
damage through overexpression of several genes (ROM1, RLM1, PIR3, CTT1, YGP1, 
MLP1, PST1, CWP1) involved in the cell wall integrity signalling pathway. Further studies, 
including cell wall integrity staining and cell wall sensitivity assays, demonstrated that 
limonene can disrupt cell wall properties. These findings underscore the position that 
monoterpene inhibition is not at the molecular level (e.g., membrane interference effects), 
and that the mechanism of action must stem from the physical interaction between an 
insoluble monoterpene phase and the surface of a cell.  
 The inhibitory cell-solvent contact mechanism is not yet understood, but by 
presenting an inert solvent to the system, toxicity can be significantly reduced. In 
particular, the nontoxic extractant farnesene, which is already produced in yeast for diesel 
markets, can be blended with monoterpene precursors to make a terpene-derived biojet 
fuel. This work describes a biphasic system that can not only relieve product toxicity in situ 
but can also consolidate recovery and downstream purification steps to produce terpene 
fuel blends that match Jet-A fuel properties.  
 In addition, adaptive laboratory evolution was used to generate several limonene-
tolerant strains. Whole-genome resequencing revealed a number of genetic targets for 
engineering tolerance. The mutations were constructed in the reference strain and their 
fitness was evaluated. A truncated version of Tcb3p protein was proven to be responsible 
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for limonene resistance. This provides new metabolic engineering strategies for further 
strain improvement.  
 Lastly, product toxicity affects key production parameters such as yield, titer and 
rate. Monoterpene-derived jet fuel production will not be viable unless the toxicity 
challenge is met. To this end, this thesis represents a starting point for the development of 
both cellular and biochemical engineering techniques to address this problem, while also 
improving our fundamental understanding of solvent toxicity in S. cerevisiae. 
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Chapter 1: General introduction  
 Petroleum dominates the world’s energy and transportation industries. 
Environmental concerns and energy security have become two of the most pressing 
issues the international community faces today. Numerous nations and governments 
around the globe have set goals to reduce their carbon emissions and dependence on 
imported oil. For example, the U.S. plans on displacing 30% of its petroleum demand with 
biofuels by 2030 1. Achieving these targets relies on the cooperation and execution of 
multiple facets of today’s complex society including research and development, industry 
investment, education and political will. However, the ultimate success of these targets will 
depend on the development of efficient and viable technologies.  
 Aviation is one of the transportation sectors leading the surge for renewable fuel 
research 2. The aviation industry is a cornerstone of the modern economy with global 
economic impact estimated at USD 3,560 billion, equivalent to 7.5% of world gross 
domestic product 2. Globally, the industry is growing, with airline traffic expected to rise 5% 
annually over the next 20 years 3. This growth has escalated concerns around fuel 
resources, given that fuel represents airlines highest operating cost (34%) 3. Along with the 
uncertainties of future fuel reserves the industry is also committed to decreasing its 
environmental impact. Roughly 3% of the world’s carbon emissions is caused by aviation 
and this number is expected to increase in the future 4. However, coming up with 
sustainable alternatives for aviation is more difficult than other transportation sectors, 
which currently have an array of renewable options (e.g., electric engines, natural gas). 
Planes differ in that they require energy dense liquid fuel. Turbine aviation fuel has specific 
physio-chemical properties and engine performance requirements 5. The goal of producing 
an alternative jet fuel replacement is to make fuels that meet or exceed the current fuel 
requirements without negative environmental, economic or social impacts.  
 Metabolic engineering in Saccharomyces cerevisiae (baker’s yeast) offers an 
attractive route for the production of replacement jet fuels. Yeast fermentation has been 
used for millennia for the production of alcohol beverages and to leaven bread. Yeast is 
the world’s most well studied organism. The knowledge base and readily available genetic 
tools enables researchers to exploit the metabolic capabilities in S. cerevisiae more than 
ever 6, 7. Recently, petroleum-compatible products (e.g., bisabolene 8 and farnesene 9) 
have been successfully produced in yeast as renewable diesel and gasoline fuels. The 
maturity of both the sugar industry and yeast fermentation was reflected in a recent 
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techno-economic analysis showing that in Australia, renewable jet fuel production via 
yeast fermentation from sugarcane was economically superior to production from algae 
and oil seed 10.  
 Monoterpenes are C10 isoprenoids built from two isoprene (C5) units. These 
complex olefins and their derivatives are major constituents of essential oils and find 
applications as flavours and fragrances (e.g. menthol), antiseptics (e.g. thymol), and 
solvents (e.g. pinene, limonene, turpentine) 11. Saturated paraffins generated from 
monoterpenes have properties similar to the light end fraction of traditional kerosene 
aviation fuel (Jet-A) making them ideal components for ‘drop in’ replacements 12, 13. 
Engineering heterologous metabolic pathways for the synthesis of monoterpenes and 
other isoprenoids, has gained attention recently as a route to produce fuels, drugs and 
chemicals from non-petroleum resources 12, 14. Reprogramming microbes to produce 
monoterpenes should be no more difficult than the already completed engineering of S. 
cerevisiae to produce farnesene, a C15 sesquiterpene replacement for diesel fuel, that 
uses the same precursors in the cell 9. Unlike farnesene, monoterpenes are highly toxic 
and this core issue must be overcome in order to realize microbial jet fuel production. This 
problem is the focal point of this thesis. The central aim of the work was to better 
understand the mode(s) of action monoterpenes have on yeast cells to develop more 
effective solutions in addressing toxicity and increasing productivity. 
 Monoterpenes are lipophilic compounds and toxicity has to been attributed to the 
interference with membrane properties 15-17. For example, β-pinene inhibits the respiration 
and essential ion (K+ and H+) transport in whole yeast cells, while loss of respiratory 
control, ATP synthesis inhibition and increased membrane fluidity is observed in isolated 
yeast mitochondria 16. These observations indicate that β-pinene interferes with 
mitochondrial membrane integrity and ATP production, while release of cytoplasmic 
material in the presence of α-pinene 17 indicates that monoterpenes also can cause severe 
damage to the plasma membrane. Limonene similarly causes severe interference with cell 
functions. Cell viability and ethanol production by S. cerevisiae using enzymatically 
digested citrus peel waste was significantly reduced in the presence of 0.02-0.10% orange 
peel oil, which contains 95-97% limonene 18-20. Although growth inhibition by orange peel 
oil, limonene and other nonsubstituted monoterpenes in yeast and bacteria is well-
established 15, 16, 20-23, the exact mechanism remains poorly understood. 
 In order to gain a greater understanding of the toxic actions monoterpenes elicit on 
cellular function it is useful to differentiate between molecular and phase toxicity 24. 
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Molecular toxicity in microorganisms is well described. For aqueous-soluble compounds in 
equilibrium, molecular toxicity increases with a solvent’s aqueous concentration, which is 
proportional to its membrane concentration. Hydrophobic compounds can interchelate into 
membranes and interfere with membrane properties 25. Increases in membrane fluidity, 
membrane permeability, denaturation of membrane-bound proteins, loss of transport 
mechanisms and reduced energy transduction are some of the consequences of 
molecular toxicity 26-29. A compounds critical membrane concentration can be calculated 
for some common microorganisms given the compounds octanol-water partitioning 
coefficient (log Pow) 30. With the membrane and aqueous phases in equilibrium, molecular 
toxicity peaks when the solvents aqueous solubility has been reached.  
 Monoterpenes are poorly soluble in water (e.g., Slimonene = 6 mg/l) 31. Any additional 
monoterpene added or produced beyond this solubility point results a distinct second 
phase. Theoretically, this means that the maximum toxicity that can be achieved on the 
molecular level must occur at very low monoterpene concentrations. The interaction of 
cells with organic phases causes a second type of toxicity, termed phase toxicity. Phase 
toxicity is a phenomological rather than mechanistic definition: toxicity occurs in the 
presence of a second phase after water and membrane saturation 32. Phase toxicity 
increases with increasing surface area (e.g., due to mixing), suggesting a significant 
kinetic component to the phenomenon 15. The exact mode of action has never been 
elucidated, though several mechanisms have been proposed: disruptions of outer cellular 
components by cell-solvent contact, extraction of nutrients from the medium and limited 
access to nutrients by cell-coating 24.  
 Understanding the mechanism is vital in order to find solutions to the problem. For 
example, molecular toxicity (e.g., membrane damage) may be addressed by heterologous 
expression of solvent efflux pumps from Pseudomonas putida 33. So far this strategy has 
failed for limonene in yeast, though it is not known if this is due to pump compatability with 
yeast, pump affinity for limonene, or if limonene simply does not cause molecular toxicity. 
If phase toxicity is the main cause of toxicity, solutions may include physiological changes 
at the cell surface, evolution of solventogenic strains or in situ product recovery techniques 
to relieve toxicity during production.   
 This thesis aims to answer two questions: 1) what is the precise mechanism of 
monoterpene toxicity in S. cerevisiae and 2) what are appropriate strategies to overcome 
inhibition? This thesis does not focus on the pathway engineering aspects of monoterpene 
production, although this topic is briefly addressed in the discussion section (Chapter 5). 
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First, I describe a quantitative measure of the inhibitory limits for five potential 
monoterpene products (Chapter 2). A biochemical engineering strategy is then outlined as 
an attractive bioprocessing option to address product toxicity in situ (Chapter 2). Second, a 
more detailed analysis towards a greater mechanistic and physiological understanding of 
monoterpene toxicity is described in Chapter 3. Chapter 4 describes another strategy, 
which utilizes evolution engineering and systems biology tools, to identify genetic targets 
for strain improvement. Finally, the current obstacles and a future perspective for 
renewable jet fuel production in S. cerevisiae are discussed in Chapter 5.  
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Alleviating Monoterpene Toxicity Using a Two-Phase Extractive 
Fermentation for the Bioproduction of Jet Fuel Mixtures in 
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ARTICLE
Alleviating Monoterpene Toxicity Using a
Two-Phase Extractive Fermentation for the
Bioproduction of Jet Fuel Mixtures in
Saccharomyces cerevisiae
Timothy C.R. Brennan, Christopher D. Turner, Jens O. Kro¨mer, Lars K. Nielsen
Australian Institute for Bioengineering and Nanotechnology (AIBN),
University of Queensland, Brisbane Qld 4072, Australia; telephone: 61-7-3346-3222;
fax: 61-7-3346-3973; e-mail: j.kromer@uq.edu.au
ABSTRACT: Monoterpenes are a diverse class of com-
pounds with applications as ﬂavors and fragrances,
pharmaceuticals and more recently, jet fuels. Engineering
biosynthetic pathways for monoterpene production in
microbial hosts has received increasing attention. However,
monoterpenes are highly toxic to many microorganisms
including Saccharomyces cerevisiae, a widely used industrial
biocatalyst. In this work, the minimum inhibitory concen-
tration (MIC) for S. cerevisiae was determined for ﬁve
monoterpenes: b-pinene, limonene, myrcene, g-terpinene,
and terpinolene (1.52, 0.44, 2.12, 0.70, 0.53mM, respective-
ly). Given the low MIC for all compounds tested, a liquid
two-phase solvent extraction system to alleviate toxicity
during fermentation was evaluated. Ten solvents were tested
for biocompatibility, monoterpene distribution, phase
separation, and price. The solvents dioctyl phthalate, dibutyl
phthalate, isopropyl myristate, and farnesene showed greater
than 100-fold increase in the MIC compared to the
monoterpenes in a solvent-free system. In particular, the
MIC for limonene in dibutyl phthalate showed a 702-fold
(308mM, 42.1 g L1 of limonene) improvement while cell
viability was maintained above 90%, demonstrating that
extractive fermentation is a suitable tool for the reduction of
monoterpene toxicity. Finally, we estimated that a limonane
to farnesane ratio of 1:9 has physicochemical properties
similar to traditional Jet-A aviation fuel. Since farnesene
is currently produced in S. cerevisiae, its use as a co-product
and extractant for microbial terpene-based jet fuel produc-
tion in a two-phase system offers an attractive bioprocessing
option.
Biotechnol. Bioeng. 2012;109: 2513–2522.
 2012 Wiley Periodicals, Inc.
KEYWORDS: monoterpene; extractive fermentation; jet
fuel; Saccharomyces cerevisiae
Introduction
Isoprenoids are a large and diverse class of natural
compounds derived from a common 5 carbon isoprene
unit (Keasling, 2010). Fermentative production of isopre-
noids using engineered microorganisms is a potential route
to deliver petroleum-compatible fuels [e.g., isopentanol
(Hull et al., 2006), farnesene (Renninger andMcPhee, 2008),
bisabolene (Peralta-Yahya et al., 2011)] from simple sugars
supplied by renewable feedstocks such as lignocellulosic
biomass and sugarcane (Fortman et al., 2008; Renouf et al.,
2008). Monoterpenes are a subclass of isoprenoids built
from two isoprene (C5) units (Fig. 1). These C10 oleﬁns and
their derivatives are major constituents of essential oils and
ﬁnd applications as ﬂavors and fragrances (e.g., menthol and
pinene) (van der Werf et al., 1997), antiseptics (e.g., thymol)
(Lambert et al., 2001), and anticancer agents (e.g., limonene
and perillyl alcohol) (Gould, 1997). Saturated parafﬁns
generated from monoterpenes have properties similar to the
light end of traditional kerosene aviation fuel (Jet-A)making
them ideal components for ‘‘drop in’’ replacements
(Fortman et al., 2008; Harvey et al., 2009; Renninger
et al., 2008). For example, Amyris, Inc. plans to use a
mixture of 50% limonane (C10 cycloparafﬁn), 10% cymene
(C10 aromatic), and 40% farnesane (C15 branched chain
parafﬁn), termed AMJ-700, in test ﬂights in 2012 (Amyris,
2009; Ryder, 2009).
Synthesis of monoterpenes in whole cell biocatalysts such
as Escherichia coli (Carter et al., 2003; Dunlop et al., 2011;
Conﬂicts of interest: None.
Dr.Jens O. Kro¨mer’s present address is Centre for Microbial Electrosynthesis
(CEMES), The University of Queensland, Queensland 4072, Australia.
Correspondence to: J. O. Kro¨mer
Contract grant sponsor: Queensland government (National and International Research
Alliances Program)
Received 2 February 2012; Revision received 20 March 2012; Accepted 16 April 2012
Accepted manuscript online 26 April 2012;
Article ﬁrst published online 28 May 2012 in Wiley Online Library
(http://onlinelibrary.wiley.com/doi/10.1002/bit.24536/abstract)
DOI 10.1002/bit.24536
 2012 Wiley Periodicals, Inc. Biotechnology and Bioengineering, Vol. 109, No. 10, October, 2012 2513
20
Reiling et al., 2004) and S. cerevisiae (Carrau et al., 2005;
Fischer et al., 2011; Oswald et al., 2007) has been limited
(e.g., 30mg L1 to 60mg L1 of monoterpene product) by
insufﬁcient supply of the monoterpene precursor geranyl
pyrophosphate and monoterpene synthase activity (Fischer
et al., 2011; Oswald et al., 2007; Reiling et al., 2004). In
principle, engineering microbes to produce monoterpenes
should be no more difﬁcult than the already completed
engineering of S. cerevisiae to produce farnesene, a C15
sesquiterpene replacement for diesel fuel (Renninger and
McPhee, 2008), which is produced from the same precursors
in the cell. However, unlike farnesene, monoterpenes are
generally highly toxic to microorganisms. Therefore, the
realization of microbial monoterpene production will rely
extensively on solving this core issue.
Monoterpenes are lipophilic compounds and their
toxicity is attributed to the interference with membrane
properties (Andrews et al., 1980; Uribe and Pena, 1990;
Uribe et al., 1985). For instance, b-pinene inhibits the
respiration and essential ion (Kþ and Hþ) transport in
whole yeast cells, while loss of respiratory control, ATP
synthesis inhibition and increased membrane ﬂuidity is
observed in isolated yeast mitochondria (Uribe et al., 1985).
These observations indicate that b-pinene interferes with
mitochondrial membrane integrity and ATP production,
while release of cytoplasmic material in the presence of a-
pinene (Andrews et al., 1980) indicates that monoterpenes
can also cause severe damage to the plasma membrane.
Limonene similarly causes severe interference with cell
functions. Cell viability and ethanol production by
S. cerevisiae using enzymatically digested citrus peel waste
was signiﬁcantly reduced in the presence of 0.02–0.10%
v v1 orange peel oil, which contains 95–97% limonene
(Pourbafrani et al., 2007; Wilkins et al., 2007). Although
growth inhibition by orange peel oil, limonene, and other
non-substituted monoterpenes in yeast and bacteria is well-
established (Grohmann et al., 1994; Murdock and Allen,
1960; Subba et al., 1967; Uribe and Pena, 1990; Uribe et al.,
1985; Wilkins et al., 2007), quantitative data on monoter-
pene toxicity are limited and the exact mechanism remains
poorly understood.
A physical approach used to overcome toxicity limitations
is to remove inhibitory products in situ during fermentation
using an extractive solvent. Numerous in situ product
recovery (ISPR) techniques (e.g., pervaporation, perstrac-
tion, gas stripping) have been reported for the recovery of
aromas, alcohols, and organic acids and an extensive review
of ISPR projects and process designs have been covered by
Stark and von Stockar (2003). Liquid–liquid extraction has
shown the greatest potential because it is simple and scalable
(Janusz, 2001) and provides the cells with an efﬁcient
product sink (Malinowski, 2001). Two-phase extractive
fermentation has been reported to enhance the production
and recovery of short-chain alcohols [e.g., ethanol (Daugulis
et al., 1987), butanol (Rofﬂer et al., 1988)], acetone (Rofﬂer
et al., 1988), organic acids (Bar and Gainer, 1987), and
volatile sesquiterpene products such as amorpha-4,11-diene
(Newman et al., 2006). However, this technique has not
been applied to overcome monoterpene inhibition. Solvent
selection is the ﬁrst crucial step in the development of an
effective two-phase bioprocess because solvents are generally
both product and host speciﬁc (Bruce and Daugulis, 1991;
Leo´n et al., 1998). The solvent needs to meet the following
key criteria: Biocompatibility with the producing organism,
high product distribution coefﬁcients, favorable phase
separation (e.g., low emulsion formation), and low cost
(Bruce and Daugulis, 1991).
A proof-of-concept two-phase extractive system for
monoterpene production with S. cerevisiae was deﬁned in
this work. First, we quantitatively determined the inhibitory
concentrations for ﬁve common monoterpene products in a
solvent-free system. In an attempt to evolve a monoterpene
tolerant phenotype, we subjected the wild type strain to
several hundred generations of limonene challenged
chemostat cultivation without signiﬁcant improvement.
We then screened ten organic solvents for biocompatibility,
monoterpene distribution, phase separation, and price to
select suitable solvent candidates to be used for extractive
fermentation. We demonstrated that using this biphasic
approach, S. cerevisiae was able to withstand signiﬁcantly
higher monoterpene concentrations compared to the
solvent-free system and the chemostat challenged strain.
Finally, we explored the use of the yeast product farnesene as
an extractant and a co-product for jet fuel production by
estimating fuel properties of a farnesane-limonane blend.
Materials and Methods
Strains, Media, and Chemicals
The S. cerevisiae strain S288C (MATa SUC2 gal2 mal mel
ﬂo1 ﬂo8-1 hap1) was kindly provided by the Australian
Wine Research Institute (AWRI, Adelaide, SA, Australia).
Rich medium (YPD) was used to store cultures at 808C in
40% glycerol. The YPD medium contained 10 g L1 yeast
extract, 10 g L1 polypeptone, and 20 g L1 dextrose
(glucose). Cells were reactivated from frozen glycerol stocks
by streaking out on chemically deﬁned medium (CDM) agar
plates (15 g L1 agar) and incubated at 308C. CDM
Figure 1. d-limonene, b-pinene, g-terpinene, terpinolene and myrcene were the
ﬁve monoterpenes analyzed in this work.
2514 Biotechnology and Bioengineering, Vol. 109, No. 10, October, 2012
21
contained the following components per liter of solution:
5 g sucrose, 1 g (NH4)2HPO4, 2 g (NH4)2SO4, 0.99 g KCl,
0.15 g CaCl22H2O, 7.8 g NaH2PO4, 7.1 g Na2HPO4, 0.5 g
MgSO47H2O, trace metals: 4.5mg ZnSO47H2O, 15mg
EDTA, 0.84mg MnCl22H2O, 0.3mg CoCl26H2O, 0.3mg
CuSO45H2O, 0.4mg Na2MoO42H2O, 4.5mg CaCl22H2O,
3mg FeSO47H2O, 1mg H3BO3, 0.1mg KI, vitamins: 0.05
d-biotin, 1mg Ca pantothenate, 1mg nicotinic acid, 1mg
myoinositol, 25mg thiamine hydrochloride, 1mg pyridoxal
hydrochloride, 0.2mg p-amino benzoic acid. All experi-
ments were carried out aerobically in CDM. Chemicals
where obtained from Sigma Aldrich (Castle Hill, NSW,
Australia) and were analytical grade (99%) except for the
following purities: d-limonene (93%), terpenolene (85%),
oleyl alcohol (85%), farnesene (mixture of isomers),
isopropyl myristate (90%).
Growth Conditions
Single colonies from CDM solid media were used as inocula
for the pre-cultures. Pre-cultures in 10mL of CDM were
incubated in 100mL bafﬂed shake ﬂasks in a shaking
incubator (Multitron, Infors, Bottmingen, Switzerland) at
200 rpm (Orbit 25mm) and 308C. Pre-cultures were grown
overnight until mid-log phase and then appropriate aliquots
of the pre-culture broth were used to inoculate 25mL of
fresh CDM medium to a target OD660 of 0.2, respectively.
Cultures were grown at 308C aerobically in 250mL bafﬂed
screw top shake ﬂasks sealed with TeﬂonTM lining to avoid
any monoterpene evaporation. Monoterpene evaporation
in sealed versus non-sealed shake ﬂasks was determined
hourly for 12 h and signiﬁcant monoterpene losses
occurred in non-sealed ﬂasks. For sealed and non-sealed
ﬂasks we observed similar growth rates (0.35 0.01 h1,
respectively) and biomass yields after 12 h of growth
(0.22 0.02 gDCW g1sucrose, respectively), showing that sufﬁ-
cient oxygen was available in the headspace of sealed ﬂasks
to ensure aerobic conditions. At 5 h after inoculation
(OD660¼ 1.0) varying amounts of monoterpene were
added aseptically into the culture medium using a 10mL
glass-syringe. Cell growth was determined by measuring the
optical density at 660 nm against water in a spectrophoto-
meter (Libra S4, Cambridge, England) and all growth
experiments were performed in triplicate. Speciﬁc growth
rates were determined from OD660 values during the
exponential growth phase after the addition of monoter-
pene. For aqueous-organic two-phase growth conditions
an equal volume (10.2mL) of organic solvent-limonene
mixture was added to exponentially growing cultures at 5 h
and growth was monitored as described. The following
amounts of limonene in the solvent mixture were tested: 1,
2.5, and 5% (vlimonene v
1
solventlimonenemix). Evaporation of
limonene from the solvents butyl oleate, dioctyl phthalate,
dibutyl phthalate, isopropyl myristate, and farnesene was
tested by measuring limonene concentration before and
after two-phase cultivation by GC/MS as described below.
Organic Solvent Biocompatibility
Ten organic solvents were tested for biocompatibility with
S. cerevisiae. A 10% (vsolvent v
1
culture) volume of solvent was
added to exponentially growing cultures at 5 h and growth
was monitored as described previously. The growth rate of
cultures with solvent was compared to a control with no
solvent and the ratio was reported as m m1max.
GC/MS analysis
Monoterpenes in the organic and aqueous phases were
quantiﬁed in GC/MS. For this the organic and aqueous
phases were separated using centrifugation. The aqueous
phase underwent a liquid–liquid extraction using hexane.
Equal volumes of hexane and aqueous phase (0.5mL) were
mixed, vortexed for 5min and allowed to phase-separate at
258C. Aliquots of the hexane extract of the aqueous phase
and of the organic phase were diluted in hexane prior to
quantiﬁcation in order for the signals to fall within the
calibration curve. A linear standard curve was achieved for
standard solutions of known monoterpene stocks in hexane
(100, 250, 500, 750, 1,000mM). Menthol was used as an
internal standard and was added to the hexane samples and
the standards with a 10mL glass-syringe (Gerstel, Mulheim,
Germany) to achieve a ﬁnal concentration of 500mM prior
to injection. For quantiﬁcation, 3mL sample was injected
into the GC program temperature vaporizer (PTV) inlet in
splitless mode at 2508C using helium as a carrier gas with a
constant ﬂow rate of 1mLmin1. Compounds were
separated using a Varian factorFOUR capillary column
(VF-5ms: 0.25mm inner diameter, 0.25mm ﬁlm, 30m
length with a 10m fused guard column) on an Agilent
7890A gas chromatograph attached to an Agilent 5975C
MSD. Initially the oven temperature was set to 408C and was
held for 5min followed by a temperature ramp of
7.58Cmin1 to 1008C, then 358Cmin1 to 3508C and
held for 5min. Detection was achieved in scan mode at 9.26
scans sec1 from 30 to 300 amu.
Monoterpene Partitioning Coefﬁcients
The partitioning coefﬁcient Kd, is deﬁned as the ratio of
monoterpene concentration in the organic phase to aqueous
phase. In order to determine Kd, equal volumes (0.5mL) of
aqueous CDM media and each organic solvent were
vortexed vigorously overnight at 308C. Known amounts
of monoterpene were added directly into the organic solvent
prior to mixing and each monoterpene Kd was determined
in triplicate for each solvent. Samples were allowed to phase
separate for 5min after mixing at 308C. Due to emulsion
formation, samples with corn oil, oleyl alcohol, and
dodecanol were centrifuged at 5,900 rcf for 5min at 258C
(Eppendorf centrifuge 5415R, rotor: FA-45-24-11) to
separate the two phases. After phase separation, monoter-
pene quantiﬁcation in the aqueous and organic phases was
determined by GC/MS as described above.
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Viability Assessment
Propidium iodide (PI) was used to measure cell viability and
membrane integrity. During limonene treated growth
experiments, aliquots from the culture broth were analyzed
at 2, 4, and 6 h after the addition of limonene or limonene-
solvent mixtures. The ﬁnal PI concentration in the sample
was 2.5mgmL1 and samples were shaken as set by Quanta
Cell Lab software well-prep mode in 96-well plates for 0.5 h
at 258C before analysis. As positive controls non-limonene
treated cells were incubated in 70% ethanol at 308C for 0.5 h,
washed and resuspended in PBS. This caused 99.5% of the
cells to be stained with PI. Cell suspensions were analyzed
using a Beckman Coulter Cell Lab SC MPL ﬂow-cytometer
with an argon-ion laser emitting 488 nm beam at 22mW.
The intensity of ﬂuorescence at FL3 (red ﬂuorescence,
620 nm) was recorded using a logarithmic scale and the
sample ﬂow rate was 30mLmin1.
Jet fuel Physicochemical Property Estimation
Physicochemical properties of limonane and limonane-
farnesane fuel blends were estimated using suitable
modeling software and compared to previously reported
(Renninger et al., 2008) fuel speciﬁcations. Modeling in
AspenPlus1 (AspenTech, 2000) was used for transport and
vapor liquid equilibrium properties (e.g., density, ﬂash
point, enthalpy of combustion, and viscosity) while the
Dortmund Data Bank software (Onken et al., 1989) was
used for freezing point calculations. The UNIFAC group
contribution method (Fredenslund et al., 1977) was used for
thermodynamic properties.
Chemostat Adaptation
A sucrose limited continuous fermentation was carried out
in a 1.4 L Multifors benchtop bioreactor (InfrosHT,
Bottmingen, Switzerland) attached to a HPR-20 QIC gas
analysis system (Hiden, Warrington, England). Synthetic
media (CBS) containing 2 g L1 sucrose, 5 g L1
(NH4)2 SO4, 3 g L
1 KH2PO4, 0.5 g L
1 MgSO47H2O,
and identical concentrations of vitamins and trace metals
of CDM, were used for chemostat experiments. An aerobic
culture of 350mL was run at 308C, 500 rpm and was sparged
with air at 0.35 L h1. The pH was maintained at 5 by
automatic addition of 2M NaOH. A dilution rate of 0.2 h1
was used with an inlet feed of 72mLh1. Limonene was
continuously fed at 125mL h1 directly into the culture
using an electronic syringe pump (New Era Pump System
Inc., Farmingdale, NY) controlled by the Syringe Pump Pro
software program (Version 1.54, Gawler, South Australia).
The limonene concentration in the chemostat was deter-
mined directly. 1ml of culture was removed and harvested
by centrifugation at 5,900 rcf for 1min at 258C. The
supernatant was separated from the cell pellet and
immediately overlayed with 200mL of hexane and then
vortexed for 30 s. The limonene concentration in the hexane
layer was analyzed by GC/MS. The steady state limonene
concentration was measured to be 0.53 0.04mM (n¼ 3).
Culture purity was routinely monitored by light microsco-
py. Culture from the reactor was used to inoculate shake
ﬂask cultures as described in the growth conditions section
to determine the MIC for limonene.
Results
Growth Inhibition by Monoterpenes
The toxicity of pure monoterpenes was determined by
adding different amounts of the monoterpene to yeast
measuring the growth rate over the ensuing 5 hr (Fig. 2). The
monoterpene was added to yeast cells already in mid-
exponential growth, in order to avoid confounding by lag
phase phenomena. The minimum inhibitory concentration
(MIC) was deﬁned as the amount of monoterpene required
to reduce the speciﬁc growth rate by 50% compared to
control cultures with no monoterpene present. As shown in
Figure 3, very low concentrations (MIC 0.4–2mM, 0.0075–
0.033% v v1) for all ﬁve monoterpenes caused growth
inhibition. Limonene was the most toxic (MIC¼ 0.44mM)
while the acyclic terpene myrcene was the least toxic
(MIC¼ 2.12mM). Even when growth is completely
inhibited by limonene (0.6mM), viability remains high
6 h after addition; it requires another magnitude increase in
concentration to see substantial loss of viability, e.g., 73%
reduction in viability at 6mM (Fig. 2B). In contrast, if
limonene is added to cultures immediately after inoculation,
signiﬁcant reduction in viability is seen even at MIC (data
not shown).
Though low, the MIC of limonene is approximately an
order of magnitude higher than its aqueous saturation point
0.045mM (Schmid et al., 1992) (SLimonene in Fig. 2 B).
Cultures with limonene present in amounts beyond its
solubility point (e.g., in Fig. 2 B, the 2nd and 3rd data points
are 0.14mM and 0.34mM, respectively) were able to grow
within 97% of the maximum growth rate with no limonene
present. In fact, all ﬁve monoterpenes had MICs well above
their solubility points (Table I).
An unsuccessful attempt was made to alleviate monoter-
pene toxicity via cell adaptation. After 885 h (225 genera-
tions) of continuous cultivation in the presence of
0.54mM limonene, no signiﬁcant improvement in the
MIC (0.45mM) was observed. Shown in Figure 2 B,
identical limonene concentrations for the mutant and wild
type had very similar impact on growth.
Solvent Selection for a Two-Phase Bioprocess to
Reduce Monoterpene Toxicity In situ
In order to alleviate the observed monoterpene toxicity, 10
organic solvents were chosen from the literature based on
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their log Pow coefﬁcients, which is deﬁned as the logarithm
of the ratio of a compound’s equilibrium concentration in
the octanol phase to the aqueous phase (Laane et al., 1987;
Vermue and Tramper, 1995). Although it is highly
dependent on the microorganism, it is generally supported
that an organic compound with log Pow >5 should be
biocompatible with S. cerevisiae (Bruce and Daugulis, 1991).
Using a 10% (v v1) solvent phase, as described previously
for similar experiments (Schewe et al., 2009), we conﬁrmed
that all 10 solvents met the criterion for biocompatibility
with S. cerevisiae (m m1max values 0.65–1.0, see Table II).
All ﬁve monoterpenes partitioned preferentially into the
organic phase over the aqueous media (log Kd 1.8–2.7, see
Table III). However, corn oil, oleyl alcohol, and dodecanol,
caused emulsions that required separation by centrifugation
(Table II). These solvents were excluded from the remaining
experiments, since interference with biomass quantiﬁcation
could not be ruled out. Considering these characteristics,
along with the solvent price, butyl oleate, dioctyl phthalate,
Figure 2. Growth and viability of limonene dosed cultures. A: Cultures were
grown exponentially and then various amounts of limonene (& control,~ 0.14 mM,*
0.34 mM, & 0.43 mM, ~ 0.46 mM, * 0.51 mM) were added exogenously at t¼ 5 h.
B: Growth rate versus increasing limonene concentration (^ wild-type, ^ mutant);
the aqueous solubility of limonene (SLimonene) is 0.045mM (Schmid et al., 1992). A 50%
reduction in growth rate compared to the control without monoterpene is approxi-
mately 0.175 h1, this concentration is deﬁned as the MIC. The mutant represents the
limonene challenged chemostat strain after 885 h of continuous cultivation. C: Cell
viability was determined for the wild type after 6 h of limonene exposure. Error
bars for growth rate and viability represent one standard deviation of biological
triplicates (viability deviations were less than 0.02 and therefore are not visible).
Figure 3. Growth rates of monoterpene dosed cultures (&-Limonene,
~-Terpinolene,*-g-Terpinene,*-b-pinene,~-Myrcene) versus increasing mono-
terpene concentration. Growth was monitored as described for limonene in the
Figure 2. Error bars represent one standard deviation for biological triplicates.
Table I. Monoterpene minimum inhibitory concentrations.
Monoterpene MICa (mM)
Aqueous solubilityb
(mM, 258C) Log Po-w
b
Limonene 0.44 0.045 4.4
Terpinolene 0.53 0.068 4.47
g-Terpinene 0.70 0.064 4.5
b-Pinene 1.45 0.052 4.42
Myrcene 2.12 0.043 4.5
aThe MIC is deﬁned as the amount of terpene required to cause a 50%
reduction in growth rate compared to the control with no monoterpene
present. Although the aqueous solubility is exceeded, concentration units
(mM) are used for explanatory reasons.
bAqueous solubilities and log Pow are taken from literature (Schmid
et al., 1992).
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dibutyl phthalate, isopropyl myristate, and farnesene were
selected for further analysis.
The ﬁve selected solvents were then investigated in a
limonene-solvent two-phase system. Limonene was the
most inhibitory monoterpene (Fig. 3) and thus was chosen
to screen the selected solvents for their ability to reduce
toxicity. Based on the relative MICs for all ﬁve mono-
terpenes, we assumed that solvent candidates that were
successful with limonene could be applied as extractants for
the other four monoterpene products. The maximum
amount of limonene that could be loaded into the solvent
mixture before growth was severely inhibited was deter-
mined. In Figure 4, at 5% (v v1) limonene in dibutyl
phthalate, growth was reduced by 50% (MIC 308.7mM)
with the amount of limonene present (42.1 g L1 aqueous
culture) being 702-fold higher than the MIC for limonene in
solvent-free cultures (Table IV). Butyl oleate was the least
effective solvent with the growth rate being reduced by 80%
in a 1% limonene load (Fig. 4). However, solvents dioctyl
phthalate, isopropyl myristate, and farnesene also signiﬁ-
cantly reduced limonene toxicity withMICs over two-orders
of magnitude higher than the MIC for limonene with no
solvent present (Table IV). Cell viability at these critical
concentrations for each limonene-solvent system was
measured using the PI staining method described above.
Viability at each of the reported MICs was over 90%
(Table IV).
Modeling Mono and Sesquiterpene Jet Fuel Blends
The fermentation products, limonene and farnesene, require
an additional processing step to be used as jet fuels. For
example, chemical hydrogenation is used to saturate C–C
double bonds that exist in terpene compounds to produce
alkane fuel targets such as limonane and farnesane (Ryder,
2009). In order demonstrate that our thermodynamic model
accurately predicted fuel properties, we used our model to
predict the previously published properties of a 97.1%
limonane fuel composition (AMJ-300 in Table V) that was
tested using industry standard (ASTM)methods (Renninger
et al., 2008). Our predicted properties of AMJ-300 (UNIFAC
Table II. Solvent selection criteria.
Solvent m m1max SD Log Pow Log Kd limonene SD Phase separation Price USD L1
Corn oil 1.0 0.09 7.4 2.15 0.23  7.4
Dodedecane 0.65 0.09 6.6 2.20 0.22 þ 50.2
Hexadecane 0.90 0.08 8.8 2.57 0.06 þ 67.1
Oleyl alcohol 0.90 0.01 5.6 2.50 0.16  17.2
Butyl oleate 0.95 0.05 9.8a 2.29 0.15 þ 6.1
Dibutyl phthalate 0.71 0.12 4.63b 1.60 0.01 þ 12.0
Dodecanol 0.65 0.09 5.32 2.47 0.15  8.5
Dioctyl phthalate 0.73 0.06 7.54a 2.53 0.11 þ 7.1
Farnesene 0.81 0.08 7.1c ND þ —
Isopropyl myristate 0.95 0.04 7.4 ND þ 12.8
mm1max was determined for biocompatibility by comparing the growth rate in the presence of 10% (v/v) solvent addition to cultures with no solvent (mmax);
log Pow is the standard partitioning coefﬁcient in an octanol-water system and values are from the previous report (Bruce and Daugulis, 1991); () indicates
poor phase separation and centrifugation was required, (þ) no centrifugation needed; bulk solvent price values were taken from (Spectrum, 2011). Standard
deviations (SD) are given (n¼ 3).
aMattiasson and Holst (1991).
bStales et al. (1997).
cKishimoto et al. (2005).
Table III. Monoterpene-solvent logKd values.
Solvent g-Terpinene Terpinolene Myrcene b-Pinene d-Limonene
Corn oil 2.63 0.13 ND 2.18 0.24 1.21 0.18 2.15 0.23
Dodedecane 2.64 0.12 ND 2.16 0.20 2.12 0.09 2.20 0.22
Hexadecane 2.73 0.10 ND 2.45 0.03 1.89 0.08 2.57 0.06
Oleyl alcohol 2.71 0.05 ND 1.92 0.30 2.08 0.12 2.50 0.16
Butyl oleate 2.5 0.24 ND 1.84 0.54 2.01 0.18 2.29 0.15
Dibutyl phthalate 2.46 0.18 2.18 0.46 2.06 0.39 1.55 0.14 1.60 0.01
Dodecanol 2.72 0.01 2.14 0.40 2.30 0.14 2.16 0.06 2.47 0.15
Dioctyl phthalate 2.64 0.03 ND 2.33 0.17 1.96 0.26 2.53 0.11
Farnesene ND 2.85 0.21 2.60 0.26 ND ND
Isopropyl myristate ND ND ND ND ND
Kd is the ratio of monoterpene in the organic solvent phase to the aqueous media phase. Standard deviations are given (n¼ 3). ND, no monoterpene was
detected in the aqueous phase.
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AMJ-300 in Table V) were comparable with those previously
reported (<10% error). Due to limonene’s toxicity, we then
used this model to ﬁnd the minimum limonane load in
farnesane that met Jet-A properties. The physicochemical
properties of a 10% (v v1) blend of limonane in farnesane
are very similar to Jet-A speciﬁcations.
Discussion
Monoterpenes are known fungicidal agents, but the exact
mechanisms of action are not well understood. For solvent-
caused toxicity in microbes, two types of toxicity have been
distinguished: Molecular and phase (Bar, 1987). Molecular
toxicity has been described as compounds that are soluble in
the aqueous phase and due to their hydrophobicity,
intercalate within the lipid bilayer and deteriorate mem-
brane function (Sikkema et al., 1995). Increases in
membrane ﬂuidity, membrane damage, denaturation of
membrane-bound proteins, and loss of energy transduction
are some of the consequences of a solvent’s impact at the
molecular level (Inoue and Horikoshi, 1991; Leo´n et al.,
1998; Sikkema et al., 1994b; Vermue et al., 1993).
Alternatively, phase toxicity occurs when the amount of
solvent present in the culture medium exceeds the
compounds solubility point and a distinct second phase
exists. The presence of a second phase means that
thermodynamically, the aqueous phase is fully saturated
as well as the different compartments of the biomass (e.g.,
cytoplasmic membrane) (Leo´n et al., 1998; Osborne et al.,
1990; Sikkema et al., 1994b). Phase toxicity could be caused
by extraction of outer-cellular components during cell-
solvent contact, extraction of nutrients from the media, or
cell-coating (Bar, 1987). We observe severe toxicity for all
ﬁve monoterpenes only well beyond their aqueous
solubilities (Table I) and in addition, the most toxic
monoterpene found in this work (limonene) caused no
growth inhibition when the aqueous media was saturated
with limonene (Fig. 2B). It was previously suggested that
monoterpene toxicity in microbes occurs at the molecular
level causing structural damage to the plasma membrane
and interfering with its normal function (Sikkema et al.,
1994a; Uribe et al., 1985). In contrast, we observed no loss of
viability at the MIC of limonene (Fig. 2B). Only at very high
limonene loadings (6.2mM) was membrane damage
observed, resulting in 73% of the total population being
no longer viable (Fig. 2B). We did observe signiﬁcant loss of
viability at the MIC of limonene, when added to the culture
immediately after inoculation, and this may explain why
previous studies (Andrews et al., 1980) have observed
molecular toxicity.We conclude that toxicity observed when
limonene is added (or slowly accumulating) during
S. cerevisiae culture must be due to phase effects.
The observation of phase toxicity has implications for
strain optimization. We have shown that although growth
stops, the cells are still viable. Controlling strains to begin
monoterpene production after the initial growth phase is a
potential route to address toxicity constraints. For example,
the highest production of lactic acid (100 to 154 g L1),
which is also considered a toxic end product, in Lactobacillus
occurs during the stationary phase of cell growth (Wee et al.,
2005). Another important implication of phase toxicity is
with respect to engineering tolerance in the biocatalyst. For
instance, engineering efﬂux systems to export compounds
from the membrane, as described recently for limonene and
the other biofuel targets n-butanol and a-pinene in E. coli
(Dunlop et al., 2011), should not alleviate monoterpene
toxicity in S. cerevisae because, as demonstrated here, the
Figure 4. Growth rate versus limonene loading in butyl oleate, dioctyl phthalate,
dibutyl phthalate, isopropyl myristate and farnesene. Limonene was loaded at 1, 2.5,
5% (vlimonene v
1
limonenesolventmix) in a limonene-solvent mixture. The % of viable cells is
given above each growth rate value. Growth was monitored as described in the
Figure 2. Error bars are one standard deviation above the mean for biological
triplicates.
Table IV. Solvent-limonene mixture MICs and cell viability.
Solvent Limonene MIC (mM) Limonene (g L1) Fold increase vs. solvent free system Cell viability (%)
No solvent 0.44 0.06 — 99
Dibutyl phthalate 308.7 42.1 702 92
Dioctyl phthalate 154.3 21.0 351 98
Isopropyl myristate 154.3 21.0 351 99
Farnesene 61 8.4 140 99
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monoterpene aqueous concentration and consequently, the
membrane concentration, is saturated well before we
observe any growth inhibition (Table I). Furthermore, we
showed that simply evolving the cells over time, which is one
of the most straightforward methods for generating
improved phenotypes (Kwon et al., 2011), showed negligible
improvement in limonene tolerance, MIC increased from
0.44 to 0.45 (see mutant in Fig. 2B).
In contrast to the limited success of cellular engineering,
manipulating phase properties by introducing an inert
solvent phase shows substantial potential (e.g., MIC for
limonene with the solvent dibutyl phthalate is 702-fold
higher than the MIC with no solvent). The monoterpene
partitioning coefﬁcients (Kd) (Bruce and Daugulis, 1991) for
the 10 biocompatible solvents studied are several orders
of magnitude higher (log Kd¼ 2–2.85, see Table III) than
those (logKd¼ 0.78) reported for an economically feasible
extractive ethanol fermentation plant (Maiorella et al.,
1984), indicating the commercial potential of such a process.
Furthermore, high limonene loads can be achieved in the
solvent phase without compromising cell viability. This
means that the solvent can act as an effective product sink in
situ without negatively impacting the producing organism.
As shown in Table IV, cultures with 42.1 g L1 of limonene
in dibutyl phthalate can maintain 92% cell viability. Dibutyl
phthalate showed the highest limonene load and this may be
explained by its similar hydrophobicity to limonene (log Pow
is 4.63 in Table II and 4.5 for limonene in Table I) compared
to the other solvents tested. To our knowledge this is
the highest monoterpene concentration reported during
fermentation with baker’s yeast.
The use of a solvent that does not require separation from
the monoterpene products would simplify this technique.
Although Figure 4 suggests that farnesene is not the best
solvent option to reduce limonene toxicity, farnesene is of
particular interest as an extractive solvent since it can be
synthesized by yeast during fermentation (Renninger and
McPhee, 2008) and, as shown above, a blend of 10% (v v1)
limonane in farnesane exhibits physicochemical properties
similar to Jet-A (Table V). Using farnesene as an extractant
and a co-product will ultimately require careful process
engineering that balances both monoterpene toxicity and
desired fuel properties. An organism with an ability to
produce both the extractant and monoterpene product in
situ will positively impact raw-material and downstream
processing costs. This is likely to outweigh toxicity
advantages of the other solvents tested. By holding the
10% (v v1) terpene fuel blend constant, we found that by
reducing the ratio of organic to culture volume from 0.05,
where we observed no growth and 88% loss in cell viability,
to 0.005, both fast cell growth (80% of mmax) and high
viability (99%) can be achieved (data not shown). The
amount of limonene in the latter system (2.8mM,
380mg L1), is 6.3-fold higher than the MIC without any
solvent present.
Conclusion
End product inhibition is a critical problem for the
microbial synthesis of monoterpene-dervied fuels and
chemicals. We have provided quantitative data for the
inhibitory limits of ﬁve common monoterpene products
and shown that in S. cerevisiae, the mechanism of toxicity is
likely to be a phase effect. As an alternative to cellular
engineering, we have demonstrated that a biphasic extractive
system can signiﬁcantly enhance fermentation by alleviating
monoterpene toxicity in situ. To make this process even
more efﬁcient, we have shown that by using farnesene as the
extractant, one could obtain a terpene mix that could be
directly used for hydrogenation into jet fuel. Depending
on the other components of the organic phase this could
at the same time reduce the downstream processing cost
(e.g., distillation).
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Physiological and Transcriptional Responses of Saccharomyces
cerevisiae to d-Limonene Show Changes to the Cell Wall but Not to
the Plasma Membrane
Timothy C. R. Brennan,a Jens O. Krömer,b Lars K. Nielsena
Australian Institute for Bioengineering and Nanotechnology, University of Queensland, Brisbane, Queensland, Australiaa; Centre for Microbial Electrosynthesis, Advanced
Water Management Centre, University of Queensland, Brisbane, Queensland, Australiab
Monoterpenes can, upon hydrogenation, be used as light-fraction components of sustainable aviation fuels. Fermentative pro-
duction of monoterpenes in engineered microorganisms, such as Saccharomyces cerevisiae, has gained attention as a potential
route to deliver these next-generation fuels from renewable biomass. However, end product toxicity presents a formidable prob-
lem for microbial synthesis. Due to their hydrophobicity, monoterpene inhibition has long been attributed to membrane inter-
ference, but the molecular mechanism remains largely unsolved. In order to gain a better understanding of the mode of action,
we analyzed the composition and structural integrity of the cell envelope as well as the transcriptional response of yeast cells
treated with an inhibitory amount of d-limonene (107 mg/liter). We found no alterations in membrane fluidity, structural mem-
brane integrity, or fatty acid composition after the solvent challenge. A 4-fold increase in the mean fluorescence intensity per cell
(using calcofluor white stain) and increased sensitivity to cell wall-degrading enzymes demonstrated that limonene disrupts cell
wall properties. Global transcript measurements confirmed the membrane integrity observations by showing no upregulation of
ergosterol or fatty acid biosynthesis pathways, which are commonly overexpressed in yeast to reinforce membrane rigidity dur-
ing ethanol exposure. Limonene shock did cause a compensatory response to cell wall damage through overexpression of several
genes (ROM1, RLM1, PIR3, CTT1, YGP1,MLP1, PST1, and CWP1) involved with the cell wall integrity signaling pathway. This is
the first report demonstrating that cell wall, rather than plasmamembrane, deterioration is the main source of monoterpene
inhibition. We show that limonene can alter the structure and function of the cell wall, which has a clear effect on cytokinesis.
Monoterpenes are 10-carbon (C10) olefins composed of two5-carbon (C5) isoprene units (1). Monoterpenes, such as
limonene, pinene, and cymene, have traditionally been used as
flavors and fragrances (2) but recently have gained attention as po-
tential light-component precursors for drop-in jet fuels (3–5). In
June 2012, a demonstration flight by Amyris Inc. proved that their
biojet fuel, AMJ-700, successfully met engine performance re-
quirements and required no changes to the aircraft (6). AMJ-700
contains 60% monoterpene-derived paraffins, which are critical
for meeting strict fuel requirements (5). Although synthesis of
monoterpene products in engineered biocatalysts, such as baker’s
yeast and Escherichia coli, is still in the developmental stages (only
30 g/liter to 1 g/liter of monoterpene product has been achieved
so far [7–10]), farnesene (a C15 sesquiterpene) uses the same pre-
cursors in the cell and is currently produced for diesel markets
(11). However, the primary challenge facing microbial monoter-
pene synthesis is product toxicity, which adversely impacts pro-
duction parameters such as titer, yield, and rate (12).
The mechanism behind monoterpene inhibition is poorly un-
derstood. While solvent stress in microorganisms has been stud-
ied extensively over the past 40 years, these reports have focused
primarily on short-chain alcohols and organic acids (13), and al-
though monoterpenes are well-known antifungal agents, only a
few quantitative studies exist (3, 14–17). Due to their lipophilicity
(log P 4.5), monoterpene inhibition has been attributed tomo-
lecular toxicity, i.e., the direct interference of solvent molecules
with membrane function (17–19). Consistent with this, increases
in membrane fluidity (17) and structural membrane damage (20)
were observed in whole yeast cells exposed to pinene.
Solvents partition between the membrane and the aqueous
phase. For a sparingly water-soluble solvent in equilibrium, the
membrane concentration will be proportional to the solvent’s
aqueous concentration, and molecular toxicity is typically ob-
served to increase proportionally with the solvent’s aqueous con-
centration (21–23). With the membrane and aqueous phases in
equilibrium,molecular toxicitymust peakwhen the aqueous con-
centration has reached its solubility limit, since both phases are
saturated at this point.
Monoterpenes are essential oils; thus, they are sparingly solu-
ble in water (e.g., Slimonene 6mg/liter) (24). In a recent study, we
found that the inhibitory concentrations for five monoterpene
products were at least an order of magnitude higher than their
aqueous saturation limits (3). The cells were also able to grow at
97% of the maximum growth rate when their cellular compart-
ments (e.g., plasmamembrane)were saturatedwithmonoterpene
(3). Thus, monoterpene toxicity is per definition not molecular
toxicity but rather phase toxicity (25). Phase toxicity has a phe-
nomenological rather than a mechanistic definition: toxicity oc-
curs in the presence of a distinct solvent phase (i.e., after water and
membrane saturation) and is a nonequilibrium (kinetic) effect
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that increases with interfacial area (e.g., larger solvent phase vol-
ume and greater agitation).
Here we investigated the direct impact that limonene has on
the yeast cell envelope. Many microorganisms, including yeast,
Pseudomonas putida, and E. coli, respond to solvent stress by alter-
ing their lipid bilayers to counteract fluidization effects (13). To
confirmwhether or not molecular toxicity effects were indeed the
source of limonene inhibition, membrane fluidity, structural
membrane integrity, and membrane composition were measured
after limonene exposure.Due to the lack of evidence formolecular
toxicity, additional experiments such as cell wall integrity (CWI)
staining and cell wall sensitivity assays were used to investigate
potential sources of phase toxicity at the surface of the cell. Lastly,
analysis of the global transcriptional response was used to support
the physiological observations.
MATERIALS AND METHODS
Strain, chemicals, and growth conditions. The Saccharomyces cerevisiae
strain S288C (MAT SUC2 gal2mal mel flo1 flo8-1 hap1) was provided by
the Australian Wine Research Institute (AWRI), Adelaide, South Austra-
lia, Australia. Analytical-grade d-limonene (93%) was purchased from
Sigma-Aldrich. The growth conditions and limonene challenge were as
described previously (3) with the following modifications. Chemically
defined medium (CBS) was used. CBS contained 20 g/liter sucrose, 5
g/liter (NH4)2SO4, 3 g/liter KH2PO4, 0.5 g/liter MgSO4 · 7H2O, and the
exact components and concentration of vitamins and trace metals de-
scribed by Brennan et al. (3). Overnight precultures (pH 5.0, 30°C) were
used to inoculate 25 ml of fresh CBS to an optical density at 660 nm
(OD660) of 0.5 against water, and then 2.8 l of limonene (107 mg/liter)
was added exogenously to the medium during mid-exponential growth
phase (at 5 h; OD660  2.5). All of the measurements described below
were taken 2 h after the limonene challenge for limonene-treated cultures
and similarly for control cultures with no limonene present.
Fluorescence anisotropy. The membrane fluidity of limonene-chal-
lenged and control cultures was determined using fluorescence anisot-
ropy as described previously (26, 27) with the following modifications.
After 2 h of limonene exposure, cells were harvested at 13,000 rpm for 1
min, washed twice with 15 mM Tris-HCl buffer, and resuspended to an
OD660 of 0.2. A 1.0-l volume of a 12 mM stock solution of diphenyl-
hexatriene (DPH) in tetrahydrofuran was then added to the resuspension
and incubated at 30°C for 30 min with continuous stirring (200 rpm) to
allow the probe to intercalate into the plasmamembrane (27). The anisot-
ropy was measured with a Spectromax M5 (Sunnyvale, CA) at excitation
and emission wavelengths of 358 and 428 nm, respectively, and recorded
using Softmax Pro (v 5.3) software. All anisotropy measurements were
analyzed in biological triplicate for limonene-treated and control cultures
at 30°C. A positive control was used to test for increase fluidity by heat
treating cells under the identical conditions described above at 50°C for 50
min. Heat-treated samples had a 16% increase in fluidity compared to the
control (anisotropy value r 0.138 0.003 [n 3]).
Confocal microscopy. Two microliters of calcofluor white (CFW)-
stained cells was loaded onto a glass slide. A coverslip was added on top,
and a thin layer of nail polish was used to seal the sample between the glass
slide and the coverslip. The images were taken throughout the coverslip
with a Zeiss 710 confocal laser scanningmicroscope (CLSM) using a Plan-
Apochromat 63/1.40 oil DIC M27 objective. The 2,048- by 2,048-pixel
map images were recorded using a 405-nm wavelength excitation laser,
and the data were collected in the 409- to 517-nmwindow. All the images
were analyzed using the ZEN 2011 software (Carl Zeiss Microscopy, Jena,
Germany).
Cellwall isolation.Cell walls were isolated and analyzed using the acid
(H2SO4) treatment method (28). Cell wall extractions were performed in
biological triplicate for both control and limonene-challenged cultures at
2 h after limonene addition. Cell wall monosaccharide concentrations
were normalized using the total dry cell wall mass for individual samples.
Lipid extraction and methylation. Yeast lipids were extracted by us-
ing the chloroform-methanol protocol described previously (26) with the
followingmodifications. At 2 h after limonene addition, the entire culture
volume (22 to 25 ml) was weighed and harvested (4,025 g) for 2 min at
25°C. The cell pellet was washed in phosphate-buffered saline (PBS) (In-
vitrogen, Life Technologies, Carlsbad, CA), resuspended, and added to a
1:1 solution of methanol and chloroform as described but with 0.27g of
nonadecanoic acid (Sigma-Aldrich) to a final concentration of 0.018
g/ml as an internal standard (ISTD). The lower chloroform phase was
removed and dried down under nitrogen. Lipid extracts were saponified
under reflux (2 h, 80°C) with 1 ml of 2 M NaOH and 2 ml of methanol.
After acidification by the addition of 200l of 37.5% concentratedHCl, 4
ml (2 aliquots of 2 ml) of chloroform was added and vortexed. Upon
phase separation, the chloroform phase (2 ml) was removed, and the
second aliquot (2 ml) of chloroform was added and vortexed. Both chlo-
roform aliquots were then recombined. To recover the lipids, the chloro-
form was evaporated under nitrogen. For methylation, 200 l of 2%
H2SO4 in methanol was added to the extracts and incubated for 2 h at
80°C. Once cooled, 200 l of 0.9% NaCl was added and vortexed, and
then the addition of 300 l of hexane was used to recover the fatty acid
methyl esters (FAME) for gas chromatography-mass spectrometry (GC-
MS) analysis. Lipid extraction was carried out in biological triplicate for
control and limonene-treated samples.
GC-MS. ForGC-MS analysis, 2l from the hexane-FAME samplewas
injected into the GC inlet in splitless mode at 350°C using helium as a
carrier gas with a constant flow rate of 1 ml/min. Compounds were sepa-
rated using a Varian factorFOUR capillary column (VF-5 ms; 0.25-mm
inner diameter, 0.25-m film, 30-m length with a 10-m fused guard col-
umn) on an Agilent 7890A gas chromatograph attached to an Agilent
5975C MSD. Initially the oven temperature was set to 70°C, and this was
held for 5 min, followed by a temperature ramp of 9°C/min to 320°C and
then 30°C/min to 350°C and holding for 6.3 min. Detection was achieved
in scan mode at 9.26 scans/s from 30 to 800 amu. Thirty-two individual
fatty acid standards (Sigma-Aldrich) were used to build a FAME library
using their target ions and retention times. FAME peaks were detected in
each sample by matching to compounds within the FAME library, and an
alkane (C7-30) standard was used as a retention time index. The relative
area for each fatty acid in a sample was calculated by dividing the FAME
area by the ISTD area, multiplying by the ratio of actual ISTD to set ISTD
mass, and then dividing by grams of dry cell weight (gDCW) of the sam-
ple. Biological triplicates were used for each condition.
Fluorochrome staining.Aliquots from control and limonene-treated
cultures were taken inmid-exponential phase 2 h after limonene addition.
Propidium iodide (PI) was used for determination of cell permeability
and membrane integrity (3). For cell wall staining, calcofluor white
(CFW) (Sigma-Aldrich) was used as described previously (29) with the
followingmodifications. Onemilliliter of culture was quickly harvested at
13,000 rpm for 1min, washed with sterileMilli-Qwater, and resuspended
in 200 l of water containing 100 g/ml of CFW. The solution was then
incubated at 30°C for 2 min, harvested, washed twice with Milli-Q water,
and resuspended in 1 ml of water before flow cytometry analysis. All data
were produced in biological triplicate.
Flow cytometry. Cell viability was analyzed using PI exactly as de-
scribed by Brennan et al. (3). For calcofluor white staining, cells were
analyzed using a BD LSRII flow cytometer with a UV laser at 350 nm.
Forward scatter (FSC), side scatter (SSC), and 450/50 band-pass (BP)
filter excitation were acquired using BD FACSDiVa software (v 6.1.1).
Postacquisition compensation analysis of total fluorescence intensity was
carried out using Flow Jo software (v 10.0). All data were analyzed in
biological triplicate.
Cell wall sensitivity assay. The sensitivity of cell walls to enzymatic
degradation was performed as described by Takahashi et al. (30). Briefly,
200 l of culture was harvested at mid-exponential phase 2 h after limo-
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nene addition, washed with sterile water, and diluted to an OD660 of 2 in
buffer containing NaH2PO4 (0.1 M, pH 7.5), 0.04% NaN3, and 40 g/ml
lyticase enzyme from Arthrobacter luteus (Sigma-Aldrich). The samples
were placed in an Eppendorf rack at 30°C and 200 rpm, and the cell
density wasmonitored hourly. An identical buffer lacking the enzymewas
used as a negative control. The percentage of the originalODwas reported
for biological triplicates for both control and limonene-challenged cul-
tures.
Transcriptomics. (i) RNA sampling and isolation. RNAwas isolated
from cultures containing no limonene (control) at mid-exponential
phase. For challenged cultures, limonene was added (107 mg/liter) at
mid-exponential phase, and RNA was sampled 2 h later. All isolations
were done with three biological replicates. For each set of replicates, 10ml
of culture was sampled and harvested for 1 min (4,025 g), the superna-
tant was discarded, and the total RNA was immediately extracted using
the RiboPure-Yeast kit (Ambion, Life Technologies, Carlsbad, CA) ac-
cording to the manufacturer’s protocol except that bead beating (Biospec
Products, Bartlesville, OK) was used to fully lyse the cells (3 times for 20 s,
followed by 1 min on ice). The total RNA was then digested (twice) using
the Turbo DNA-free kit (Invitrogen, Life Technologies, Carlsbad, CA)
and then cleaned and concentrated using the RNA Clean & Concentra-
tor-25 kit (Zymo Research, Irvine, CA) according to both manufacturer’s
instructions. DNA contamination was assessed by quantitative reverse
transcription-PCR (qRT-PCR). The total RNA sample quality was then
measured using an Agilent 2100 Bioanalyzer and RNA 6000 Nano kit
according to manufacturer’s methods (Agilent, Santa Clara, CA). Sample
labeling and hybridization to Affymetrix yeast genome 2.0 arrays were
performed by the Ramaciotti Centre for Gene Function Analysis (Univer-
sity of New South Wales, Sydney, Australia).
(ii) Microarray data analysis. Statistical analysis of the raw microar-
ray data was carried out using GenePattern (31). The six Affymetrix CEL
files were imported, normalized, and log transformed using the following
software modules within GenePattern: GarvanCaArray2.3.0Importer,
NormalizeAffymetrix3prime, and LogTransform. Detection of differen-
tially expressed genes and statistical analysis of the samples were carried
out using the limma package (32) within the LimmaGP module. The
differentially expressed gene set was then filtered using a cutoff at a Bon-
ferroni-corrected P value of0.01. The filtered gene list was then used as
input into g:Profiler to asses significantly changed pathways, reactions,
and Gene Ontology (GO) terms using a hypergeometric test (33). The
results were visualized using the MultiExperiment Viewer software (34).
Using the unfiltered gene expression values (log2), the entire transcrip-
tome data set was viewed using the Saccharomyces Genome Database
(SGD) pathways tool (http://pathway.yeastgenome.org) for metabolic
mapping and identification. The rawmicroarray data are publically avail-
able at http://pwbc.garvan.unsw.edu.au/caarray/project/details.action
?project.id607.
RESULTS
In order to study the response to limonene, the dose added must
be sublethal. We have previously observed substantial cell death if
inhibitory levels of limonene are added to the inoculum (3).When
added in mid-exponential phase, however, cell growth is arrested
(Fig. 1a), while viability remains greater than 98% after 2 h of
limonene exposure (Fig. 1b). Viability is measured through PI
stain exclusion and confirms structural membrane integrity. Fur-
ther investigation of membrane properties revealed no significant
changes in membrane fluidity as measured through fluorescence
anisotropy (Fig. 1b), nor were there any significant changes to the
fatty acid composition after limonene treatment (Fig. 2b).
While 2 h of limonene treatment caused no significant changes
in the cell wall polysaccharide composition (Fig. 2a), it greatly
affected cell wall integrity. Limonene-treated cells were hypersen-
sitive to the cell wall binding dye calcofluor white (CFW), exhib-
iting a 4-fold increase in mean fluorescence intensity (MFI) of
5,231 471 compared to that of control cells (MFI 1,270 45)
(Fig. 3a). In confocal microscopy (Fig. 3b and c), the hypersensi-
tivity to CFW appears as enriched fluorescence in the bud neck
region of the cells. Limonene-treated cells were also more suscep-
tible to cell wall-degrading enzymes (Fig. 4). A 40% drop in cell
density was observed after 1 h for limonene-challenged cells, com-
pared to 20% found in the control.
Global gene expression analysis identified 277 upregulated and
176 downregulated genes (Bonferroni-corrected P value of
0.01). Enrichment analysis identified the expected downregula-
tion of biological processes linked to cell growth, e.g., cytokinesis,
ribosome biogenesis, nucleotide biosynthesis, and amino acid
biosynthesis (see the supplemental material). The only biological
process identified as significantly enriched in the upregulated gene
set was iron ion homeostasis. Though none of the stress-related
biological processes were significantly enriched, several KEGG
pathways linked to stress (glutathione metabolism, peroxisome,
and autophagy) were identified (see the supplemental material).
While global repression trends in amino acid synthesis, ribo-
some activity, and protein synthesis were to be expected for ar-
rested cells, we were particularly interested in how the gene ex-
pression data related to the physiological observations of the cell
envelope. Limonene-treated cells induced expression of seven
fatty acid metabolism and six glycerophospholipid metabolism
genes (Table 1 and Fig. 5c); however, global metabolic mapping
showed no overexpression of either ergosterol or saturated and
unsaturated fatty acid biosynthesis pathways (Table 1; see Table S1
in the supplemental material). Limonene treatment also caused
the overexpression of carbohydrate, xenobiotic, amino acid, and
sulfur transport activity (Table 1 and Fig. 5c), as well as the expres-
FIG 1 (a) Growth plot for control and limonene-treated (107 mg/liter) cul-
tures. (b)Cell viability andmembrane fluidity (anisotropy, r)measurements at
2 h after limonene addition. Error bars represent one standard deviation (SD)
above and below the mean for biological replicates.
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sion of several common stress-associated genes (Fig. 5a). Finally,
limonene exposure induced a number of genes associatedwith cell
wall organization and biogenesis (Table 1 and Fig. 5b). The ob-
served impact on the structural integrity of the cell wall (Fig. 3 and
4) was further supported by the regulation of the cell wall integrity
(CWI) signaling pathway. Several key signaling genes (MTL1,
ROM1, MPK1, BAG7, and MLP1) and the major transcription
factor gene RLM1 were upregulated (Fig. 6). Furthermore, 12 of
RLM1’s 25 gene targets were overexpressed,most of which encode
proteins associatedwith cell wall organization and/or wall biogen-
esis (Fig. 6).
DISCUSSION
Monoterpene toxicity is generally assumed to be due to mem-
brane interference, as observed for ethanol (17–19). Yeast cells
respond to ethanol exposure by increasing their ergosterol and
unsaturated fatty acid composition to increase membrane rigidity
(35–37). An early microarray study of -terpinene toxicity ob-
served global upregulation of genes involved in ergosterol synthe-
sis and sterol uptake (15). In the current study, however, we ob-
served no evidence of membrane interference by limonene.
Membrane integrity, fluidity (Fig. 1), and fatty acid composition
(Fig. 2b) did not change significantly in response to limonene.
Furthermore, no increase in the expression of genes in the ergos-
terol and fatty acid biosynthesis pathways was observed (Table 1;
see Fig. S1 in the supplemental material).
We would have expected results similar to those observed for
-terpinene (15). Like limonene, terpinenes are cyclic monoter-
penes. Terpinene was used at a higher concentration (170mg/liter
rather than 107 mg/liter) but is also slightly less toxic; the terpi-
nene concentration was chosen as the 50% inhibitory concentra-
tion (IC50) in the previous study (15), while our study used nearly
two times the IC50 for limonene (3). The monoterpenes were
added to cells in mid-exponential phase, i.e., 5 h in culture in our
study and overnight in the terpinene study. In both studies, the
response was measured at 2 h after monoterpene addition. One
significant difference was that complex (YPD) medium was used
in the terpinene study, compared to minimal medium in our
study. Another major difference was that a number of genes in-
FIG 2 Cell envelope compositional changes due to limonene shock. (a) Cell
wall polysaccharide compositions for control and limonene-treated cells. (b)
Fatty acid composition at 2 h after limonene challenge. 10:0, decanoic acid;
12:0, dodecanoic acid; 14:0, myristic acid; 15:0, pentadecanoic acid; 16:0,
palmitic acid; 17:0, heptadecanoic acid; 18:0, octadecanoic acid; 20:0, eico-
sanoic acid; 21:0, docosanoic acid; 24:0, tetracosanoic acid; 18:19cis, oleic
acid; 18:19trans, elaidic acid; 18:29,12, linoleic acid; 18:39,12,15 linolenic
acid. Error bars represent one SD above the mean (n 3).
FIG 3 (a) Flow cytometry measurements of limonene-treated and control
cells using the cell wall binding probe calcofluor white (CFW) at 2 h after
limonene addition.Mean fluorescence intensity/cell (arbitrary units, n 3)
SD. Inset, forward side scatter versus CFW intensity. (b and c) Confocal mi-
croscopy images of control cells (b) and limonene-treated cells (c) stainedwith
CFW. Arrows indicate the chitin-enriched bud neck.
FIG 4 Cell wall sensitivity measurements using lyticase enzyme for limonene-
treated cells. All data were carried out in biological triplicate and, error bars
represent one SD above and below the mean.
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TABLE 1 Differentially expressed genes associated with the plasma membrane and cell wall cellular compartments and functionsa
Process (GO term, no. of
genes,b P value)
Upregulated genes Downregulated genes
Gene Protein description
Fold
changec Gene Protein description
Fold
change
Fatty acid metabolic process
(0006631, 7, 3.58E	02)
CAT2 Carnitine acetyl-CoA transferase present in both mitochondria
and peroxisomes; transfers activated acetyl groups to carnitine
to form acetylcarnitine, which can be shuttled across
membranes
1.65 ELO1 Elongase I, medium-chain acyl elongase,
catalyzes carboxy-terminal
elongation of unsaturated C12–C16
fatty acyl-CoAs to C16–C18 fatty acids
	2.21
OLE1 Delta(9) fatty acid desaturase, required for monounsaturated
fatty acid synthesis and for normal distribution of
mitochondria
1.90
POT1 3-Ketoacyl-CoA thiolase with broad chain-length specificity;
cleaves 3-ketoacyl-CoA into acyl-CoA and acetyl-CoA during
beta-oxidation of fatty acids
2.84
HTD2 Mitochondrial 3-hydroxyacyl-thioester dehydratase involved in
fatty acid biosynthesis; required for respiratory growth and for
normal mitochondrial morphology
0.98
EHT1 Acyl-coenzyme A:ethanol O-acyltransferase that plays a minor
role in medium-chain fatty acid ethyl ester biosynthesis;
possesses short-chain esterase activity; localizes to lipid
particles and the mitochondrial outer membrane
0.92
FAS2 Alpha subunit of fatty acid synthetase, which catalyzes the
synthesis of long-chain saturated fatty acids; contains the acyl-
carrier protein domain and beta-ketoacyl reductase, beta-
ketoacyl synthase and self-pantetheinylation activities
1.06
Glycerophospholipid
metabolism (0564
[KEGG], 6, 1.42E	02
INO1 Inositol 1-phosphate synthase, involved in synthesis of inositol
phosphates and inositol-containing phospholipids;
transcription is coregulated with other phospholipid
biosynthetic genes by Ino2p and Ino4p, which bind the
UASINO DNA element
4.10
CLD1 Mitochondrial cardiolipin-specific phospholipase; functions
upstream of Taz1p to generate monolyso-cardiolipin;
transcription increases upon genotoxic stress; involved in
restricting Ty1 transposition; has homology to mammalian
CGI-58
1.89
CHO1 Phosphatidylserine synthase; functions in phospholipid
biosynthesis; catalyzes the reaction CDP-diacylglycerol
 L-
serine CMP
 L-1-phosphatidylserine; transcriptionally
repressed bymyo-inositol and choline
1.15
CKI1 Choline kinase, catalyzing the first step in phosphatidylcholine
synthesis via the CDP-choline (Kennedy pathway); exhibits
some ethanolamine kinase activity contributing to
phosphatidylethanolamine synthesis via the CDP-
ethanolamine pathway
1.28
CHO2 PEMT, catalyzes the first step in the conversion of
phosphatidylethanolamine to phosphatidylcholine during the
methylation pathway of phosphatidylcholine biosynthesis
1.13
OPI3 Phospholipid methyltransferase (methylene-fatty-acyl-
phospholipid synthase); catalyzes the last two steps in
phosphatidylcholine biosynthesis
0.95
Xenobiotic transporter
activity (0042910, 3,
2.18E	02)
PDR5 Plasma membrane ABC transporter; multidrug transporter
actively regulated by Pdr1p; also involved in steroid transport,
cation resistance, and cellular detoxification during
exponential growth
2.00 PDR12 Plasma membrane ABC transporter;
weak-acid-inducible multidrug
transporter required for weak organic
acid resistance; induced by sorbate
and benzoate and regulated by
War1p; mutants exhibit sorbate
hypersensitivity
	1.54
YOR1 Plasma membrane ABC transporter; multidrug transporter
mediates export of many different organic anions, including
oligomycin; similar to human CFTR
1.65
PDR15 Plasma membrane ABC transporter, multidrug transporter, and
general stress response factor implicated in cellular
detoxification; regulated by Pdr1p, Pdr3p, and Pdr8p;
promoter contains a PDR-responsive element
3.19
Amino acid and sulfur
transmembrane
transport (0003333 and
0072348, 9,
0.00136–0.01)
AGP3 Low-affinity amino acid permease; may act to supply the cell with
amino acids as nitrogen source under nitrogen-poor
conditions; transcription is induced under conditions of sulfur
limitation; plays a role in regulating Ty1 transposition
5.09
MUP1 High-affinity methionine permease; integral membrane protein
with 13 putative membrane-spanning regions; also involved in
cysteine uptake
4.63
MUP3 Low-affinity methionine permease similar to Mup1p 1.87
MMP1 High-affinity S-methylmethionine permease; required for
utilization of S-methylmethionine as a sulfur source; has
similarity to S-adenosylmethionine permease Sam3p
2.28
SAM3 High-affinity S-adenosylmethionine permease; required for
utilization of S-adenosylmethionine as a sulfur source; has
similarity to S-methylmethionine permease Mmp1p
2.23
(Continued on following page)
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TABLE 1 (Continued)
Process (GO term, no. of
genes,b P value)
Upregulated genes Downregulated genes
Gene Protein description
Fold
changec Gene Protein description
Fold
change
ALP1 Arginine transporter; expression is normally very low, and it is
unclear what conditions would induce significant expression
1.22
YCT1 High-affinity cysteine-specific transporter with similarity to the
Dal5p family of transporters; GFP fusion protein localizes to
the endoplasmic reticulum; YCT1 is not an essential gene
4.33
SUL2 High-affinity sulfate permease; sulfate uptake is mediated by
specific sulfate transporters Sul1p and Sul2p, which control
the concn of endogenous activated sulfate intermediates
1.47
SUL1 High-affinity sulfate permease of the SulP anion transporter
family; sulfate uptake is mediated by specific sulfate
transporters Sul1p and Sul2p, which control the concn of
endogenous activated sulfate intermediates
1.80
Cell wall organization
(0005576, 22, 7.86E	02)
YGP1 Cell wall-related secretory glycoprotein; induced by nutrient
deprivation-associated growth arrest and upon entry into
stationary phase; may be involved in adaptation prior to
stationary-phase entry; has similarity to Sps100p
4.03 HPF1 Haze-protective mannoprotein that
reduces the particle size of aggregated
proteins in white wines
	2.52
PIR3 O-glycosylated covalently bound cell wall protein required for
cell wall stability; expression is cell cycle regulated, peaking in
M/G1, and also subject to regulation by the cell integrity
pathway
4.99 GAS3 Low-abundance, possibly inactive
member of the GAS family of GPI-
containing proteins; putative 1,3-
beta-glucanosyltransferase with
similarity to other GAS family
members; localizes to the cell wall;
mRNA induced during sporulation
	2.27
FIT2 Mannoprotein that is incorporated into the cell wall via a GPI
anchor; involved in the retention of siderophore iron in the
cell wall
2.01 UTR2 Chitin transglycosylase that functions in
the transfer of chitin to beta(1-6) and
beta(1-3) glucans in the cell wall;
similar to and functionally redundant
with Crh1; GPI-anchored protein
localized to bud neck
	2.56
SUC2 Invertase, sucrose-hydrolyzing enzyme; a secreted, glycosylated
form is regulated by glucose repression, and an intracellular,
nonglycosylated enzyme is produced constitutively
2.63 SUN4 Cell wall protein related to glucanases;
possibly involved in cell wall
septation; member of the SUN family
	2.21
TIP1 Major cell wall mannoprotein with possible lipase activity;
transcription is induced by heat and cold shock; member of
the Srp1p/Tip1p family of serine-alanine-rich proteins
2.06 DSE4 Daughter cell-specific secreted protein
with similarity to glucanases;
degrades cell wall from the daughter
side, causing daughter to separate
from mother
	1.89
SPI1 GPI-anchored cell wall protein involved in weak acid resistance;
basal expression requires Msn2p/Msn4p; expression is
induced under conditions of stress and during the diauxic
shift; similar to Sed1p
4.74 SCW11 Cell wall protein with similarity to
glucanases; may play a role in
conjugation during mating based on
its regulation by Ste12p
	2.99
PST1 Cell wall protein that contains a putative GPI attachment site;
secreted by regenerating protoplasts; upregulated by activation
of the cell integrity pathway, as mediated by Rlm1p;
upregulated by cell wall damage via disruption of FKS1
1.88 DSE2 Daughter cell-specific secreted protein
with similarity to glucanases;
degrades cell wall from the daughter
side, causing daughter to separate
from mother; expression is repressed
by cAMP
	3.16
FIT3 Mannoprotein that is incorporated into the cell wall via a GPI
anchor; involved in the retention of siderophore iron in the
cell wall
1.73 CTS1 Endochitinase; required for cell
separation after mitosis;
transcriptional activation during the
G1 phase of the cell cycle is mediated
by transcription factor Ace2p
	2.36
HSP150 O-mannosylated heat shock protein that is secreted and
covalently attached to the cell wall via beta-1,3-glucan and
disulfide bridges; required for cell wall stability; induced by
heat shock, oxidative stress, and nitrogen limitation
0.97 EGT2 GPI-anchored cell wall endoglucanase
required for proper cell separation
after cytokinesis; expression is
activated by Swi5p and tightly
regulated in a cell cycle-dependent
manner
	2.09
CWP1 Cell wall mannoprotein that localizes specifically to birth scars of
daughter cells, linked to a beta-1,3- and beta-1,6-glucan
heteropolymer through a phosphodiester bond; required for
propionic acid resistance
1.07
PRB1 Vacuolar proteinase B (yscB), a serine protease of the subtilisin
family; involved in protein degradation in the vacuole and
required for full protein degradation during sporulation;
activity inhibited by Pbi2p
1.30
DIA3 Protein of unknown function involved in invasive and
pseudohyphal growth
1.35
TDH1 Glyceraldehyde-3-phosphate dehydrogenase, isozyme 1, involved
in glycolysis and gluconeogenesis; tetramer that catalyzes the
reaction of glyceraldehyde-3-phosphate to
1,3-bis-phosphoglycerate; detected in the cytoplasm and cell
wall
1.15
a Abbreviations: CoA, coenzyme A; PEMT, phosphatidylethanolamine methyltransferase; ABC, ATP binding cassette; CFTR, cystic fibrosis transmembrane receptor; GFP, green
fluorescent protein; GPI, glycosylphosphatidylinositol; cAMP, cyclic AMP.
b Number of genes associated with the reported Gene Ontology accession number. The total number of differentially expressed genes was 453.
c Log2 ratio of expression in treated cells to that in control cells.
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volved in redox activity and glutathione metabolism (see the sup-
plemental material) were found for limonene but not for terpi-
nene exposure. Dioxygenase and oxidoreductase genes JLP1 and
OYE3, for example, were highly upregulated (6.7- and 3.6-fold
changes, respectively [see the supplementalmaterial]) during lim-
onene exposure. Glutathione biosynthesis (GSH1, 1.3-fold in-
duced) and peroxide protection CTT1 andGPX1 (2.2- and 3-fold
induced, respectively) genes (see the supplemental material) were
also found in this work but not in the terpinene study. Differences
between the two transcriptional responses may stem from culture
conditions ormonoterpene load, as well as differences in chemical
properties between the two compounds and their potential to
form epoxides.
Because redox and glutathione metabolism activity was ob-
served, we wanted to exclude oxidative stress as possible source of
molecular toxicity. Expression of GSH1, CTT1, and GPX1 is a
well-characterized response to oxidative stress in S. cerevisiae (38).
Signature genes involved in antioxidant defense systems, however,
were not overexpressed. Genes for key transcriptional regulators
(YAP1 and SKN7), thioredoxins (TRX1,TRX2,TRR1, andTRR2),
glutaredoxins (GLX1, -2, 3, -4, and -5), and superoxide dismutases
(SOD1 and -2) as well as for two key stress response element
(STRE) regulators (MSN2 and MSN4) were not induced during
limonene shock (38, 39). A potential cause of increased redox
activitymay come fromoxygenated limonene compounds such as
limonene epoxides, which can form when limonene is exposed to
air for long periods of time (40). Epoxide compounds have been
reported to cause oxidative damage in yeast (41), and limonene-
1,2-epoxide, for example, is 23 times more soluble in water than
limonene (137 mg/liter) (42). There may be differences between
the toxic effects of monoterpene hydrocarbons and oxy-function-
alizedmonoterpene compounds. For example, 1,8-cineole (an ep-
oxy-monoterpene) was endogenously produced in yeast with no
report of toxicity limitations up to 1 g/liter (10), while a separate
study reported that limonene stops growth at 60 mg/liter (3).
While limonene itself is toxic at the phase level, limonene epoxides
may have caused redox imbalances to cells on the molecular level.
In order to rule this out, the experiments were repeated under
anaerobic conditions. We found no limonene epoxide formation
in GC-MS but observed the same adverse effects on growth (see
Fig. S2 in the supplemental material). This means that although
limonene epoxides can form in aerobic cultures (see Fig. S3 in the
supplemental material), limonene itself remains the primary
source of toxicity.
Membrane-bound efflux pumps play a critical role in solvent-
tolerance in P. putida (43). Expression of the AcrAB-TolC efflux
proteins in E. coli led to higher tolerance of cyclohexane (44) and
increased tolerance and production of pinene and limonene (8).
Similar to the bacterial pumping system, cellular detoxification in
yeast is driven primarily by pleiotropic drug resistance (PDR)
pumps, which are a subfamily of yeast’s ABC proteins (45). We
found threeABC transporter genes inducedunder limonene stress
(YOR1, PDR15, and PDR5) (Fig. 5c and Table 1). The same three
transporters were identified in a recent study, but overexpression
failed to improve tolerance for limonene (46), and the pumpsmay
lack affinity to limonene.
Absence of amembrane effect is consistent with limonene tox-
icity being phase toxicity rather than molecular toxicity. There is
no evidence of molecular toxicity, as the system is saturated at a
water concentration of 6 mg/liter and the IC50 is 10 times greater
than the solubility. The solvent phase contacts the cell wall rather
than the cell membrane. Having primary roles in protection from
turgor pressure and cell division, the cell wall is essential for sur-
vival (47). Its latticework is tightly held together by strong hydro-
gen bonding networks between cellulose and chitin chains as well
as covalent glycosidic linkages between all three wall components
FIG 5 Gene expression values (log2) for each biological replicate (control versus limonene-treated cells) for genes involved in stress responses (a), cell wall
organization and cytokinesis (b), and plasma membrane transport and fatty acid metabolism (c).
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(glucan, mannoprotein, and chitin) (48). Calcofluor white is a
fluorochrome that binds to the cell wall by hydrogen bondingwith
chitin and -linked polysaccharides (49–51), but in fungi, CFW
preferentially binds to the chitin, which is localized in the bud
neck (29). In Fig. 3a, a 4-fold increase in the MFI demonstrates
that more fluorochrome is bound per cell after limonene treat-
ment. Increased sensitivity to CFW is indicative of cell wall dam-
age in S. cerevisiae, Candida albicans (52), Aspergillus niger (53),
and a number of other fungi (54). Disruption of the crystalline
lattice of chitin polymers has been shown to weaken the cell wall,
causing cell arrest and accumulation of chitin deposits in S. cerevi-
siae (55). Althoughwe did not find higher levels of chitin (Fig. 2a),
this mechanism is in concert with our CFW hypersensitivity and
growth inhibition results. A decrystallizing effect is also seen in
Fig. 4, where the cell walls were found to be more susceptible to
glucan-specific degradation with lyticase enzymes after having
been treated with limonene. Because we found no changes in the
total wall composition after limonene exposure (Fig. 2a), the data
suggest that limonene can alter the properties of the cell wall.
Given its pivotal role in the budding process, particularly in sep-
tum formation (47, 56), our results indicate that by disrupting the
cell wall structure, limonene has a profound effect on cell growth.
The cellular response to limonene further demonstrates cell
wall stress. Twelve differentially expressed genes that were found
in this study (CWP1, PIR3, SED1, PST1, SLT2, MLP1, ECM4,
HSP12, DDR2, SLR3, FBP26, and AFR1) belong to a cluster of 20
well-characterized genes that represent the main transcriptional
fingerprint of cell wall stress (57, 58). Furthermore, several genes
directly involved in the cell wall integrity (CWI) signaling path-
way, the sole purpose of which is to respond to cell wall stress (59),
were upregulated in response to limonene exposure (Fig. 6). The
guanosine nucleotide exchange factor geneROM1, the cell surface
sensor geneMLT1, and the genes SLT2 andMLP1, coding for the
mitogen-activated protein kinase (MAPK) proteins cascade, were
induced (Fig. 6). RLM1 codes for the transcription factor respon-
sible for the majority of the transcriptional output of CWI (59).
RLM1was slightly overexpressed (1.2-fold [log2]), while five of its
targets (PST1,CWP1,PIR3,CTT1, andYGP1 in Fig. 6)were highly
FIG 6 Cell wall integrity (CWI) signaling pathwaywith transcriptomic expression changes during limonene stress. Colors indicate the fold change (log2) cutoffs.
Genes in bold represent genes that were differentially expressed (Bonferroni-corrected P value of0.01). PM, plasma membrane; PIP2, phosphatidylinositol-
4,5-bisphosphate. (Adapted from reference 70 with permission.)
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upregulated. In particular, PIR3 and YGP1, which are required for
cell wall organization and stability, were two of the most highly
induced genes found, having fold changes of 5 and 4, respectively
(Fig. 6 and Table 1). Lastly, the cellular response to limonene
caused decreased transcript levels for transcription, ribosomal ac-
tivity, and purine nucleotidemetabolism. These repression trends
were also found in two independent studies profiling the global
transcriptional response to cell wall damage (57, 58).
The physical interaction between an insoluble limonene
phase and a cell is still unclear. We have shown here that lim-
onene dispersions can alter surface properties of yeast cells by
disrupting the normal structure of the cell wall, but the rela-
tionship between limonene’s rheological behavior in an aque-
ous culture and its apparent toxicity to a microorganism is yet
to be determined. In a recent study (3), limonene toxicity was
dramatically reduced in the presence of an inert extractant. The
extractive solvents dibutyl phthalate (DBP) and isopropyl my-
ristate (IPM), for example, are harmless to yeast cells and are at
least an order of magnitude more viscous than limonene
(limonene  0.008 P [60], DBP  0.166 P [61], and IPM 
0.043 P [62]). The viscosity of a fluid has a strong influence on
droplet size, which affects the dispersion’s overall surface area
(63). Future work is required to characterize how fluid prop-
erties (e.g., viscosity, droplet size, and interfacial tension) af-
fect the interfacial contact between cells and monoterpene dis-
persions. This information could render more insight into the
phase mechanisms responsible for inhibition in biphasic sys-
tems.
The impact on cell physiology can change if surfactants are
used to solvate monoterpene compounds before they are added.
Due to their low aqueous solubility, monoterpenes are commonly
administered in biological cultures via emulsifying agents, such as
Tween 80 and dimethylformamide (DMF) (8, 17, 64). Because of
their amphiphilic nature, surfactants and cosolvents change the
interfacial properties at the oil-water interface (65, 66). The result
is the formation of micelles, with monoterpene-rich interiors and
watery exteriors (65–67). In a recent study, a limonene-Tween 80
solvent mixture caused membrane deterioration and upregula-
tion of ergosterol biosynthesis in yeast (64). These authors found
that exogenous ergosterol addition enhanced tolerance (64). In
our study, no cosolvent was used; limonene exposure caused no
upregulation of ergosterol biosynthesis (see Fig. S4 in the supple-
mental material) or damage to the membrane (Fig. 1). Further-
more, growth did not improvewith ergosterol supplementation in
this work (see Fig. S5 in the supplemental material), but we did
observe changes in the dose response when Tween 80 was used as
a cosolvent compared to limonene alone. At a constant limonene
concentration (107 mg/liter), the limonene-Tween 80 mixture
caused no growth disturbance, while limonene without Tween 80
caused growth to cease (see Fig. S6 in the supplemental material).
While Tween 80 is nontoxic to yeast cells (68), there are clearly
multifunctional effects at play when surfactants and toxic solvents
are used simultaneously. A detailed mechanism of cosolvent ef-
fects on microorganisms is unknown. However, the introduction
of cosolvents with hydrophobic compounds, such as monoter-
penes, may facilitate more favorable interactions or access of mi-
celle fluid structures with biological membranes, which has been
reported for some common detergents (69). Variations in exper-
imental conditions, such as the type of surfactant used and the
surfactant concentration, may explain the differences in inhibi-
tory concentrations and mechanistic conclusions found in most
monoterpene toxicity studies. Nevertheless, the ultimate goal is to
develop yeast strains that producemonoterpenes endogenously in
the absence of specialized surfactants. Therefore, understanding
the physiological impact of limonene alone was of particular in-
terest in this work.
In conclusion, microbial synthesis of monoterpene products
will not be viable unless the toxicity issue is solved. In order to
engineer tolerant strains successfully, a greater understanding of
the mechanism causing inhibition is first required. While monot-
erpene inhibition has long been attributed to the disruption of
membrane properties (17–19), this is the first study in S. cerevisiae
demonstrating thatmonoterpene toxicity is not due tomembrane
deterioration. Increasing membrane rigidity through changes in
fatty acid content or by actively pumping monoterpene com-
pounds from the cell (46)was not found to increase tolerance.Our
results underscore the position thatmonoterpene inhibition is not
at the molecular level (e.g., membrane interference effects) (3)
and that the mechanism of action must stem from the physical
interaction between an insoluble monoterpene phase and the sur-
face of a cell. To this end, we have demonstrated here that limo-
nene can alter the properties of yeast cell walls while triggering a
compensatory transcriptional response to cell wall damage. Our
data indicate chitin, a critical cell wall component, to be a primary
target for limonene action, but the exact mechanism remains un-
clear. This study reveals that the development of monoterpene-
resistant yeast strains will most likely not require alterations to the
plasma membrane. Instead, the presented work suggests that
strategies that focus on maintaining cell wall integrity and cell
surface properties are likely to be more useful targets for strain
improvement in the future.
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Chapter 4 
 
Evolutionary engineering improves tolerance towards replacement jet 
fuels in yeast 
 
Chapter 4 is in final preparation to be submitted to the Proceedings of the National 
Academy of Sciences of the United States of America. 
 
TCRB, JK and LKN designed the experiments. TCRB carried out the experiments and 
analysis. TCW designed the molecular engineering experiments and carried the molecular 
engineering experiments. BS, TCRB designed the cell wall proteomics experiment. TCRB, 
JK and LKN wrote the paper. 
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Abstract: Monoterpenes are liquid hydrocarbons that can serve as immediate precursors 
for replacement jet fuels. Microbial production of next-generation fuels, including 
monoterpenes and other isoprenoids, continues to be a major focus of R&D efforts 
worldwide. However, monoterpenes are toxic to microorganisms, presenting a major 
challenge for microbial synthesis. Here we subjected the wild-type (WT) yeast strain 
(S288C) to approximately 200 generations of limonene-challenged laboratory evolution. 
Eight strains were isolated across the evolutionary time course and whole-genome 
resequencing revealed two key loci targets for engineering tolerance (PDR3, TBC3). 
Genomic reconstruction in the ancestral strain recovered the evolved phenotype improving 
limonene fitness by nine-fold. The data show that the limonene-tolerant phenotype is 
exclusively caused by a single point mutation in TCB3, which results in a truncated version 
of Tcb3p1-989 (tTcb3p). The tTcb3p strain also showed tolerance improvements (11- and 8-
fold) towards two other monoterpenes (β-pinene and myrcene) and a 4-fold improvement 
for the biojet fuel blend AMJ-700t (10% cymene, 50% limonene, 40% farnesene). To date, 
these are the highest reported concentrations of monoterpenes tolerated by 
Saccharomyces cerevisiae, a major catalyst in the biotech industry. This is a key initial 
step towards the microbial synthesis of monoterpene-derived jet fuels and towards 
revealing new biological functions for tricalbin proteins (TCB1/2/3). Collectively, elevated 
tolerance due to tTcb3p can now be used to pursue the microbial production or catalysis of 
a class of compounds ─ C10 alkenes ─ that due to their inherent toxicity, have halted 
research efforts for decades. 
 
Key words: evolutionary engineering, genome resequencing, tolerance engineering, 
hydrocarbons, monoterpene, jet fuel, Saccharomyces cerevisiae 
 
Introduction 
 
The first synthetic aviation fuel came from extracting liquid oil from coal. The German 
chemist Freidrich Bergius, developed this technique in 1913 and it later provided nearly all 
of Germany’s aviation gasoline in World War II 1. Shortly after WWII, as energy security 
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concerns escalated in the origins of the Cold War, the U.S. Interior Department called for 
another Manhattan project to pursue synthetic fuel research based on the Bergius process 
2. After four years of pilot-scale demonstration it was estimated that synthetic fuels from 
shale would cost nearly three and a half times that of conventional gasoline 2. In 1953 the 
program was terminated. In their final report, the National Petroleum Council concluded 
that further advances in technology were absolutely required in order for synthetic fuels to 
compete economically with petroleum products 3. Over half a century later, we find 
ourselves faced with the same problem: how do we make alternative fuels affordable? 
 
In the last decade, engineering microbial cell factories that convert renewable biomass into 
replacement liquid transportation fuels has gained global attention as a route to mitigate 
environmental and energy concerns 4, 5. Producing more than 60 million tons of beer and 
30 million tons of wine annually, S. cerevisiae is the industries oldest and most widely 
used biocatalysts today 6. The products that can be synthesized by engineered microbes, 
including baker’s yeast, are rapidly changing 7-12. The revolution in modern synthetic and 
systems biology has equipped researchers with numerous tools (e.g., omics technologies) 
to exploit the metabolic capabilities of microorganisms more than ever 13-16. As a result, 
new petroleum-compatible hydrocarbons (e.g., farnesane 17, bisbolane 18, limonane 19) 
have emerged, as researchers are no longer limited to targeting traditional fermentation 
products such as bioethanol.  
 
Monoterpenes are a class of isoprenoids that share a common ten-carbon (C10) backbone 
derived from two five-carbon (C5) isoprene units 20. Traditionally used in the flavour and 
fragrance industry, monoterpenes, such as d-limonene, are now being sought after as 
potential chemopreventive agents 21, 22 and precursors for light end components of “drop-
in” jet fuels 23, 24. Due to their structural complexity, chemical synthesis and extraction of 
isoprenoids from biological tissues suffer from low yields, impurities and high-cost 25. 
Microbial synthesis offers an alternative route 8, with the ability to convert monomeric 
sugars into a variety of enantiomerically pure monoterpene products 26, 27. Limonane, is a 
monocyclic paraffin that matches and has improved physicochemical properties (e.g., < -
70°C freezing point) compared to traditional kerosene-based aviation fuel (Jet-A) 28. In a 
demonstration flight in June 2012, Amyris, Inc. showed that their biojet fuel (AMJ-700) met 
engine performance requirements while requiring no aircraft modifications 29. In addition to 
meeting engine and fuel specifications, AMJ-700, which contains a mixture of 50% 
limonane (C10 cycloparaffin), 10% cymene (C10 aromatic) and 40% farnesane (C15 
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branched chain paraffin), could also reduce greenhouse-gas emissions by 82% compared 
to traditional jet fuels 30.  
 
Monocyclic paraffins, such as limonane, are critical for meeting the strict performance 
requirements for Jet-A aviation fuel 28. Limonane can be produced directly from a range of 
biologically-synthesized monoterpene precursors (e.g., limonene, terpinene, terpinolene, 
pinene) after a single hydrogenation step, which is required to reduce monoterpenes 
double C-C bonds 28. Although synthesis of monoterpenes in yeast is still in the 
developmental stages 28, 31, 32, farnesene (a C15 sesquiterpene), uses the same precursors 
in the cell and is currently produced for diesel markets 17, indicating the potential for 
commercial-scale jet fuel production. The limitation is, however, that monoterpenes are 
highly toxic to host engineering platforms (e.g., in S. cerevisiae, limonene stops growth at 
60 mg/l 19). Maximizing titers is an absolute requirement for producing biofuels that can 
compete economically with traditional petrochemicals 33. End product inhibition negatively 
impacts production parameters such as yield, titer and rate. Therefore, toxicity is the most 
critical problem facing microbial monoterpene synthesis.  
 
The antimicrobial action of monoterpenes remains poorly understood. Without detailed 
knowledge of the specific mechanism(s) responsible for monoterpene inhibition, rational 
forward engineering approaches are limited 34. In the last decade, adaptive laboratory 
evolution (also termed ‘reverse engineering’) has proven to be a successful technique in 
the field of microbial biotechnology 35, 36 [reviewed in 37, 38]. This non-targeted approach 
builds a desired phenotype from the bottom-up 35, offering advantages over forward 
engineering in that no extensive knowledge of inhibition, biochemical pathways, gene 
regulation or complex physiological responses are required in the initial plan 34. Once a 
tolerant strain has been isolated, today’s high throughput technologies (for example 
genome resequencing and ome analysis) can then be used to help understand the 
molecular basis for the improved phenotype 14, 38, 39. Coupling reverse and foreword 
engineering methods has been successful in the development and characterization of 
variety of industrially important microorganisms and products 37, 40, 41. However, these 
efforts have primarily focused on alcohol 40, 42, 43  and organic acid 44, 45 tolerance. Unlike 
these compounds, which have been studied extensively in both bacteria and yeast 46, 
monoterpenes are an emerging class of products that elicit unknown modes of inhibition 
and stress to microorganisms. Identifying resistive mechanism(s) is an essential 
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prerequisite for rationally engineering strains capable of producing monoterpene products 
beyond their inhibitory limits.  
 
Here we used evolutionary engineering to isolate a superior yeast phenotype, with the 
objective to gain insight into the mechanism(s) behind monoterpene toxicity and to identify 
genetic targets for engineering tolerance. The evolved strains are able to withstand 
several-fold higher concentrations of toxic monoterpenes compared to the un-evolved 
strain. Whole-genome resequencing identified a set of key mutations and these loci targets 
(PDR3 and TCB3) were reconstructed in the WT. The evolved tolerant phenotype was 
successfully recovered upon the introduction of these mutations into the parent strain. 
These beneficial mutations can now assist strain engineers in the development of robust 
microorganisms with a greater capacity to tolerate monoterpenes during fermentation or 
biocatalysis in S. cerevisiae 
 
Materials and Methods 
 
Strains, media and chemicals 
 
The Saccharomyces cerevisiae strain S288C (MAT_ SUC2 gal2 mal mel flo1 flo8-1 hap1) 
was provided by the Australian Wine Research Institute (AWRI), Adelaide, South Australia, 
Australia. Analytical-grade quality (e.g., d-limonene (93%)) was purchased from Sigma-
Aldrich for all solvents tested. Unless otherwise noted, synthetic media (CBS) consisted of 
2 g/l sucrose, 5 g/l (NH4)2 SO4, 3 g/l KH2PO4, 0.5 g/l MgSO4·7H2O, and vitamins and trace 
metals described in 19. YPD solid medium consisted of 10 g/l yeast extract, 10 g/l 
polypeptone and 20 g/l sucrose. LM is YPD medium containing 300 mg/l limonene. 
Limonene is insoluble in water at the described concentration so a WT plate was used as 
a control and we assumed the system was well mixed on solid plates.  
 
Evolution by serial batch passages 
 
Adaptive evolution was employed using serial batch passaging during increased limonene 
exposure. The parent strain (S288C) was transferred from a glycerol stock stored at -80°C 
and grown on solid YPD medium at 30ºC. A single isolate of the parent strain was used to 
inoculate 10 ml of CBS media and this pre-culture was grown overnight until the mid-
exponential growth phase. The appropriate volume from the pre-culture was used to 
47
inoculate 22 ml of CBS media to a target OD660 = 0.2. The initial volume of limonene 
added to the culture at inoculation was 1.0 µl (38 mg/l). Limonene was directly added to 
the culture aseptically using a 10 µL glass-syringe (Gerstel, Mulheim, Germany) 
immediately after inoculation. The culture was then incubated at 30°C at 200 rpm (Orbit 25 
mm, Multitron, Infors, Bottmingen, Switzerland) in 250 ml Teflon™-lined screw-top baffled 
shake flasks until the cell density reached mid-exponential phase (OD660 ~ 1-2, 
corresponding to approximately 4 doubling times) before they were transferred. For the 
next round, the appropriate volume of the previous limonene-challenged culture was used 
to inoculate fresh medium (22 ml) to a target OD660 = 0.2. After several transfers (2-4) at a 
given limonene load, the amount of limonene was increased (between 0.2 – 0.5 µl of 
additional limonene). After 52 daily sequential passages the final limonene load was 5.8 µl 
(222 mg/l). After each passage, 0.5 ml of culture was added to 0.5 ml of 40% v/v glycerol 
solution and the samples were stored at -80°C.  
 
Screening mutants 
 
Mutants were first screened by streaking frozen glycerol stocks out onto solid LM medium 
plates. The largest single colonies (8-12) were then subjected to a second competitive 
growth screen in liquid CBS medium containing 95 mg/l of limonene. Isolates were pre-
cultured in CBS medium (10 ml) overnight at 30ºC (200 rpm) and the appropriate volume 
of the pre-culture was used to inoculate 22 ml of CBS to an OD660 = 0.15 in 250 ml 
Teflon™-sealed screw-top shake flasks. Then 2.5 µl of limonene was added immediately 
after inoculation and growth was monitored for 12 h using a Libra S4 spectrophotometer at 
660 nm. The mutant with the highest specific growth rate was chosen for tolerance testing.  
 
Tolerance test 
 
The evolved and un-evolved strains were evaluated for resistance to each toxic compound 
as described in 19. Briefly, cultures were grown until mid-exponential phase (~ OD660  = 1.0) 
and then dosed with varying amounts of solvent. The optical density was evaluated for the 
ensuing 6 h. The minimum inhibitory concentration (MIC) is defined as the amount of 
solvent required to inhibit the specific growth rate by approximately 50% compared to that 
of the control strain with no solvent present. In some cases, 3.6 µl (138 mg/l) of limonene 
was added to the innoculum (22 ml at OD660  = 0.2) and growth was monitored as 
described above. The ratio of the OD660 at 12 and 0 h was used as a relative fitness metric 
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for solvent tolerance as described in 40. CBS media containing 5 g/l sucrose was used in 
all tolerance tests. All tolerance tests were performed in biological triplicate for each 
compound and strain. 
 
Solvent recovery and cell viability  
 
After 12 h of limonene exposure, 1 ml of dodecane was added to the culture, vortexed for 
1 min and the mixture was transferred to a sterile 50 ml falcon tube. The suspension was 
then harvested for 5 min (5,000 rcf) and the top dodecane-solvent layer (1 ml) was 
transferred to a glass vial and stored at -20°C for later analysis. To calculate recovery, the 
ratio of the final solvent amount (determined by GC-MS) at the end of 12 h culture, was 
compared to the solvent amount recovered under identical conditions but in the absence of 
cells. All data was performed in triplicate. 
 
DNA isolation 
 
All strains were isolated according to 47 with the following modifications. A total of 5 ml of 
culture was harvested at mid-log (OD ~ 3) (16,000 rcf, 25°C), washed twice with distilled 
water, pelleted, and resuspended in 800 µl of lysis buffer (1% SDS, 50 mM EDTA, 0.1 M 
TrisHCl, pH 7.5)). The suspension was then transferred to FastPrep screw cap tubes 
containing 1 g of 0.5 µm acid washed beads and 100 µl of 5 M NaCl. To lyse the cells, four 
cycles of 30 s with 1 min on ice in between cycles was carried out in a mechanical bead 
beater (John Morris Scientific, Pty Ltd.). The suspension was then harvested (16,000 rcf, 
4°C) for 15 min, and the resulting clear liquid (roughly 800 µl) was transferred to new 1.5 
ml extra-clean tubes (Mo Bio). 777 µl of chloroform isoamylalcohol (24:1) was then added 
and incubated at 25°C for 30 min with gentle rocking. The mixture was then pelleted for 15 
min (16, 000 rcf, 25°C) and the top, aqueous layer was transferred to a new extra-clean 
tube and mixed with 70% v/v isopropanol and centrifuged (16,000 rcf, 25°C) for 6 min. The 
isopropanol suspension was decanted and the pellet was resuspended in 70% ethanol. 
The ethanol suspension was centrifuged (16,000 rcf, 25°C) for 6 min and the pellet was 
allowed to dry for 45 min. The pellet was then resuspended in 50 µl of DNA and RNA-free 
water containing 100 μg/ml RNAse A and incubated at room temperature for 30 min.  
 
Genome sequencing 
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Paired-end (100 bp) genomic DNA libraries were generated using TruSeq DNA Sample 
Preparation Kits according to the manufactures instructions (Illumina, San Diego, CA, 
USA). Whole genome re-sequencing was performed by the Queensland Centre for 
Medical Genomics (Institute for Molecular Bioscience, University of Queensland, Australia) 
using an illumina HiSEQ 2500 system  (HiSEQ Control Software 2.0.5, RTA 1.17.20) 
following the standard rapid sequencing workflow of cluster generation and sequencing by 
synthesis. Initially libraries were loaded onto an illumina cBot instrument for template 
hybridization and initial extension steps using the TruSEQ Rapid Duo cBot Sample 
Loading Kit (cat# CT-402-4001). Flowcells were then moved to the HiSEQ 2500 
instrument to complete cluster generation and sequencing using TruSeq Rapid Cluster Kit 
- Paired-End (cat# PE-402-4001) and TruSeq Rapid SBS Kits – 200 Cycle (cat# FC-402-
4001) following the manufacturer’s publications. Samples were loaded at a concentration 
of 6pM and a total of 209 cycles of sequencing were completed consisting of 2x 101bp 
reads and a single 7bp index sequence.  
 
For mutation analysis, the default settings in Bowtie2 48 were used in the alignment. The 
input paired end reads (101 bp) were trimmed based on quality (3 bases from the start and 
23 bases from the end) to produce 75 bp reads for each sample. The results from the 
mapping were used to identify single nucleotide polymorphisms (SNPs) and insertions and 
deletions (INDELS) between the mutant and reference strain and alignments were viewed 
using the Integrative Genomics Viewer (IGV) software 49. SNPs and INDELS were filtered 
using a Phred-like consensus quality >30 and for SNPs, the coverage depth was ≥ 10. For 
INDELS, some INDELS were filtered out if the number of reads with INDELS was less 
than the number of reads without INDELS. Annotation and prediction of the effects caused 
by the mutations was carried out using the program SnpEff 50. The data was run against 
the ensemble build (EF4.68) of the S288C reference genome and used as input in the 
SnpEff database. 
 
Genomic reconstruction 
 
Introduction of the mutations, PDR3 (Q763L) and TCB3 (frame shift at 989), into the 
background strain (WT) was carried out using the recyclable dominant marker cassette 
amdSYM described in 51. The details of the construction and primers used can be found in 
the supplemental material. A gain-of-function assay was performed for all reconstructed 
strains. As described above, the relative fitness towards limonene, cymene, β-pinene, 
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myrcene and AMJ-700t was investigated for the WT, evolved (TB516) and reconstructed 
strains.  
 
Fluorochrome staining and flow cytometry 
 
For WT and single mutant (tcb3-989) strains, cell viability and cell wall damage were 
assessed using the vital staining dye propidium iodide (PI) and cell wall binding dye 
calcofluor white (CFW). Briefly, cells were treated with an inhibitory amount of limonene 
(115 mg/l) during midlog growth phase (20 g/l CBS media). After 2 h of treatment, cell 
viability (described in 19) and cell wall staining (described in 52) were tested in biological 
triplicate.  
 
Transcriptomics 
 
Total RNA was isolated from single mutant (tcb3-989) cultures during mid-exponential 
growth phase. For control (no limonene) and limonene challenged cultures (107 mg/l) 
approximately 10 ml of culture was quickly pelleted (17,572 rcf x g) for 2 min at 4°C and 
then immediately resuspended in 2 ml of RNAlater® solution (Life Technologies, Carlsbad, 
CA) and stored at 4°C. The RiboPure-Yeast kit (Ambion, Life Technologies, Carlsbad, CA) 
was used for total RNA extraction according to manufacturer’s instructions except bead 
beating was used to lyse the cells described in 52. The RNA quality was assessed using an 
Agilent 2100 Bioanalyzer and RNA 6000 Nano kit according to manufacturer’s methods 
(Agilent, Santa Clara, CA). For the microarrays (Affymetrix yeast genome 2.0), sample 
labeling and hybridization was performed at the Ramaciotti Centre for Gene Function 
Analysis (University of New South Wales, Sydney, Australia). Analysis of differentially 
expressed genes and gene set analysis (GSA) was carried out in R using the default 
values in Piano 53. All data was performed in biological triplicate. 
 
Cell wall proteomics 
 
The total cell wall extracts were isolated for WT and single mutant (tcb3-989) cultures 
during mid-exponential growth phase. Cultures were inoculated to a starting OD660 = 0.1 in 
22 ml of CBS (5 g/l sucrose) and allowed to grow until OD660 = 1.0 in the absence and 
presence of limonene challenge (107 mg/l). Approximately 20 ml of culture was pelleted 
(4,025 X g for 5 min at room temperature), washed with sterile water, snap frozen and 
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stored at -80°C. Cell wall protein extraction followed the method described in 54. Briefly, 
yeast cells were lysed with a bead beater, insoluble cell wall material was stringently 
washed, N-glycans were released with EndoH and deglycosylated proteins covalently 
linked to the cell wall polysaccharide were digested with trypsin. Peptides were desalted 
with C18 ZipTips (Millipore) and detected by LC-ESI-MS/MS with a Prominence nanoLC 
system (Shimadzu) and TripleTof 5600 mass spectrometer with a Nanospray III interface 
(AB SCIEX). For information dependent acquisition (IDA), analyses were performed as 
described (Bailey et al 2012 J Prot Res). Identical LC conditions were used for SWATH-
MS, with an MS-TOF scan from an m/z of 350-1800 for 0.05 s followed by high sensitivity 
information independent acquisition with 26 m/z isolation windows with 1 m/z window 
overlap each for 0.1 s across an m/z range of 400-1250. Collision energy was 
automatically assigned by the Analyst software (AB SCIEX) based on m/z window ranges. 
Proteins were identified from IDA data using ProteinPilot (AB SCIEX) as described (Bailey 
et al 2012 J Prot Res). False discovery rate analysis using ProteinPilot was performed on 
all searches. Peptides identified with greater than 99 % confidence and with a local false 
discovery rate of less than 1 % were included for further analysis. S. cerevisiae cell wall 
proteins identified in this discovery data were used as the spectral library for analysis of 
SWATH MS/MS data using the SWATH processing script within PeakView 1.2 (AB 
SCIEX). Fragment ion peak area was used for quantification. The software package 
MSstats 55 was used for statistical analysis in R. Statistical significance cutoff was set at p 
< 0.05. All data was performed in biological triplicate. 
 
 
Results 
 
Evolved mutants show improved tolerance towards limonene 
 
Serial batch passaging was used to isolate limonene-tolerant yeast strains. The WT strain, 
S288C, underwent 52 daily sequential transfers under limonene stress. The limonene load 
increased from 38 mg/l to 222 mg/l. Tolerant strains were isolated and tested for limonene 
tolerance at different time points during the adaptive evolution process. Four strains were 
isolated between 80-190 generations and 4 strains were isolated at 200 generations. Two 
tests were used to demonstrate the improvement in fitness. The MIC and relative fitness 
were measured for each strain and compared to the WT [Fig 1 and Table 1 (MIC) and Fig 
2 (relative fitness)]. All of the evolved strains showed at least a 1.9-fold improvement in the 
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MIC (Table 1) and at least a 4-fold improvement in the relative fitness for limonene (Fig 2). 
The maximum relative fitness score (10.9 ± 1.6) was achieved at 120 generations (strain 
TB302) and did not significantly improve for later generations (160-200 in Fig 2). For all 
strains and all tolerance tests, cell viability remained above 95% after 12 h of fermentation 
(data not shown). These results show that adaptive evolution employing serial batch 
transfer under constant limonene challenge was successful for isolating limonene-tolerant 
phenotypes.  
 
In addition, in order to rule out whether or not the evolved strains were metabolizing or 
converting limonene to undesirable products internally, we recovered limonene after the 
fermentation and analyzed it via GC-MS. For all of the evolved and WT strains, all of the 
limonene was recovered and no side products were detected (Table S1). This 
demonstrates that no significant loss or biocatalytic transformation occurred during 
fermentation.  
 
Identification of key mutations by whole-genome sequencing 
 
Whole-genome resequencing was used to identify mutations in the eight isolated strains 
and their genomes were compared with that of the parent strain, S288C. A summary of the 
sequencing results are listed in Table S1 and the key mutations for each strain are listed in 
Table 1. Both high quality mapping (≥ 98%) and coverage (≥ 100x) of the genome 
sequences were achieved for the evolved strains. After filtering, approximately 30-40 total 
mutations were found per strain (Table S1). Roughly 2-10 SNPs were identified for the 
evolved mutants and several of them were found in coding regions. The rest of the 
mutations were INDELs and the majority of these were in non-coding regions (Table S1). 
The key mutations are listed in Table 1 along with the relative fitness scores in Fig 2. At 84 
generations (strain TB21 in Fig 2), a single SNP in the PDR3 gene showed a 2.7-fold 
improvement in limonene fitness. A mutation in transcriptional activator of the pleiotropic 
drug resistance network, PDR3, was found in every subsequent strain after 83 generations 
(Fig 2). Interestingly, the location of the SNP changed across the evolutionary time course. 
At 84 generations (strain TB21) the SNP was located at Q962F, at 160 (TB 405) it was 
located at Q763L and at 188 (TB478) the SNP was at G948S and then back to Q763L for 
all four strains isolated at 200 generations (Table 1). We chose PDR3 (Q763L) as a target 
for engineering because this SNP was present in 6/7 mutants that achieved the maximum 
fitness score (~ 10 in Fig 2).  
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 The second mutation and gene of interest was TCB3. Three tricalbin (calcium and lipid 
binding domains) proteins exist in yeast, which are encoded by genes TCB1,-2,-3. Two of 
these genes (TCB2, TCB3) were found to be mutated in this study. TCB2 was mutated in 
one strain, along with PDR3, at 120 generations. This strain (TB302) achieved the 
maximum relative fitness (score of ~ 10) harboring only these two mutations (Fig 2). A 
mutation in TCB3 (frame shift at amino acid position 989), however, was found in the six 
subsequent strains, all of which resulted in maximum fitness scores (Fig 2). Therefore 
TCB3, rather than TCB2, was chosen as a target for engineering.  
 
Genomic reconstruction of the limonene-tolerant phenotype  
 
We next constructed single- and double- mutations in the WT for PDR3 (Q763L) and 
TCB3 (frame shift 989) genes and investigated their relative fitness in a gain-of-function 
assay. The single base change in pdr3-763 showed no significant (p < 0.05) improvement 
in fitness compared to the WT (Fig 3). The frame shift mutation in tcb3-989, however, 
increased limonene fitness by 9-fold and showed no statistical difference in fitness 
compared to the evolved strain (Fig 3). This data revealed that the mutation TCB3 was the 
major contributor to limonene tolerance. The double mutant, pdr3-763 and tcb3-989, 
resulted in a relative fitness score of 11.5 ± 0.5, which is also statistically (p < 0.05) not 
significant compared to the fitness score achieved by the evolved mutants (Fig 3). In 
addition, because the mutation in TCB3 caused a truncated version of Tcb3p, we 
questioned whether this mutation resulted in a nonfunctional protein. To test this, we used 
a non-functional version of TCB3 where the ORF was replaced by the amdSYM marker in 
the single mutant strain tcb3-989. The knock-out TCB3 strain showed no resistance to 
limonene and matched that of the WT fitness (∆tcb3 in Fig 3). This clearly demonstrates 
that the evolved Tcb3p is indeed a functional protein and that the limonene-tolerant 
phenotype is exclusively caused by this single mutation. 
 
It was recently demonstrated that a truncated version of Tcb3p, containing 491amino 
acids, can co-localize in the perinuclear endoplasmic reticulum (nER) and the cortical ER 
(cER), whereas the full Tcb3p protein resides exclusively in the cER 56. We questioned if 
limonene resistance was associated with this dual localization property. Shown in Fig 3., a 
similarly truncated version of Tcb3p1-531 resulted in limonene tolerance. While the exact 
protein length shown here is not the same (531 vs. 491) as described by Manford et al. 56, 
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this data strongly indicates that limonene resistance is linked to Tcb3p’s ability to reside in 
the perinuclear ER. 
 
Changes to the cell wall transcriptome, proteome and cell wall integrity 
 
A recent study showed that limonene can damage the cell wall 52. We questioned if the 
mutated Tcb3p protein caused global regulatory and cell wall protein composition changes 
during limonene stress.  The total number of differentially expressed genes (upregulated = 
24, downregulated = 5) was substantially lower for mutant cells compared to the WT 
during limonene stress (Table S3). This is most likely due to the large number of regulated 
genes associated with growth defects in the WT 52. The mutant showed very small 
perturbations to growth when challenged with limonene and thus the smaller gene list was 
not surprising (Fig. S2). Roughly 30% of the upregulated gene list (Table S3), however, 
was associated with cell wall maintenance. Several genes involved in iron ion homeostasis 
were also upregulated (SIT1, HMX1, ARN1, FRE5, TIS11), this response was similarly 
observed for WT treated cells 52. 
 
We were particularly interested in the impact tTcb3p had on cell wall integrity regulation 
and cell wall protein abundance during limonene shock. Shown in Fig 4, the CWI signalling 
pathway, which was highly upregulated in the WT 52, was not induced in mutant cells. 
Limonene stress induced ECL1, SMP1, TIR2, and YPL277C in the mutant but not in the 
WT and only three upregulated genes were shared between both strains (YGP1, FIT2, 
FIT3). Differences between the cell wall protein profiles were also observed. For untreated 
cells, Ygp1p was the only protein induced in the mutant compared to the WT (Table S3). 
The cell wall proteins Plb1p, Plb2p, Ecm33p, Tos1p, Cis3p and Uth1p were found to be 
lower in abundance in the mutant vs. the WT (Table S3). During limonene challenge, cell 
wall proteins Pbl2p, Cis3p, Yps7p, and Ccw14p were induced in the mutant but absent in 
the WT. Gas3p was the only common regulated cell wall protein found (Fig 4). Taken 
together, these data demonstrate that both the TCB3 mutation and limonene affect protein 
secretion or cell wall biosynthesis, but in different ways. The mechanistic understanding of 
this, however, is still unresolved. 
 
We next wanted to test if these different regulatory responses resulted in changes in cell 
wall integrity. CFW was used to test if limonene-treated cells were hypersensitive to the 
cell wall binding probe. Cells with higher MFI showed higher sensitivity and shift in 
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fluorescence vs. non-damaged cells (Fig 5). Shown in Fig 5 (b and c), ~ 60% of WT cells 
showed substantial cell wall damage after limonene treatment. This was a ten-fold 
increase in number of damaged cells compared to the untreated control (6% in Fig 5b). 
Alternatively, the mutant cells, harboring the single mutation in Tcb3p, showed a much 
smaller change in sensitivity to CFW after limonene treatment [approximately two-fold 
increase in number of cells damaged (24% vs. 11%, Fig 5e and f)]. These results 
demonstrate that the tTcb3p protein has the ability to preserve cell wall integrity during 
limonene treatment.  
 
Tolerance towards other terpenes  
 
Finally, we investigated if the improved phenotype could be applied to solvents other than 
limonene. The single mutation in TCB3 (tcb3-989) resulted in substantial increases in 
fitness towards β-pinene and myrcene compared to the WT (11- and 8-fold in Fig 6). 
These data matched or improved the fitness compared to the evolved strain (TB516 in Fig 
6). The reconstructed mutant showed no fitness increase for the aromatic monoterpene 
cymene. In addition, both evolved and reconstructed strains showed at least a 4-fold 
improvement in fitness towards the biojet fuel blend AMJ-700t (Fig 6). AMJ-700t contains 
by volume 50% limonene, 10% cymene and 40% farnesene. This fuel blend is different 
than AMJ-700 in that contains the olefin precursors (cymene, limonene and farnesene) 
that are produced via yeast fermentation. In order to be used as “drop-in” jet fuels, 
limonene and farnesene are chemically processed into the paraffins limonane and 
farnesane (termed AMJ-700) 28. Taken together, this data demonstrates that by 
introducing the single mutation in TCB3 described here, one can achieve increased 
resistance to a range of monoterpenes and the biojet fuel precursor blend AMJ-700t.  
 
Discussion 
  
Product toxicity is the major limitation for the fermentative production of monoterpenes in 
yeast. In an effort to alleviate monoterpene toxicity in S. cerevisiae, rational forward 
engineering strategies  ̶  involving pumping monoterpene products, such as limonene, out 
of the cellular membrane  ̶  have failed 57. This result highlights one of the limitations 
behind forward engineering methods. In order to solve problems successfully, the problem 
itself needs to be initially well defined. Monoterpene toxicity in microorganisms is poorly 
understood. Monoterpene inhibition in yeast has long been attributed to membrane 
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interference due to its lipophilicity (log P = 4.5). However, recent reports demonstrate that 
limonene has no deleterious effects to membrane integrity or composition and were 
described to cause defects in the cell wall 52. These differences may be due to the use of 
polar aprotic cosolvents (e.g., Tween 80 or dimethyl formamide (DMF)), which are 
commonly used to solvate monoterpenes before administering them into cultures 52. 
Nevertheless, alternative strategies ̶ that do not rely on an initial mechanistic 
understanding of inhibition  ̶are required for strain improvement.  
 
In this study, we used evolutionary engineering to isolate resistant yeast phenotypes. 
Adaptive evolution employing serial batch passaging resulted in strains with improved 
fitness towards limonene (Fig 2). Genome resequencing across the evolutionary time 
course allowed for a spatiotemporal representation of the environmentally selected 
mutations. The mutations in the transcription factor PDR3 were in every evolved strain (Fig 
2). Interestingly, the SNP location changed during evolution (Table 1). The fact that PDR3 
was mutated in three separate locations during evolution lends the suggestion that this 
activator was important to resistance. However, given the evidence that overexpression of 
ABC transports failed to improve limonene tolerance 57, we did not expect PDR3 to be a 
major player. This was indeed the case, genomic reconstruction of the Q763L mutation in 
the WT showed no fitness improvement (Fig. 3). 
   
TCB3 was mutated in all of the evolved strains with maximum fitness scores (Fig 2). A 
mutation in TCB2 was also found early on (120 generations, strain TB302 in Fig 2.). By 
exclusion, the fact that the mutation in PDR3 (Q763L) resulted in no fitness improvement 
means that the TCB2 mutation was the sole contributor to tolerance in strain TB302, which 
achieved the maximum fitness score (Fig. 2). This suggests that the tricalbin [TRI (three) 
CA (calcium) L (lipid) BIN (binding)] 58 proteins Tcb1/2/3p play an important role in 
limonene resistance. We chose the mutation in TCB3, rather than TCB2, because it was 
found in the majority of the maximum evolved strains. Genomic reconstruction of tcb3-989 
in the WT revealed that the limonene resistant phenotype was exclusively caused by this 
single point mutation. The correlation of a genotype to phenotype is a complex problem 59. 
In budding yeast, no other report has ever described a single point mutation that confers 
tolerance towards next-generation biofuels.  
 
The question that remained was simple. How did tTcb3p relieve toxicity during limonene 
treatment and what else could we learn about the native Tcb3p function? We postulated 
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that limonene was interfering with ER inheritance at the bud site through chitin 
decrystallization and that the unique ability of tTcb3p to reside in the nER enabled cells to 
overcome this. Inheritance of the nER and cER have drastically different fates during the 
budding process 60. For the cER to be successfully inherited into the daughter cell, yeast 
use actin to move cER tublars along the major axis of the mother-bud axis 60, 61. The 
tricalbins (Tcb1/2/3) and other tether proteins (Ist2p) that exclusively localize to cER, are 
unable to diffuse naturally across the diffusion barrier caused by the septum ring at the 
mother-bud neck 56, 62. Therefore, mRNAs encoding for Tcb1/2/3 and Ist2 have to be 
transported as cargo via actin cables by myosin motor proteins such as Myo4p and She3p 
60, 61. Alternatively, inheritance of the nER takes place during mitosis and does not require 
actin but relies on the mitotic spindle to push the nER into the bud 60. Because the 
mutation at tcb3-989 enables tTcb3p to reside in the nuclear ER, pre-existing tTcb3p can 
be inherited directly from the mother cell. This allows tTcb3p to initially establish the cER in 
the newly formed bud without having to be transplanted by actin via cER inheritance. This 
mechanism would be in concert with a similar ER-PM tethering protein Scs2p, which 
resides in both the nER and cER, and is able to establish the cER in the newly formed bud 
in absence of the two other ER-PM tethering proteins (double mutant ∆ist2, ∆tcb1/2/3) 56. 
While we do show that limonene can disrupt cell wall chitin, future work is required to show 
the tTcb3p changes ER morphology and inheritance during limonene stress. 
 
Conclusion 
 
Solving the toxicity issue is key to the viable production of monoterpene-derived 
bioaviation fuels. Limonene toxicity in yeast is poorly understood and previous forward 
engineering approaches (e.g., transporters) have failed to improve resistance. This work 
used evolution engineering to identify genetic targets for engineering limonene tolerance in 
yeast. This study revealed a novel genetic mutation to confer limonene resistance in the 
truncation of the tricalbin protein Tcb3p. We showed that this mutation can rescue cells 
from cell wall damage during limonene challenge but the exact mechanism remains 
unclear. This may be due to the ability of tTcb3p to colocalize to the nER and the cER may 
be important in ER inheritance during limonene exposure. This is a key step towards the 
development of solvenogenic yeast strains with a greater capacity to tolerate toxic olefins. 
This study will hopefully aid biofuel strain engineers and molecular biologists in revealing 
new funcitons of tricalbins in the future.  
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Tables 
 
Table 1. Summary of limonene MICs and mutations for evolved strains 
 
Strain Ge
n 
MICa 
(mg/l) 
FC
b 
Mutation Gene Function 
WT 0 69 - - - - 
       
TB21 84 130 1.9 SNP (L962F) PDR3 Transcriptional activator of the 
pleiotropic drug resistance network 
       
TB30
2 
120 130 1.9 SNP (Q763L) PDR3 See above 
    INDEL (frame 
shift 316) 
TCB2 ER protein located in the mother 
and daughter bud, involved in ER-
plasma membrane tethering  
       
TB40
5 
160 122 1.8 SNP (Q763L) PDR3 See above 
    INDEL (frame 
shift 989) 
TCB3 ER protein located in the mother 
and daughter bud, involved in ER-
plasma membrane tethering 
    INDEL (frame 
shift 192) 
SNP (Q192G) 
TSA1 Thioredoxin peroxidase 
    SNP (D380H) UBP11 Ubiquitin-specific protease 
       
TB47
8 
188 150 2.1 SNP (G948S) PDR3 See above 
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    SNP 
(nonsense 
Q1197*) 
TCB3 See above 
    SNP (P790T) ARO80 Zinc finger transcriptional activator 
of aromatic amino acid catabolic 
genes 
    SNP (E718D) CPA2 Large subunit of carbamoyl 
phosphate synthetase, which 
catalyzes a step in the synthesis of 
citrulline, an arginine precursor 
    SNP (P195L) DID4 Protein of the ESCRT-III complex, 
required for sorting of integral 
membrane proteins into lumenal 
vesicles of multivesicular bodies, 
and for delivery of newly 
synthesized vacuolar enzymes to 
the vacuole, involved in 
endocytosis 
       
TB51
1 
200 138 2.0 SNP (Q763L) PDR3 See above 
    INDEL (frame 
shift 989) 
TCB3 See above 
    INDEL (frame 
shift 192), 
SNP (Q192G) 
TSA1 See above 
    SNP (W580S) KSP1 Serine/threonine protein kinase 
    SNP 
(nonsense 
Q1014*) 
PSE1 Karyopherin/importin that interacts 
with the nuclear pore complex 
    SNP (L84S) RPL30 Ribosomal 60S subunit protein 
       
TB51
6 
200 138 2.0 SNP (Q763L) PDR3 See above 
    INDEL (frame TCB3 See above 
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shift 989) 
    INDEL, SNP 
(Q192G) 
TSA1 See above 
    SNP (R159T) CDC34 Ubiquitin-conjugating enzyme, 
regulates cell cycle progression by 
targeting key substrates for 
degradation 
       
TB51
7 
200 145 2.1 SNP (Q763L) PDR3 See above 
    INDEL (frame 
shift 989) 
TCB3 See above 
    SNP 
(nonsense 
Q1014*) 
PSE1 See above 
    SNP (L84S) RPL30 See above 
       
TB51
9 
200 138 2.0 SNP (Q763L) PDR3 See above 
    INDEL (frame 
shift 989) 
TCB3 See above 
    SNP (G826R) SIP3 Transcription cofactor, acts through 
interaction with DNA-bound Snf1p 
    SNP (L127F) YMR10
2C 
Protein of unknown function 
a The minimum inhibitory concentration (MIC) is defined as the amount of limonene 
required to inhibit the specific growth rate by approximately 50% compared to growth rate 
with no solvent present for each strain. 
b Fold change (FC) is the ratio of the MIC for the evolved and WT strain. 
 
 
Figures 
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Figure 1. Growth of WT and evolved strain TB478 during limonene challenge. (a) Wild-
type (WT), (b) mutant TB478 challenged with various amounts of limonene during mid-
exponential growth. (c) Growth rate of WT and TB478 against increasing limonene load. 
Error bars represent one SD above and below the mean from biological replicates (n = 3).  
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Figure 2. Summary of the evolved strains’ relative fitness and genetic mutations. Each 
strain is a single isolate and the mutation in that strain are listed above. ReFlative fitness is 
defined as the ratio of the cell density (OD660) at 12 and 0 h during limonene exposure 
(138 mg/l). Error bars represent one SD above the mean for biological replicates (n = 3). 
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Figure 3. Relative fitness towards limonene for reconstructed mutations. Beneficial 
mutations in PDR3 and TCB3 were constructed in the parent strain (WT). Relative fitness 
is defined in Fig 2. Error bars represent one SD above the mean for biological replicates (n 
= 3). Significance was determined by one-way ANOVA to correct for multiple comparisons 
relative to the WT (****p < 0.001, ns, not significant; p < 0.05). 
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Figure 4. Cell wall transcriptome and proteome response during limonene stress (+/- 
limonene treatment). Venn diagram representing overlap and differences in cell wall gene 
expression (upregulated genes only) and protein abundance for WT and single mutant 
(tcb3-989) cells. Upregulated cell wall genes from the WT were used from Brennan et al. 
52. Upregulated genes (mutant) and cell wall proteins (WT and mutant) were analyzed in 
this study.  
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Figure 5. Histograms representing the variation in fluorescence emitted from WT and 
single mutant (tcb3-989) cells. (a and d) nonstained cells; (b and e) untreated control cells 
stained with CFW; (c and f) cells stained with CFW after 2 h of limonene treatment. Cells 
with damaged cell walls show an increase in sensitivity and fluorescence towards CFW. 
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The mean fluorescence intensity (MFI) and percentage of damaged cells (Pop %) are 
reported for biological replicates (n = 3, ± SD).  
 
 
Figure 6. Relative fitness towards other terpenes. WT, evolved (TB516), and the 
reconstructed WT (single mutant: tcb3-989) strains were subjected to relative fitness 
assays for β-pinene (198 mg/l), myrcene (361 mg/l), cymene (140 mg/l) and AMJ-700t 
(225 mg/l). AMJ-700t contains by volume (10% cymene, 50% limonene, 40% farnesene). 
Controls represent no treatment. Relative fitness is defined in Fig 2. Error bars represent 
one SD from the mean for biological replicates (n = 3). 
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Chapter 5: Discussion 
 Product toxicity is the limiting factor facing microbial monoterpene production. This 
thesis used multiple angles to address this issue. First, a better understanding of the 
actual mechanism(s) of action were required in order to begin developing viable strategies 
to overcome toxicity. Chapter 2 quantified exactly how much monoterpene was required to 
inhibit cell growth and provided a biochemical route to address toxicity in situ. This work 
led to the key distinction between phase and molecular toxicity, which was then further 
investigated using systems biology tools (e.g., transcriptomics) in Chapter 3. Chapter 4 
then described ALE as a tool to further understand toxicity mechanism(s) and provide 
gene targets for engineering tolerance in the future.   
 To be a viable substitute for a petroleum fuel, alternative fuels need to be produced 
in sufficient quantities. Currently, the endogenous production of monoterpenes in S. 
cerevisiae (1 g/l)1 are well below the titers required to be economically competitive in the 
transportation industry (~ 100 g/l). Monoterpenes are produced primarily via the 
mevalonate pathway, which has been studied extensively and are reviewed elsewhere 2-4 
(Fig 5.1). The success of monoterpene production will rely on the careful balance of 
pathway intermediates, redox cofactors and the control of the FPP synthase (controlled by 
the ERG20 gene) 2. FPPS is responsible for adding one C5 IPP unit to the growing C10 
GPP chain to make C15 FPP. The availability of GPP, the precursor for monoterpenes, for 
synthesis seems to be a key parameter for production because with the exception of a few 
wine strains, yeast does not produce GPP de novo 5, 6. GPP is not released from the FPPS 
active site and is primarily used for the formation of FPP. Tight control over the amount of 
GPP and FPP available for monoterpene production and cellular development is 
important. Monoterpene synthase (MTS) activity, which acts to cyclize the GPP to form the 
C10 monoterpene product, may also be critical area to focus on for strain improvement 2. 
The addition of a chaperone heat-shock protein (HSP90) improved production of cineole 
by 60%, suggesting that protein-protein interactions could augment MTS catalytic activity 
and productivity 1.  
 Several groups have reported much higher titers for monoterpene alcohols 
(monoterpenoids), such as geraniol (36 mg/l) 7 and cineole (1 g/l) 1, compared to 
monoterpene olefins such as limonene (1.5 mg/l) 8. Oxyfunctionalized monoterpenes, 
which contain epoxy or hydroxyl groups, most likely have very different physiological 
effects in baker’s yeast compared to monoterpene olefins. Differences in physio-chemical 
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properties (e.g., solubility) can drastically change the resulting impact a solvent has 
towards a microorganism 9. A clear distinction should be made between monoterpene 
olefins and monoterpene alcohols when discussing production constraints. Due to the 
oxygen moieties, the energy densities are lower for monoterpene alcohols compared to 
their olefin counterparts (e.g., ∆cH°limonane = 44 MJ/kg and ∆cH°cineole = 39 MJ/kg) 10, 11. 
Given the strict engine performance requirements for jet fuels 12, a product’s energy 
content should also be highly considered in the design of microbial biocatalysts.  
 Comparing the minimum inhibitory concentration for each monoterpene product 
across species is an important parameter when choosing a host platform for engineering. 
Production of monoterpenes in E. coli has been reported to be substantially higher than 
yeast. Alonso-Gutierrez et al. reported titers of around 400 mg/l for limonene 13. Although a 
strict experimental interrogation of the inhibitory limits of monoterpenes in E. coli has yet to 
be determined, there are clearly differences in mechanisms of inhibition between the two 
organisms. This most likely has to do with the differences in the cellular envelope 
organization. E. coli has two membranes separated by a periplasmic space 14 whereas 
yeast have a single membrane adjacent to a rigid and thick cell wall 15. The mass transfer 
rate of a limonene droplet from inside a cell, across the cellular envelope, and into the 
extracellular medium (or vice versa) will depend on the droplets membrane and cell wall 
partitioning behaviour. A rigorous, quantitative in vivo analysis of this phenomenon has yet 
to be completed for E. coli and yeast. Mass transport of monoterpenes in yeast is 
assumed to has be a passive diffusion process 16 and Ciamponi et al. demonstrated that 
the cell wall, rather than the plasma membrane, was the main determinate for limonene 
mass transfer 17. This was the first study highlighting that transport resistance may depend 
more on cell wall partitioning than membrane partitioning.  
 Even if the metabolic engineering community can overcome the various pathway 
and transport issues, product toxicity remains the primary limitation for monoterpene 
production. In order to find solutions to this problem, it is important to first know what the 
mechanism of toxicity is. This is the rationale of this thesis: if we can understand the 
precise mechanism(s) of toxicity, we can build better solutions.  
 In 1987, Rahael Bar published a seminal paper describing two classes of solvent 
toxicity for microorganisms: molecular and phase. Molecular toxicity is cellular inhibition 
caused by dissolved solvent molecules (e.g., interchelating into membranes and disrupting 
membrane function), whereas phase toxicity is inhibition caused by the presence of 
separate organic phase 18. Bar concluded that in order to systematically study the 
74
fundamental impact solvents exert on microorganisms, the two effects must be clearly 
distinguished from the beginning 18. Before Chapter 2 was published, no distinction 
between phase and molecular toxicity had ever been made for monoterpenes. The 
literature ascribed monoterpene toxicity to molecular effects, namely interference with 
membrane properties and membrane function 19-22. However, monoterpenes, such as 
limonene, are sparingly soluble in water (Slimonene = 6 mg/l) and the inhibitory 
concentrations reported were well in excess of solubility. How then could limonene be toxic 
at the molecular level if it existed as a separate organic phase? This was the key question 
that initiated the investigation.  
 In Chapter 2, we quantified how much monoterpene solvent it took to decrease cell 
growth. The MICs for limonene and other monoterpenes were an order of magnitude 
larger than their aqueous solubility, meaning that (1) monoterpene toxicity is a phase effect 
and (2) structural membrane damage (using vital PI stain) did not occur. We then 
examined a biochemical engineering strategy to address toxicity using two-phase 
fermentation. Extractive fermentation demonstrated that the MIC for limonene in a two-
phase system could be increased 700-fold. However, further investigations for strain 
engineering techniques were necessary as there are two main drawbacks when using two-
phase systems during fermentation: energy required for higher mixing rates and energy 
intensive recovery processing such as distillation. 
 Chapter 3 investigated if other hallmarks of membrane interference are present 
when cells are treated with limonene. The model for molecular toxicity and membrane 
interference is the impact of ethanol on yeast 23, 24. Ethanol’s mode of action in yeast is 
through the fluidization of the plasma membrane 23. Physical membrane damage, increase 
in membrane fluidity, upregulation of monounsaturated fatty acids, ergosterol biosynthesis 
are common physiological responses to ethanol 23. Logically, if membrane fluidization is 
the mechanism, we should observe these same effects with limonene. We did not. 
Chapter 3 showed that structural membrane damage, membrane fluidity, membrane 
composition and key transcriptional responses (e.g., fatty acid and ergosterol synthesis) 
did not change during limonene stress. This work is the first body of data demonstrating 
that the membrane is not the target of toxicity for limonene in yeast. 
 Three distinctions should be noted between previous studies 19, 22, 25 and this thesis 
in terms of the experimental approaches used to investigate monoterpene toxicity. Firstly, 
we added monoterpenes in mid-exponential phase (5 hours post inoculation) rather than 
upon inoculation. When added at inoculation, limonene caused overt cell death (assessed 
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using vital PI stain), while viability remained high when the same amount was added in 
mid-exponential phase. Evidently, the combination of inoculation and limonene stress 
exceeded the cells ability to cope. The membrane failure observed in previous studies 
could be the result of cell death as opposed to the cause of cell death. Secondly, we did 
not use surfactants to aid in the aqueous solvation of monoterpenes. It is possible that 
molecular toxicity does occur in the ternary water-limonene-surfactants, where far higher 
limonene concentrations are reached in the continuous phase. The experimental approach 
used in this thesis resembles a production environment far better than previous studies; 
monoterpenes will accumulate later in the culture and surfactants are not added to 
increase solubility. Chapter 3 demonstrated that growth in the presence of a limonene-
solvent system is very different than limonene alone (Appendix). Lastly, all tests in this 
thesis were performed using exogenous addition of monoterpene in non-producing strains. 
This choice was made due to the lack of access and resources to monoterpene-producing 
strains. Unfortunately Amyris Inc. was unable to provide producing strains due to legal 
issues and our own group (as well as other groups) could not provide engineered strains 
with titers beyond inhibitory limits. 
 If limonene was not disrupting the membrane, then how was it inhibiting cell 
growth? A description of the mechanism(s) of phase toxicity is only partially answered 
here. Described in Chapter 3, the cell wall was found to be damaged after limonene 
exposure. This was an interesting finding because the cell wall is the first line of defence 
and the first cellular component to come in contact with extracellular species (i.e., 
emulsion droplets). The data showed that limonene droplets interfere with the normal 
organization of cell wall structures. Chitin is considered the hydrophobic core of the cell 
wall 26 and is central in providing the cell wall’s mechanical strength 15. Limonene 
dispersions may have a higher affinity for hydrophobic chitin structures compared to other 
glucose or mannan sugar polymers found in the cell wall. Given its pivotal role in cell 
separation and cytokinesis the disruption of cell wall integrity must be one of the key 
modes of action of limonene toxicity.  
 The cell wall is a highly dynamic organelle that can change quickly in response to 
environmental cues and future studies probing the nanomechanical properties of yeast cell 
walls could be very enlightening. Atomic force microscopy (AFM) can provide precise real-
time mechanical measurements at the cell surface 27. It has already been used, in vivo, to 
reveal that the cell wall has strict characteristic motion frequencies that are dependent on 
temperature and metabolic processes 28. Here, AFM analysis was attempted to study cell 
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surface effects of limonene but the experiment failed due to the inability to immobilize the 
cells properly within porous membranes (immobilization is a requirement for AFM studies). 
However, if the cell stabilization step can be achieved AFM studies could be critical in the 
evaluation of phase toxicity within microbial biphasic emulsion systems in the future. 
Silicon microwell arrays with etched wells roughly size of cells (~5 um) could also be 
potentially method to immobilize cells for AFM as well. 
 What is still unclear is how limonene dispersions disrupt cell wall architecture. The 
data in Chapter 3 shows that chitin and cell wall microfibrils are somewhat decrystallized 
after limonene treatment. Given that the cell wall content and thickness did not change 
after limonene exposure (Chapter 3) this means that limonene causes structural damage 
to the cell wall lattice structure. If limonene droplets are indeed localizing within the cell 
wall and interfering with microfibril packing (e.g., swelling effect), then their droplet size 
must be within the limits of the thickness of the cell wall (100-200 nm) 29. Determining the 
droplet size distribution (DSD) for organic solvents would be useful data to relate how 
dispersions compare to cell size. Monoterpene DSD has not been reported in fermentation 
systems. However, a cell wall loosening effect would be supported by a recent study 
discussed earlier where limonene was found to swell cell walls more readily than the 
monoterpenoids linalool and carvone during flavour encapsulation 17. Another proposed 
phase toxicity effect is that of cell-coating, where the solvent coats the cell surface 
blocking nutrient transport. This is highly unlikely given that the sugar uptake rate was the 
same for treated and non-treated cells during fermentation (data not shown). Cell wall 
swelling and/or structural damage during solvent-cell contact are likely mechanisms of 
phase toxicity but these still require an analysis of the DSD (It should be noted that 
measurements for farnesene and limonene’s DSD was attempted but failed due to 
experimental instrument issues). 
 The phase toxicity phenomenon must have a key kinetic component, but this space 
is not well described. If we assume that an oil droplet negatively impacts a cell during cell-
oil contact then phase toxicity would be proportional to this interfacial area. Mixing rate, 
DSD and total droplet surface area are important properties in emulsion systems. For 
example, the total interfacial area (TIA) of a yeast culture at OD600nm = 1 is roughly 1x1011 
µm2 (given a cell is perfectly round with diameter of 5 µm). If a toxic amount of limonene is 
added (3 µl) the TIA of limonene would be approximately three orders of magnitude 
smaller than that of the cells (4x108 µm2) if the radius was 25 µm. If the average radius of 
a limonene droplet shrunk to 25 nm then the TIA would roughly match that of the cell TIA 
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(4x1011 µm2). Thus, DSD is a key property in determining the interfacial contact area 
between cells and oil dispersions.  
 The average radius of a limonene-water dispersion system would also be useful in 
studying the phenomena of hydrophobicity and its potential role in phase toxicity. The 
hydrophobic effect, which is the tendency for oil and water to segregate, is qualitatively 
well understood but rigorous quantitative descriptions are lacking 30. In 1959, Walter 
Kauzman noted that water’s interaction with hydrophobic species seemed to cause 
particles to cluster forming hydrophobic units 31. Hydrophobicity is a complex phenomenon 
that depends on whether small molecular units or large clusters, or a combination of both 
are involved in the system. The radius of a hydrophobic particle, or its length, is important 
because it impacts the solvation energy (∆𝐺 free energy required to solvate a species in 
water). Depending on the length, when hydrophobic particles cluster together the overall 
volume to surface area is much larger than that of an individual particle. This larger ratio 
lowers the energy requirement for solvation and is the main driving force for cluster 
assembly.  
 ∆𝐺 is a useful quantity in describing hydrophobicity and can also be used to 
estimate other important properties such as oil-water surface tension, 𝛾 (∆𝐺 ≈ 4𝜋𝑟2𝛾) 30, 
32. Because phase toxicity involves the interfacial interactions between water, the surface 
of cells and solvent clusters, surface behaviour must be important. Surface tension is 
proportional to a fluid’s viscosity: 𝛾 = 𝐴𝑒−𝐵/𝜂, where 𝜂 is viscosity and A and B are 
temperature and fluid dependent constants 33. Chapter 3 highlights that limonene is an 
order of magnitude less viscous than IPM and IPM is not harmful to cells at all. Given 
viscosity’s role in determining fluid behaviour, differences in surface tension and droplet 
size clearly change hydrophobic effects at the water-particle interphase 30, 34 and thus must 
impact the way solvents interact with cells. This means that fluid rheology impacts phase 
toxicity.  
 Ideally, we would have one quantity that describes a solvent’s relevant fluid 
mechanical behaviour during fermentation and its phase toxicity effect on an organism. 
Log Pow works for molecular toxicity at the membrane level but cannot be used for phase 
toxicity because membrane-water partitioning is irrelevant once the cells and the water 
phases are saturated (i.e., beyond the solvent’s solubility). Chemical engineers use 
dimensionless numbers to describe and predict patterns (e.g., Reynolds number (Re) for 
fluid flow in a pipe). Presented here is a theoretical dimensionless quantity called the 
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Brennan number (Br). Br contains the necessary biochemical parameters encountered 
during fermentation in a bioreactor involving water-immiscible non-Newtonian fluids:  
𝐵𝑟 =  𝑃𝑘𝑏𝑇𝜙
𝛾𝜂𝑉𝑝
 
Where power (from impeller) is P  ∝ 𝜌𝑙𝑁3𝐷𝑖5 in [J/s] 
35 with 𝑁 = impeller speed [rev/s], 
𝐷𝑖  diameter of impeller [cm], 𝜌𝑙 is density of liquid [g/cm3]. Interfacial tension 𝛾 [J/s2], 
viscosity 𝜂 [kg/m•s], temperature 𝑇 [K], average particle volume [m3], Boltzmann’s constant 
[m2kg/s2K] and volume fraction of the oil phase 𝜙.  
 The idea would be to plot Br as a function of the microbes specific growth rate, 
𝜇𝑚𝑎𝑥, for various solvents (see below). Similar to the cut off for laminar and turbulent flow 
regimes using the Re number (~ 2300) the goal would be to identify patterns between 
rheology and toxicity. Could there similarly be a transition from non-toxic to toxic regimes 
corresponding to one Brennan number for all solvents? 
 
Figure 5.2. Theoretical plot of specific growth rate versus Br number for various solvents.  
 The characterization of a solvent’s rheological properties within a microbial 
fermentation system requires more attention. This is of particular interest because the 
types of products that are being targeted today via metabolic engineering and microbial 
fermentation are petroleum-compatible fuels (e.g., farnesene, bisbolene, pinene), which 
are essentially water-immiscible oils that exist as a separate phase in culture. Linking fluid 
rheology, such as 𝛾 or DSD, to microbial toxicity is an untouched space. These studies 
would add to the fundamental knowledge of both phase toxicity and important phenomena 
such as hydrophobicity within microbial systems.  
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 Although our efforts were only partially realized in revealing the cellular 
mechanism(s) of inhibition, a solution to the toxicity problem was still required. In Chapter 
2 we took advantage the immiscibility physio-chemical property and established a 
biochemical engineering route to alleviate toxicity in situ. The initial idea was based on the 
observation that inhibition only occurred in a biphasic system. If an inert hydrophobic 
solvent could act as a reservoir, then we suspected that the monoterpene particles would 
thermodynamically prefer the solvent phase rather than water. In situ product removal 
(ISPR) is a well-studied field with numerous successful examples of two-phase liquid-liquid 
extraction designs 36. However, most biphasic extraction techniques require further 
processing to recover the desired product 36. The use of a solvent that could serve as an 
extractant and a coproduct would eliminate energy intensive downstream processing 
operations (e.g., distillation) associated with common ISPR techniques. Chapter 2 proved 
that farnesene is a suitable solvent for this purpose, being that it can be blended with C10 
monoterpene products to generate jet fuels and that it can also serve as an excellent 
extractant.  
 The final chapter (Chapter 4) focused on generating a cellular engineering strategy 
to address toxicity. Adaptive laboratory evolution (ALE) is a technique that does not 
depend on prior knowledge of inhibition. It builds a desired phenotype from the bottom up 
37. ALE is a fascinating and powerful technique. Researchers now have the ability to 
interrogate adaptive evolution on the molecular level. This strategy was of particular 
interest in addressing limonene toxicity because of the uncertainties around the 
mechanism(s) at play. Chapter 4 demonstrated that ALE was successful at generating 
limonene-resistant phenotypes. When coupled with genome resequencing and genomic 
reconstruction, the precise beneficial mutation (tTcb3p) was identified. This result 
successfully linked the genotype to phenotype, which is a nontrivial and complex    
problem 38. Interestingly, in Chapter 2 ALE was used in a CSTR design vs. batch 
passaging for approximately the same duration (200 generations in Chapter 4). The CSTR 
design may have failed to produce resistant isolates due to the lack of experimental 
sensitivity in controlling limonene concentration, which is more accurate to control and 
measure in batch mode. In addition, in Chapter 3 there were no differences found in 
expression of Tcb3/2 when dosed with limonene highlighting that these targets would not 
have been found using dose response coupled with transcriptomics analysis. 
Nevertheless, extractive fermentation and tTcb3p now serve as useful tools to the 
scientific community. The success of Chapter 4, however, generated another intriguing 
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question: how does tTcb3p relieve limonene toxicity and what greater mechanistic 
understanding can we gain from it? 
 There are three pieces of data that are important to solving this puzzle: (1) cells 
stop dividing but they are still viable, (2) limonene causes cell wall damage only in WT 
cells, and (3) the truncation in Tcb3p causes it to co-localize in the nER and the cER. The 
working hypothesis is that limonene interferes with ER inheritance during cytokinesis 
through the disruption of cell wall chitin at the bud neck. This doesn’t kill cells, but stops 
proliferation (initially observed in Chapter 2).  
 Recent literature would support this mechanism. As discussed in Chapter 4, the 
nER and cER are inherited into daughter cells via different processes 39. Because tTcb3p 
can localize to both ER domains, pre-existing nER-bound tTcb3p may be inherited directly 
from the mother cell; circumventing cER inheritance altogether. cER inheritance is more 
sensitive to the structural integrity of the septum apparatus, required for actin stabilization, 
than nER inheritance 40-42. It has been shown that a similar ER-PM tethering protein, 
Scs2p, which resides in both the nER and cER, is able to establish the cER in daughter 
cells in absence of the two other ER-PM tethering protein families (double mutant ∆ist2, 
∆tcb1/2/3) 43. Suggesting that if cER inheritance is blocked, nER-inherited tTcb3p and 
Scs2p, could establish the ER in daughter cells without assistance. 
 In addition, recent evidence showed that during ER stress, the nucleus and nER 
were transmitted to the daughter cell but the cER delivery was inhibited, suggesting that 
nER is free of ER stress 44. This means that nER tTcb3p may initially establish the cER in 
the newly formed bud during stress. In mutant cells, establishment of the cER in the 
daughter cell may result in formation cell wall maintenance, proper septum degradation 
and other cellular processes required to finalize cytokinesis. Alternatively, WT daughter 
cells would lack the ER and all of the biological functions that depend on it. However, ER 
inheritance in WT cells still needs to be demonstrated during limonene shock.  
 Internal cellular signalling may also play a role. It was recently shown that when ER 
stress is detected, the ER stress surveillance (ERSU) pathway activates Slt2p. Activation 
of SLT2 delays ER inheritance and cytokinesis 44. Chapter 3 showed that limonene 
treatment causes cell wall damage and activation of SLT2 in WT cells. SLT2 is not 
activated for mutant cells (Chapter 4, Fig. 5). SLT2 activation may be serving as an 
additional regulatory signalling mechanism that aids in ER inheritance and cytokinesis 
delays during limonene stress.   
 Regardless of whether limonene blocks ER inheritance or not, Chapter 4 revealed 
that Tcb3/2p are important proteins that may have physiological functions beyond ER-
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membrane tethering. It may serve as a starting point for more defined studies on nER and 
cER inheritance and the role of the cER in daughter-mother cell separation (an area that is 
still not fully understood 39). In addition, the data also suggests that there could be a clear 
behavioural distinction between the nER and cER during cellular stress. This has been 
described for particular ER stresses 44 but further investigations to test for functional 
differences between the two domains would be impactful in the future.  
 Finally, this thesis highlights some key insights in terms of the strategies to be used 
for strain improvement in the future. The production of renewable biofuels and chemicals 
requires the development of solventogenic organisms 24, 45. Engineering tolerance in yeast 
and E. coli for this purpose has received increased attention in recent years 45. The 
ultimate goal of tolerance engineering is to identify straightforward genetic modifications 
that result in increased resistance towards a particular compound. To this end, this work 
showed that evolution engineering techniques trumped dose response strategies coupled 
with transcriptomics, such as those experiments presented in Chapter 3. In general, 
numerous reports use a dose response experimental design with the goal of isolating 
resistant gene targets for further engineering 24. The limitation of this approach is that it 
almost always relies on global gene expression data with the assumption that higher gene 
expression will result in improved fitness in a constructed strain. When growth is severely 
impaired by a solvent, the resulting transcriptomic data is often complex and unclear. For 
example in Chapter 3, the microarray data showed upregulation of several general stress 
response related genes, exporters, cell wall repair enzymes and a few fatty acid 
metabolism genes. With around 300 differentially upregulated genes it was uncertain how 
the transcriptome data could be successfully translated into a viable genetic engineering 
strategy for strain development. Chapter 3 did not result in the identification of concrete 
tolerant gene targets. This demonstrates that dose response techniques followed by 
microarray or RNAseq analysis suffer because gene lists are often too big and 
ascertaining precise gene targets for further analysis is difficult and resource intensive.  
 Evolution engineering offers a more effective way to generate genetic leads for 
strain improvement. Due to the surge in next-generation sequencing adaptive laboratory 
evolution (ALE) has become a very active research area in the last decade 46. In yeast, 
this technique is attractive for several reasons: (1) short doubling times (~ 2 h) (2) well 
established genome resources (http://www.yeastgenome.org) and (3) low mutation rates. 
S. cerevisiae generates roughly one adaptive mutation per 1011 cell divisions 47. Thus, the 
resulting mutation list (i.e., target list) from the ALE method is substantially smaller 
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compared to the dose response gene list. In Chapter 4 for example, the total number of 
gene targets was 14 compared to 300 from transcription analysis in Chapter 3. Another 
advantage is that ALE results in the precise genetic information for further investigation 
whereas transcriptomic results assume that overexpression of a particular gene(s) will 
confer tolerance. This is not always the case. For example, ABC transporters (PDR5, 
YOR1, PDR15) were induced when yeast cells were treated with limonene 48 (similar to 
our observations in Chapter 3). However, overexpression of these genes failed to improve 
tolerance to limonene 48.  
 In terms of future production, both the plasma membrane and cell wall results will 
have implications for producing yeast strains. Efflux will likely negatively impact yields due 
to its high energy use; whereas cell wall remodelling due to mutated Tcb3p does not 
require additional ATP. Thus, the single mutation in TCB3 or two-phase extractive 
fermentation are more likely to be successful and generalizable in a producing strains to 
improve toxicity limitations. Nevertheless, because of the clear differences in makeup of 
the cellular envelope yeast and bacteria may have different strategies to deal with toxicity; 
as efflux pumps have been shown to improve production and tolerance in industrially 
relevant hosts such as E. coli 25and P. putida34 but not yeast 48. 
 In conclusion, this thesis set out to answer two questions: (1) what is the precise 
mechanism of monoterpene toxicity in S. cerevisiae and (2) what are the strategies to 
overcome inhibition? Outlined here are two strategies to overcome monoterpene toxicity: 
biphasic extraction and truncating Tcb3p. Moreover, this thesis has contributed to the 
fundamental understanding of monoterpene inhibition in yeast. Before this body of work, 
monoterpene toxicity was considered to be molecular toxicity caused by membrane 
damage. This work demonstrates that this is not the case and monoterpene toxicity is in 
fact, phase toxicity, which can cause cell wall damage. We describe key areas of further 
investigation (e.g., rheological properties, mass transfer kinetics) that will hopefully guide 
researchers in fruitful directions in the future. Lastly, this work serves as a starting point for 
biological studies of ER morphology and inheritance with an emphasis on the discovery of 
additional biological functions for tricalbin proteins.  
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  Figure 5.1. Terpene biosynthetic pathways. Right: DXP pathway. Left: Mevalonate 
pathway. Image used with permission from 3.  
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Title: Physiological and transcriptional response to d-limonene in Saccharomyces cerevisiae 
shows changes to the cell wall, not the plasma membrane 
Authors: Timothy C. R. Brennan1, Jens O. Krömer2#, Lars K. Nielsen1  
 
 
SI Fig 1. Metabolic map of entire transcriptome dataset.   
Total number of data rows (not including comment lines): 10563  
Number of rows for which the gene could not be found: 9804  
Number of rows for which the gene name was ambiguous: 0  
Number of rows for which the gene is valid, but for which a data value was missing or 
malformed: 0 
The table below shows statistics for the selected column/column ratio for all genes and for 
those genes that appear in the Overview (or in any of the selected overviews, if multiple were 
selected). 
Data Statistics All Genes Overview Genes 
Number of values: 759 619 
Minimum value: -3.037 -3.037 
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Maximum value: 5.5071 5.5071 
Median: -0.0144 0.032449998 
Mean: -0.0021671697 0.019628845 
Standard deviation: 0.9757149 1.027266 
 
SI Table 1. Metabolic pathway analysis of exposure to limonene. Values are log2 
treatment/control ratio and only pathways exceeding threshold value of ±2 are shown. 
Pathway Pathway Diagram Enzymes, Genes, and Enzyme 
Cellular Locations 
lysine 
biosynthesis 
 
homocitrate synthase LYS2
0 
  
homocitrate synthase LYS2
1 
  
homoaconitase LYS4   
homo-isocitrate 
dehydrogenase 
LYS1
2 
  
alpha aminoadipate reductase LYS2   
saccharopine dehydrogenase 
(NADP+, L-glutamate-
forming) 
LYS9   
saccharopine dehydrogenase 
(NAD+, L-lysine-forming) 
LYS1   
 
arginine 
biosynthesis 
 
ornithine 
carbamoyltransferase 
ARG3   
acetylornithine 
aminotransferase 
ARG8   
acetylglutamate 
kinase / N-acetyl-
gamma-glutamyl-
phosphate reductase 
ARG5,6   
carbamoyl phosphate 
synthetase 
CPA1 CPA2   
acetylglutamate 
synthase 
ARG2   
acetylornithine 
acetyltransferase 
ARG7   
arginosuccinate 
synthetase 
ARG1   
argininosuccinate 
lyase 
ARG4   
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glycine 
cleavage 
complex 
 
glycine decarboxylase 
complex P subunit 
GCV2   
GCV1 GCV1   
dihydrolipoamide 
dehydrogenase 
LPD1   
 
folate 
interconversio
ns 
 
C1-tetrahydrofolate 
synthase 
ADE3   
mitochondrial C1-
tetrahydrofolate 
synthase 
MIS1   
Serine 
hydroxymethyltrans
ferase, 
mitochondrial 
SHM1   
serine 
hydroxymethyltrans
ferase 
SHM2   
thymidylate 
synthase 
CDC21   
dihydrofolate 
reductase 
DFR1   
glycine cleavage 
complex 
GCV1 GCV2 L
PD1 
  
MTHFR MET13   
MTHFR MET12   
NAD-dependent 
5,10-
methylenetetrahydra
folate 
dehydrogenase 
MTD1   
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folate 
biosynthesis 
 
aminodeoxychorismat
e synthase 
ABZ1   
GTP-cyclohydrolase I FOL2   
aminodeoxychorismat
e lyase 
ABZ2   
2-amino-4-hydroxy-6-
hydroxymethyldihydr
opteridine 
pyrophosphokinase 
[multifunctional] 
FOL1   
dihydrofolate synthase FOL3   
dihydrofolate 
reductase 
DFR1   
glycine cleavage 
complex 
GCV1 GCV2
LPD1 
  
Serine 
hydroxymethyltransfe
rase, mitochondrial 
SHM1   
serine 
hydroxymethyltransfe
rase 
SHM2   
thymidylate synthase CDC21   
MTHFR MET13   
MTHFR MET12   
NAD-dependent 5,10-
methylenetetrahydrafo
late dehydrogenase 
MTD1   
C1-tetrahydrofolate 
synthase 
ADE3   
mitochondrial C1-
tetrahydrofolate 
synthase 
MIS1   
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de novo 
biosynthesis of 
purine 
nucleotides 
 
phosphoribosylpyro
phosphate 
amidotransferase 
ADE4   
glycinamide 
ribotide 
transformylase 
ADE8   
5'-
phosphoribosylfor
myl glycinamidine 
synthetase 
ADE6   
phosphoribosylglyc
inamidine 
synthetase / 
phopshoribosylami
noimidazole 
synthetase 
ADE5,7   
phosphoribosylami
noimidazole-
carboxylase 
ADE2   
phosphoribosyl 
amino 
imidazolesuccinoca
rbozamide 
synthetase 
ADE1   
inosine 
monophosphate 
cyclohydrolase 
[multifunctional] 
ADE16   
inosine 
monophosphate 
cyclohydrolase 
[multifunctional] 
ADE17   
IMP dehydrogenase IMD2   
IMP dehydrogenase IMD3   
IMP dehydrogenase IMD4   
GMP synthase GUA1   
guanylate kinase GUK1   
adenylosuccinate 
synthetase 
ADE12   
adenylosuccinate 
lyase 
ADE13   
adenylate kinase ADK1   
mitochondrial 
GTP:AMP 
phosphotransferase 
ADK2   
ribonucleotide 
reductase 
RNR1 RNR2 R
NR3RNR4 
  
nucleoside 
diphosphate kinase 
YNK1   
 
folate 
transformation
s 
 
Serine 
hydroxymethyltrans
ferase, 
mitochondrial 
SHM1   
serine 
hydroxymethyltrans
ferase 
SHM2   
MTHFR MET13   
MTHFR MET12   
glycine cleavage GCV1 GCV2 L   
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complex PD1 
NAD-dependent 
5,10-
methylenetetrahydra
folate 
dehydrogenase 
MTD1   
mitochondrial C1-
tetrahydrofolate 
synthase 
MIS1   
C1-tetrahydrofolate 
synthase 
ADE3   
5,10-
methenyltetrahydrof
olate synthetase 
FAU1   
 
gluconeogenes
is 
 
malic enzyme MAE1   
pyruvate carboxylase PYC2   
pyruvate carboxylase PYC1   
cytosolic malate 
dehydrogenase 
MDH2   
phosphoenolpyruvate 
carboxylkinase 
PCK1   
enolase I ENO1   
enolase ENO2   
phosphoglycerate mutase GPM1   
3-phosphoglycerate kinase PGK1   
glyceraldehyde-3-
phosphate dehydrogenase 
TDH3   
glyceraldehyde 3-
phosphate dehydrogenase 
TDH2   
glyceraldehyde-3-
phosphate dehydrogenase 
TDH1   
aldolase FBA1   
fructose-1,6-
bisphosphatase 
FBP1   
glucose-6-phosphate 
isomerase 
PGI1   
 
arginine 
degradation 
(anaerobic) 
 
arginase CAR1   
ornithine aminotransferase CAR2   
delta 1-pyrroline-5-
carboxylate reductase 
PRO3   
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allantoin 
degradation 
 
allantoinase DAL1   
allantoicase DAL2   
ureidoglycolate 
hydrolase 
DAL3   
urea carboxylase / 
allophanate hydrolase 
DUR1,2   
 
leucine 
biosynthesis 
 
alpha-isopropylmalate 
synthase 
LEU4   
alpha-isopropylmalate 
synthase, minor isozyme 
LEU9   
isopropylmalate isomerase LEU1   
beta-IPM dehydrogenase LEU2   
branched-chain amino acid 
aminotransferase 
BAT1   
branched-chain amino acid 
transaminase 
BAT2   
 
valine 
degradation 
 
branched-chain amino acid 
aminotransferase 
BAT1   
branched-chain amino acid 
transaminase 
BAT2   
pyruvate decarboxylase / 
decarboxylase 
PDC1   
pyruvate decarboxylase / 
decarboxylase 
PDC5   
pyruvate decarboxylase / 
decarboxylase 
PDC6   
alcohol dehydrogenase ADH1   
alcohol dehydrogenase ADH2   
alcohol dehydrogenase ADH3   
alcohol dehydrogenase ADH4   
alcohol dehydrogenase ADH5   
formaldehyde 
dehydrogenase / alcohol 
dehydrogenase 
SFA1   
 
citrulline 
biosynthesis 
 
carbamoyl phosphate 
synthetase 
CPA1 CPA2   
ornithine 
carbamoyltransferase 
ARG3   
 
serine 
biosynthesis 
from 3-
phosphoglycer
ate 
 
3-phosphoglycerate 
dehydrogenase 
SER3   
3-phosphoglycerate 
dehydrogenase 
SER33   
phosphoserine 
transaminase 
SER1   
phosphoserine 
phosphatase 
SER2   
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glutathione-
glutaredoxin 
redox 
reactions 
 
glutathione oxidoreductase GLR1   
glutathione transferase GTT1   
glutathione transferase GTT2   
Glutathione peroxidase GPX2   
glutathione-peroxidase HYR1   
Glutathione peroxidase GPX1   
 
glyoxylate 
cycle 
 
cytosolic malate 
dehydrogenase 
MDH2   
peroxisome malate 
dehydrogenase 
MDH3   
citrate synthase CIT2   
aconitate hydratase ACO2   
aconitase ACO1   
isocitrate lyase ICL1   
malate synthase 2 DAL7   
malate synthase MLS1   
 
isoleucine 
degradation 
 
branched-chain amino 
acid aminotransferase 
BAT1   
branched-chain amino 
acid transaminase 
BAT2   
ketoisocaproate 
decarboxylase / 
decarboxylase 
THI3   
decarboxylase ARO10   
pyruvate decarboxylase / 
decarboxylase 
PDC1   
pyruvate decarboxylase / 
decarboxylase 
PDC5   
pyruvate decarboxylase / 
decarboxylase 
PDC6   
alcohol dehydrogenase ADH1   
alcohol dehydrogenase ADH2   
alcohol dehydrogenase ADH3   
alcohol dehydrogenase ADH4   
alcohol dehydrogenase ADH5   
formaldehyde 
dehydrogenase / alcohol 
dehydrogenase 
SFA1   
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de novo 
biosynthesis of 
pyrimidine 
ribonucleotide
s 
 
carbamyl phosphate 
synthase / aspartate 
transcarbamylase 
URA2   
dihydrooratase URA4   
dihydroorotate 
dehydrogenase 
URA1   
orotate 
phosphoribosyltransferase 
URA10   
orotate 
phosphoribosyltransferase 
URA5   
orotidine-5'-phosphate 
decarboxylase 
URA3   
uridylate kinase URA6   
CTP synthase URA7   
CTP synthase URA8   
 
acetoin 
biosynthesis II 
 
pyruvate decarboxylase / 
decarboxylase 
PDC1   
pyruvate decarboxylase / 
decarboxylase 
PDC5   
pyruvate decarboxylase / 
decarboxylase 
PDC6   
 
sucrose 
degradation 
 
invertase SUC2   
 
glycine 
biosynthesis 
from 
glyoxylate 
 
alanine:glyoxylate 
aminotransferase 
AGX1   
 
phenylalanine 
degradation 
 
aromatic amino acid 
aminotransferase I 
ARO8   
aromatic amino acid 
aminotransferase II 
ARO9   
pyruvate decarboxylase / 
decarboxylase 
PDC1   
pyruvate decarboxylase / 
decarboxylase 
PDC5   
pyruvate decarboxylase / 
decarboxylase 
PDC6   
decarboxylase ARO10   
alcohol dehydrogenase ADH1   
alcohol dehydrogenase ADH2   
alcohol dehydrogenase ADH3   
alcohol dehydrogenase ADH4   
alcohol dehydrogenase ADH5   
formaldehyde 
dehydrogenase / alcohol 
dehydrogenase 
SFA1   
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beta-alanine 
biosynthesis 
 
amine oxidase FMS1   
aldehyde dehydrogenase 
(stress inducible 
cytoplasmic) 
ALD2   
aldehyde dehydrogenase 
(stress inducible 
cytoplasmic) 
ALD3   
 
fatty acid 
oxidation 
pathway 
 
fatty acid transporter FAT1   
acyl-CoA synthetase FAA2   
acyl-CoA synthase FAA3   
long chain fatty acyl:CoA 
synthetase 
FAA4   
long chain fatty acyl:CoA 
synthetase 
FAA1   
d3,d2-Enoyl-CoA 
Isomerase 
ECI1   
delta(3,5)-delta(2,4)-
dienoyl-CoA isomerase 
DCI1   
fatty-acyl coenzyme A 
oxidase 
POX1   
3-hydroxyacyl-CoA 
dehydrogenase 
FOX2   
3-oxoacyl CoA thiolase POT1   
 
superpathway 
of glutamate 
biosynthesis 
 
NADP-dependent 
isocitrate dehydrogenase 
IDP1   
NADP-dependent 
isocitrate dehydrogenase 
IDP2   
NADP-dependent 
isocitrate dehydrogenase 
IDP3   
glutamine synthetase GLN1   
NADP-dependent 
glutamate dehydrogenase 
GDH3   
NADP-dependent 
glutamate dehydrogenase 
GDH1   
glutamate synthase 
(NADH) 
GLT1   
 
oxidative 
branch of the 
pentose 
phosphate 
pathway 
 
glucose-6-phosphate 
dehydrogenase 
ZWF1   
6-phosphogluconolactonase SOL3   
6-phosphogluconolactonase SOL4   
6-phosphogluconate 
dehydrogenase 
GND2   
6-phosphogluconate 
dehydrogenase, 
decarboxylating 
GND1   
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superpathway 
of glucose 
fermentation 
 
hexokinase II HXK2   
hexokinase I HXK1   
glucokinase GLK1   
glucose-6-phosphate 
isomerase 
PGI1   
phosphofructokinase PFK1 PFK2   
aldolase FBA1   
triosephosphate 
isomerase 
TPI1   
glyceraldehyde-3-
phosphate 
dehydrogenase 
TDH3   
glyceraldehyde 3-
phosphate 
dehydrogenase 
TDH2   
glyceraldehyde-3-
phosphate 
dehydrogenase 
TDH1   
3-phosphoglycerate 
kinase 
PGK1   
phosphoglycerate 
mutase 
GPM1   
enolase I ENO1   
enolase ENO2   
pyruvate kinase CDC19   
pyruvate kinase PYK2   
pyruvate 
decarboxylase / 
decarboxylase 
PDC1   
pyruvate 
decarboxylase / 
decarboxylase 
PDC5   
pyruvate 
decarboxylase / 
decarboxylase 
PDC6   
aldehyde 
dehydrogenase (stress 
inducible cytoplasmic) 
ALD2   
aldehyde 
dehydrogenase (major 
mitochondrial) 
ALD4   
aldehyde 
dehydrogenase (minor 
mitochondrial) 
ALD5   
aldehyde 
dehydrogenase (major 
cytoplasmic) 
ALD6   
alcohol 
dehydrogenase 
ADH1   
alcohol 
dehydrogenase 
ADH2   
alcohol 
dehydrogenase 
ADH3   
alcohol 
dehydrogenase 
ADH4   
alcohol 
dehydrogenase 
ADH5   
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tryptophan 
degradation 
 
aromatic amino acid 
aminotransferase I 
ARO8   
aromatic amino acid 
aminotransferase II 
ARO9   
pyruvate decarboxylase / 
decarboxylase 
PDC1   
pyruvate decarboxylase / 
decarboxylase 
PDC5   
pyruvate decarboxylase / 
decarboxylase 
PDC6   
decarboxylase ARO10   
alcohol dehydrogenase ADH1   
alcohol dehydrogenase ADH2   
alcohol dehydrogenase ADH3   
alcohol dehydrogenase ADH4   
alcohol dehydrogenase ADH5   
formaldehyde 
dehydrogenase / alcohol 
dehydrogenase 
SFA1   
 
salvage 
pathways of 
pyrimidine 
ribonucleotide
s 
 
cytidine deaminase CDD1   
deoxycytidine kinase / 
cytidine kinase / uridine 
kinase 
URK1   
nicotinic acid riboside 
hydrolase [multifunctional] 
URH1   
cytosine deaminase FCY1   
UPRTase FUR1   
nucleoside diphosphate 
kinase 
YNK1   
 
removal of 
superoxide 
radicals 
 
cytoplasmic superoxide 
dismutase 
SOD1   
mitochondrial superoxide 
dismutase 
SOD2   
catalase A CTA1   
catalase T CTT1   
 
de novo 
biosynthesis of 
pyrimidine 
deoxyribonucl
eotides 
 
ribonucleotid
e reductase 
RNR1 RNR2 RNR3 R
NR4 
  
dUTP 
pyrophosphat
ase 
DUT1   
thymidylate 
synthase 
CDC21   
uridylate 
kinase / 
thymidylate 
kinase 
CDC8   
nucleoside 
diphosphate 
kinase 
YNK1   
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non-oxidative 
branch of the 
pentose 
phosphate 
pathway 
 
D-ribulose-5-Phosphate 3-
epimerase 
RPE1   
ribose-5-phosphate ketol-
isomerase 
RKI1   
transketolase TKL2   
transaldolase TAL1   
transketolase TKL1   
 
TCA cycle, 
aerobic 
respiration 
 
pyruvate 
carboxylase 
PYC2   
pyruvate 
carboxylase 
PYC1   
mitochondr
ial malate 
dehydrogen
ase 
MDH1   
citrate 
synthase 
CIT1   
citrate 
synthase 
CIT3   
aconitate 
hydratase 
ACO2   
aconitase ACO1   
NAD-
dependent 
isocitrate 
dehydrogen
ase 
IDH1 IDH2   
2-
ketoglutarat
e 
dehydrogen
ase 
complex 
LPD1 KGD1 KGD2   
succinyl-
CoA ligase 
LSC1 LSC2   
succinate 
dehydrogen
ase 
(ubiquinon
e) 
SDH4 SDH3 SDH2 SD
H1 
  
minor 
succinate 
dehydrogen
ase 
(ubiquinon
e) 
SDH4 SDH3 SDH2 YJ
L045W 
  
fumarate 
hydralase 
FUM1   
 
myo-inositol 
biosynthesis 
 
L-myo-inositol-1-phosphate 
synthase 
INO1   
inositol monophosphatase INM1   
inositol monophosphate INM2   
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SI Table 2. Differentially expressed genes 2 h after limonene exposure. Genes are 
categorized based on either cellular compartments and/or biological processes. 
Gene Description FC 
a 
P value 
b 
Cell wall cellular compartment  
Cytokinesis 
XBP1 Transcriptional repressor that binds to promoter 
sequences of the cyclin genes, CYS3, and SMF2; 
expression is induced by stress or starvation during 
mitosis, and late in meiosis; member of the Swi4p/Mbp1p 
family; potential Cdc28p substrate, XBP1 
2.1 2.58E-
05 
AFR1 Alpha-factor pheromone receptor regulator, negatively 
regulates pheromone receptor signaling; required for 
normal mating projection (shmoo) formation; required for 
Spa2p to recruit Mpk1p to shmoo tip during mating; 
interacts with Cdc12p, AFR1 
1.9 1.81E-
04 
MET30 F-box protein containing five copies of the WD40 motif, 
controls cell cycle function, sulfur metabolism, and 
methionine biosynthesis as part of the ubiquitin ligase 
complex; interacts with and regulates Met4p, localizes 
within the nucleus, MET30 
1.6 2.18E-
03 
DSE4 Daughter cell-specific secreted protein with similarity to 
glucanases, degrades cell wall from the daughter side 
causing daughter to separate from mother, DSE4 
-1.9 2.50E-
04 
GAS2 1,3-beta-glucanosyltransferase, involved with Gas4p in 
spore wall assembly; has similarity to Gas1p, GAS2 
-2.0 8.47E-
04 
EGT2 Glycosylphosphatidylinositol (GPI)-anchored cell wall 
endoglucanase required for proper cell separation after 
cytokinesis, expression is activated by Swi5p and tightly 
regulated in a cell cycle-dependent manner, EGT2 
-2.1 7.20E-
03 
SUN4 Cell wall protein related to glucanases, possibly involved 
in cell wall septation; member of the SUN family, SUN4 
-2.2 1.47E-
04 
GAS3 Putative 1,3-beta-glucanosyltransferase, has similarity to 
Gas1p; localizes to the cell wall, GAS3 
-2.3 6.04E-
04 
CTS1 Endochitinase, required for cell separation after mitosis; 
transcriptional activation during late G and early M cell 
cycle phases is mediated by transcription factor Ace2p, 
CTS1 
-2.4 9.10E-
04 
UTR2 Cell wall protein that functions in the transfer of chitin to 
beta(1-6)glucan; putative chitin transglycosidase; 
glycosylphosphatidylinositol (GPI)-anchored protein 
localized to the bud neck; has a role in cell wall 
maintenance, UTR2 
-2.6 3.22E-
04 
SCW11 Cell wall protein with similarity to glucanases; may play a 
role in conjugation during mating based on its regulation 
by Ste12p, SCW11 
-3.0 3.29E-
04 
DSE1 Daughter cell-specific protein, may participate in -3.1 1.03E-
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pathways regulating cell wall metabolism; deletion affects 
cell separation after division and sensitivity to drugs 
targeted against the cell wall, DSE1 
03 
DSE2 Daughter cell-specific secreted protein with similarity to 
glucanases, degrades cell wall from the daughter side 
causing daughter to separate from mother; expression is 
repressed by cAMP, DSE2 
-3.2 7.35E-
04 
SPS4 Protein whose expression is induced during sporulation; 
not required for sporulation; heterologous expression in E. 
coli induces the SOS response that senses DNA damage, 
SPS4 
-3.7 3.24E-
06 
Cell wall organization   
YGP1 Cell wall-related secretory glycoprotein; induced by 
nutrient deprivation-associated growth arrest and upon 
entry into stationary phase; may be involved in adaptation 
prior to stationary phase entry; has similarity to Sps100p, 
YGP1 
4.0 1.13E-
07 
PIR3 O-glycosylated covalently-bound cell wall protein 
required for cell wall stability; expression is cell cycle 
regulated, peaking in M/G1 and also subject to regulation 
by the cell integrity pathway, PIR3 
5.0 9.39E-
07 
FIT2 Mannoprotein that is incorporated into the cell wall via a 
glycosylphosphatidylinositol (GPI) anchor, involved in 
the retention of siderophore-iron in the cell wall, FIT2 
2.0 6.39E-
05 
TIP1 Major cell wall mannoprotein with possible lipase 
activity; transcription is induced by heat- and cold-shock; 
member of the Srp1p/Tip1p family of serine-alanine-rich 
proteins, TIP1 
2.1 1.44E-
04 
YPK2 Protein kinase with similarityto serine/threonine protein 
kinase Ypk1p; functionally redundant with YPK1 at the 
genetic level; participates in a signaling pathway required 
for optimal cell wall integrity; homolog of mammalian 
kinase SGK, YPK2 
1.8 5.36E-
04 
SPI1 GPI-anchored cell wall protein involved in weak acid 
resistance; basal expression requires Msn2p/Msn4p; 
expression is induced under conditions of stress and 
during the diauxic shift; similar to Sed1p, SPI1 
4.7 8.17E-
04 
SNA3 Integral membrane protein localized to vacuolar 
intralumenal vesicles, computational analysis of large-
scale protein-protein interaction data suggests a possible 
role in either cell wall synthesis or protein-vacuolar 
targeting, SNA3 
1.2 8.98E-
04 
FRT2 Tail-anchored endoplasmic reticulum membrane protein, 
interacts with homolog Frt1p but is not a substrate of 
calcineurin (unlike Frt1p), promotes growth in conditions 
of high Na+, alkaline pH, or cell wall stress; potential 
Cdc28p substrate, FRT2 
1.7 3.36E-
03 
USV1 Putative transcription factor containing a C2H2 zinc 
finger; mutation affects transcriptional regulation of genes 
1.2 4.26E-
03 
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involved in protein folding, ATP binding, and cell wall 
biosynthesis, USV1 
PST1 Cell wall protein that contains a putative GPI-attachment 
site; secreted by regenerating protoplasts; up-regulated by 
activation of the cell integrity pathway, as mediated by 
Rlm1p; upregulated by cell wall damage via disruption of 
FKS1, PST1 
1.9 4.73E-
03 
ECM4 Omega class glutathione transferase; not essential; similar 
to Ygr154cp; green fluorescent protein (GFP)-fusion 
protein localizes to the cytoplasm, ECM4 
1.4 2.94E-
04 
TDH1 Glyceraldehyde-3-phosphate dehydrogenase, isozyme 1, 
involved in glycolysis and gluconeogenesis; tetramer that 
catalyzes the reaction of glyceraldehyde-3-phosphate to 
1,3 bis-phosphoglycerate; detected in the cytoplasm and 
cell wall [Source:SGD;Acc:S000003588] 
1.1 5.38E-
03 
FIT3 Mannoprotein that is incorporated into the cell wall via a 
glycosylphosphatidylinositol (GPI) anchor, involved in 
the retention of siderophore-iron in the cell wall, FIT3 
1.7 5.54E-
03 
Hsp150 O-mannosylated heat shock protein that is secreted and 
covalently attached to the cell wall via beta-1,3-glucan 
and disulfide bridges; required for cell wall stability; 
induced by heat shock, oxidative stress, and nitrogen 
limitation, HSP150 
1.0 6.70E-
03 
CWP1 Cell wall mannoprotein, linked to a beta-1,3- and beta-
1,6-glucan heteropolymer through a phosphodiester bond; 
involved in cell wall organization, CWP1 
1.1 7.41E-
03 
YPS6 
Putative GPI-anchored aspartic protease, YPS6 
1.2 8.35E-
03 
GSC2 Catalytic subunit of 1,3-beta-glucan synthase, involved in 
formation of the inner layer of the spore wall; activity 
positively regulated by Rho1p and negatively by Smk1p; 
has similarity to an alternate catalytic subunit, Fks1p 
(Gsc1p), GSC2 
1.6 1.04E-
03 
RIM21 Component of the RIM101 pathway, has a role in cell 
wall construction and alkaline pH response; has similarity 
to A. nidulans PalH, RIM21 
1.1 5.03E-
03 
SLT2 Serine/threonine MAP kinase involved in regulating the 
maintenance of cell wall integrity and progression through 
the cell cycle; regulated by the PKC1-mediated signaling 
pathway,  
0.9 0.05730
8 
MLP1 Protein kinase implicated in the Slt2p mitogen-activated 
(MAP) kinase signaling pathway; associates with Rlm1p, 
--- 
2.1 1.38E-
03 
ECM4 Omega class glutathione transferase; not essential; similar 
to Ygr154cp; green fluorescent protein (GFP)-fusion 
protein localizes to the cytoplasm, ECM4 
1.4 2.94E-
04 
FBP26 Fructose-2,6-bisphosphatase, required for glucose 
metabolism 
1.4 7.85E-
04 
Transmembrane transport   
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AGP3 Low-affinity amino acid permease, may act to supply the 
cell with amino acids as nitrogen source in nitrogen-poor 
conditions; transcription is induced under conditions of 
sulfur limitation, AGP3 
5.1 3.92E-
06 
MUP1 High affinity methionine permease, integral membrane 
protein with 13 putative membrane-spanning regions; also 
involved in cysteine uptake, MUP1 
4.6 1.75E-
04 
YCT1 High-affinity cysteine-specific transporter with similarity 
to the Dal5p family of transporters; green fluorescent 
protein (GFP)-fusion protein localizes to the endoplasmic 
reticulum; YCT1 is not an essential gene, YCT1 
4.3 3.25E-
04 
HXT5 Hexose transporter with moderate affinity for glucose, 
induced in the presence of non-fermentable carbon 
sources, induced by a decrease in growth rate, contains an 
extended N-terminal domain relative to other HXTs,  
3.9 8.32E-
06 
STL1 Glycerol proton symporter of the plasma membrane, 
subject to glucose-induced inactivation, strongly but 
transiently induced when cells are subjected to osmotic 
shock, STL1 
3.9 2.35E-
03 
PDR15 Plasma membrane ATP binding cassette (ABC) 
transporter, multidrug transporter and general stress 
response factor implicated in cellular detoxification; 
regulated by Pdr1p, Pdr3p and Pdr8p; promoter contains a 
PDR responsive element, PDR15 
3.2 4.08E-
04 
MMP1 High-affinity S-methylmethionine permease, required for 
utilization of S-methylmethionine as a sulfur source; has 
similarity to S-adenosylmethionine permease Sam3p, 
MMP1 
2.3 1.05E-
03 
SAM3 High-affinity S-adenosylmethionine permease, required 
for utilization of S-adenosylmethionine as a sulfur source; 
has similarity to S-methylmethionine permease Mmp1p, 
SAM3 
2.2 1.71E-
03 
JEN1 Lactate transporter, required for uptake of lactate and 
pyruvate; phosphorylated; expression is derepressed by 
transcriptional activator Cat8p during respiratory growth, 
and repressed in the presence of glucose, fructose, and 
mannose, JEN1 
2.2 2.20E-
03 
JEN1 Lactate transporter, required for uptake of lactate and 
pyruvate; phosphorylated; expression is derepressed by 
transcriptional activator Cat8p during respiratory growth, 
and repressed in the presence of glucose, fructose, and 
mannose, JEN1 
2.2 2.20E-
03 
CSR2 Nuclear protein with a potential regulatory role in 
utilization of galactose and nonfermentable carbon 
sources; overproduction suppresses the lethality at high 
temperature of a chs5 spa2 double null mutation; potential 
Cdc28p substrate, CSR2 
2.1 3.02E-
05 
PDR5 Plasma membrane ATP-binding cassette (ABC) 
transporter, short-lived multidrug transporter actively 
regulated by Pdr1p; also involved in steroid transport, 
2.0 3.66E-
03 
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cation resistance, and cellular detoxification during 
exponential growth, PDR5 
MUP3 Low affinity methionine permease, similar to Mup1p, 
MUP3 
1.9 8.15E-
04 
YOR1 Plasma membrane ATP-binding cassette (ABC) 
transporter, multidrug transporter mediates export of 
many different organic anions including oligomycin, 
YOR1 
1.7 8.81E-
03 
ALP1 Arginine transporter; expression is normally very low and 
it is unclear what conditions would induce significant 
expression, ALP1 
1.2 3.81E-
03 
ZRT1 High-affinity zinc transporter of the plasma membrane, 
responsible for the majority of zinc uptake; transcription 
is induced under low-zinc conditions by the Zap1p 
transcription factor, ZRT1 
-1.1 7.69E-
03 
PDR12 Plasma membrane ATP-binding cassette (ABC) 
transporter, weak-acid-inducible multidrug transporter 
required for weak organic acid resistance; induced by 
sorbate and benzoate and regulated by War1p; mutants 
exhibit sorbate hypersensitivity, PDR12 
-1.5 8.27E-
04 
Redox processes   
JLP1 Fe(II)-dependent sulfonate/alpha-ketoglutarate 
dioxygenase, involved in sulfonate catabolism for use as a 
sulfur source, contains sequence that closely resembles a J 
domain (typified by the E. coli DnaJ protein), JLP1 
6.7 1.80E-
05 
OYE3 Widely conserved NADPH oxidoreductase containing 
flavin mononucleotide (FMN), homologous to Oye2p 
with slight differences in ligand binding and catalytic 
properties; may be involved in sterol metabolism, OYE3 
3.6 9.43E-
05 
IDP2 Cytosolic NADP-specific isocitrate dehydrogenase, 
catalyzes oxidation of isocitrate to alpha-ketoglutarate; 
levels are elevated during growth on non-fermentable 
carbon sources and reduced during growth on glucose, 
IDP2 
3.1 1.51E-
04 
GPX1 Phospholipid hydroperoxide glutathione peroxidase 
induced by glucose starvation that protects cells from 
phospholipid hydroperoxides and nonphospholipid 
peroxides during oxidative stress, GPX1 
3.0 8.70E-
03 
IRC15 Putative S-adenosylmethionine-dependent 
methyltransferase of the seven beta-strand family; null 
mutant displays increased levels of spontaneous Rad52 
foci, --- 
2.9 5.70E-
05 
NDE2 Mitochondrial external NADH dehydrogenase, catalyzes 
the oxidation of cytosolic NADH; Nde1p and Nde2p are 
involved in providing the cytosolic NADH to the 
mitochondrial respiratory chain, NDE2 
2.7 9.11E-
06 
HMX1 ER localized, heme-binding peroxidase involved in the 
degradation of heme; does not exhibit heme oxygenase 
activity despite similarity to heme oxygenases; expression 
2.5 9.76E-
03 
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regulated by AFT1, HMX1 
FMO1 Flavin-containing monooxygenase, localized to the 
cytoplasmic face of the ER membrane; catalyzes 
oxidation of biological thiols to maintain the ER redox 
buffer ratio for correct folding of disulfide-bonded 
proteins, FMO1 
2.4 1.45E-
04 
GRE2 NADPH-dependent methylglyoxal reductase (D-
lactaldehyde dehydrogenase); stress induced (osmotic, 
ionic, oxidative, heat shock and heavy metals); regulated 
by the HOG pathway, GRE2 
2.2 3.38E-
03 
GTO1 Omega-class glutathione transferase; induced under 
oxidative stress; putative peroxisomal localization, GTO1 
2.2 9.17E-
05 
CTT1 Cytosolic catalase T, has a role in protection from 
oxidative damage by hydrogen peroxide, CTT1 
2.2 1.98E-
04 
GND2 6-phosphogluconate dehydrogenase (decarboxylating), 
catalyzes an NADPH regenerating reaction in the pentose 
phosphate pathway; required for growth on D-glucono-
delta-lactone, GND2 
2.1 1.28E-
04 
FRE5 Putative ferric reductase with similarity to Fre2p; 
expression induced by low iron levels; the authentic, non-
tagged protein is detected in highly purified mitochondria 
in high-throughput studies, FRE5 
2.1 9.73E-
04 
FMP46 Putative redox protein containing a thioredoxin fold; the 
authentic, non-tagged protein is detected in highly 
purified mitochondria in high-throughput studies, FMP46 
2.0 5.29E-
03 
YHB1 Nitric oxide oxidoreductase, flavohemoglobin involved in 
nitric oxide detoxification; plays a role in the oxidative 
and nitrosative stress responses, YHB1 
1.9 4.92E-
03 
OLE1 Delta(9) fatty acid desaturase, required for 
monounsaturated fatty acid synthesis and for normal 
distribution of mitochondria, OLE1 
1.9 3.32E-
04 
MET8 Bifunctional dehydrogenase and ferrochelatase, involved 
in the biosynthesis of siroheme, a prosthetic group used 
by sulfite reductase; required for sulfate assimilation and 
methionine biosynthesis, MET8 
1.9 4.47E-
04 
GDH3 NADP(+)-dependent glutamate dehydrogenase, 
synthesizes glutamate from ammonia and alpha-
ketoglutarate; rate of alpha-ketoglutarate utilization 
differs from Gdh1p; expression regulated by nitrogen and 
carbon sources, GDH3 
1.8 5.97E-
04 
MXR1 Peptide methionine sulfoxide reductase, reverses the 
oxidation of methionine residues; involved in oxidative 
damage repair, providing resistance to oxidative stress 
and regulation of lifespan, MXR1 
1.8 1.94E-
03 
BDH2 Putative medium-chain alcohol dehydrogenase with 
similarity to BDH1; transcription induced by 
constitutively active PDR1 and PDR3; BDH2 is an 
essential gene, BDH2 
1.7 3.83E-
03 
YKL107W Putative protein of unknown function, --- 1.6 5.03E-
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04 
TRX3 Mitochondrial thioredoxin, highly conserved 
oxidoreductase required to maintain the redox 
homeostasis of the cell, forms the mitochondrial 
thioredoxin system with Trr2p, redox state is maintained 
by both Trr2p and Glr1p, TRX3 
1.6 2.39E-
03 
HBN1 Putative protein of unknown function; similar to bacterial 
nitroreductases; green fluorescent protein (GFP)-fusion 
protein localizes to the cytoplasm and nucleus, HBN1 
1.5 2.10E-
04 
YDL124W NADPH-dependent alpha-keto amide reductase; reduces 
aromatic alpha-keto amides, aliphatic alpha-keto esters, 
and aromatic alpha-keto esters; member of the aldo-keto 
reductase (AKR) family, --- 
1.5 4.20E-
04 
ECM4 Omega class glutathione transferase; not essential; similar 
to Ygr154cp; green fluorescent protein (GFP)-fusion 
protein localizes to the cytoplasm, ECM4 
1.4 2.94E-
04 
GUT2 Mitochondrial glycerol-3-phosphate dehydrogenase; 
expression is repressed by both glucose and cAMP and 
derepressed by non-fermentable carbon sources in a 
Snf1p, Rsf1p, Hap2/3/4/5 complex dependent manner, 
GUT2 
1.3 4.40E-
03 
MCR1 Mitochondrial NADH-cytochrome b5 reductase, involved 
in ergosterol biosynthesis, MCR1 
1.3 1.58E-
03 
RPH1 JmjC domain-containing histone demethylase which can 
specifically demethylate H3K36 tri- and dimethyl 
modification states; transcriptional repressor of PHR1; 
Rph1p phosphorylation during DNA damage is under 
control of the MEC1-RAD53 pathway, RPH1 
1.3 7.43E-
03 
AAD6 Putative aryl-alcohol dehydrogenase with similarity to P. 
chrysosporium aryl-alcohol dehydrogenase, involved in 
the oxidative stress response, AAD6 
1.2 7.73E-
03 
RNR3 Ribonucleotide-diphosphate reductase (RNR), large 
subunit; the RNR complex catalyzes the rate-limiting step 
in dNTP synthesis and is regulated by DNA replication 
and DNA damage checkpoint pathways via localization of 
the small subunits, RNR3 
1.2 8.96E-
03 
GDH2 NAD(+)-dependent glutamate dehydrogenase, degrades 
glutamate to ammonia and alpha-ketoglutarate; expression 
sensitive to nitrogen catabolite repression and intracellular 
ammonia levels, GDH2 
1.1 1.67E-
03 
OYE2 Widely conserved NADPH oxidoreductase containing 
flavin mononucleotide (FMN), homologous to Oye3p 
with slight differences in ligand binding and catalytic 
properties; may be involved in sterol metabolism, OYE2 
1.1 4.40E-
03 
FRE6 Putative ferric reductase with similarity to Fre2p; 
expression induced by low iron levels, FRE6 
1.1 7.08E-
03 
UGA2 Succinate semialdehyde dehydrogenase involved in the 
utilization of gamma-aminobutyrate (GABA) as a 
nitrogen source; part of the 4-aminobutyrate and 
1.1 5.39E-
03 
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glutamate degradation pathways; localized to the 
cytoplasm, UGA2 
FAS2 Alpha subunit of fatty acid synthetase, which catalyzes 
the synthesis of long-chain saturated fatty acids; contains 
beta-ketoacyl reductase and beta-ketoacyl synthase 
activities; phosphorylated, FAS2 
1.1 6.48E-
03 
PRX1 Mitochondrial peroxiredoxin (1-Cys Prx) with thioredoxin 
peroxidase activity, has a role in reduction of 
hydroperoxides; induced during respiratory growth and 
under conditions of oxidative stress; phosphorylated, 
PRX1 
1.1 2.76E-
03 
GTT1 ER associated glutathione S-transferase capable of 
homodimerization; expression induced during the diauxic 
shift and throughout stationary phase; functional overlap 
with Gtt2p, Grx1p, and Grx2p, GTT1 
1.0 9.16E-
03 
HTD2 Mitochondrial 3-hydroxyacyl-thioester dehydratase 
involved in fatty acid biosynthesis, required for 
respiratory growth and for normal mitochondrial 
morphology, HTD2 
1.0 3.55E-
03 
LOT6 FMN-dependent NAD(P)H:quinone reductase that may be 
involved in quinone detoxification; gene expression 
increases in cultures shifted to a lower temperature, LOT6 
0.9 5.86E-
03 
Biosynthesis of secondary metabolites  
FBP1 Fructose-1,6-bisphosphatase, key regulatory enzyme in 
the gluconeogenesis pathway, required for glucose 
metabolism, FBP1 
5.5 7.81E-
05 
PDC6 Minor isoform of pyruvate decarboxylase, decarboxylates 
pyruvate to acetaldehyde, involved in amino acid 
catabolism; transcription is glucose- and ethanol-
dependent, and is strongly induced during sulfur 
limitation, PDC6 
4.3 3.70E-
04 
INO1 Inositol 1-phosphate synthase, involved in synthesis of 
inositol phosphates and inositol-containing phospholipids; 
transcription is coregulated with other phospholipid 
biosynthetic genes by Ino2p and Ino4p, which bind the 
UASINO DNA element, INO1 
4.1 7.39E-
07 
AGX1 Alanine:glyoxylate aminotransferase (AGT), catalyzes the 
synthesis of glycine from glyoxylate, which is one of 
three pathways for glycine biosynthesis in yeast; has 
similarity to mammalian and plant alanine:glyoxylate 
aminotransferases, AGX1 
3.1 8.96E-
06 
IDP2 Cytosolic NADP-specific isocitrate dehydrogenase, 
catalyzes oxidation of isocitrate to alpha-ketoglutarate; 
levels are elevated during growth on non-fermentable 
carbon sources and reduced during growth on glucose, 
IDP2 
3.1 1.51E-
04 
IRC15 Putative S-adenosylmethionine-dependent 
methyltransferase of the seven beta-strand family; null 
mutant displays increased levels of spontaneous Rad52 
2.9 5.70E-
05 
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foci, --- 
POT1 3-ketoacyl-CoA thiolase with broad chain length 
specificity, cleaves 3-ketoacyl-CoA into acyl-CoA and 
acetyl-CoA during beta-oxidation of fatty acids, POT1 
2.8 5.84E-
04 
CTT1 Cytosolic catalase T, has a role in protection from 
oxidative damage by hydrogen peroxide, CTT1 
2.2 1.98E-
04 
GND2 6-phosphogluconate dehydrogenase (decarboxylating), 
catalyzes an NADPH regenerating reaction in the pentose 
phosphate pathway; required for growth on D-glucono-
delta-lactone, GND2 
2.1 1.28E-
04 
MET8 Bifunctional dehydrogenase and ferrochelatase, involved 
in the biosynthesis of siroheme, a prosthetic group used 
by sulfite reductase; required for sulfate assimilation and 
methionine biosynthesis, MET8 
1.9 4.47E-
04 
GAL3 Transcriptional regulator involved in activation of the 
GAL genes in response to galactose; forms a complex 
with Gal80p to relieve Gal80p inhibition of Gal4p; binds 
galactose and ATP but does not have galactokinase 
activity, GAL3 
1.3 2.31E-
03 
MCR1 Mitochondrial NADH-cytochrome b5 reductase, involved 
in ergosterol biosynthesis, MCR1 
1.3 1.58E-
03 
ACS1 Acetyl-coA synthetase isoform which, along with Acs2p, 
is the nuclear source of acetyl-coA for histone acetlyation; 
expressed during growth on nonfermentable carbon 
sources and under aerobic conditions, ACS1 
1.2 2.15E-
03 
SDH4 Membrane anchor subunit of succinate dehydrogenase 
(Sdh1p, Sdh2p, Sdh3p, Sdh4p), which couples the 
oxidation of succinate to the transfer of electrons to 
ubiquinone, SDH4 
1.1 4.66E-
03 
YNK1 Nucleoside diphosphate kinase, catalyzes the transfer of 
gamma phosphates from nucleoside triphosphates, usually 
ATP, to nucleoside diphosphates by a mechanism that 
involves formation of an autophosphorylated enzyme 
intermediate, YNK1 
1.1 4.62E-
03 
SAM2 S-adenosylmethionine synthetase, catalyzes transfer of the 
adenosyl group of ATP to the sulfur atom of methionine; 
one of two differentially regulated isozymes (Sam1p and 
Sam2p), SAM2 
0.9 8.18E-
03 
Small metobolic processes   
PDC6 Minor isoform of pyruvate decarboxylase, decarboxylates 
pyruvate to acetaldehyde, involved in amino acid 
catabolism; transcription is glucose- and ethanol-
dependent, and is strongly induced during sulfur 
limitation, PDC6 
4.3 3.70E-
04 
INO1 Inositol 1-phosphate synthase, involved in synthesis of 
inositol phosphates and inositol-containing phospholipids; 
transcription is coregulated with other phospholipid 
biosynthetic genes by Ino2p and Ino4p, which bind the 
UASINO DNA element, INO1 
4.1 7.39E-
07 
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YGP1 Cell wall-related secretory glycoprotein; induced by 
nutrient deprivation-associated growth arrest and upon 
entry into stationary phase; may be involved in adaptation 
prior to stationary phase entry; has similarity to Sps100p, 
YGP1 
4.0 1.13E-
07 
PDR15 Plasma membrane ATP binding cassette (ABC) 
transporter, multidrug transporter and general stress 
response factor implicated in cellular detoxification; 
regulated by Pdr1p, Pdr3p and Pdr8p; promoter contains a 
PDR responsive element, PDR15 
3.2 4.08E-
04 
AGX1 Alanine:glyoxylate aminotransferase (AGT), catalyzes the 
synthesis of glycine from glyoxylate, which is one of 
three pathways for glycine biosynthesis in yeast; has 
similarity to mammalian and plant alanine:glyoxylate 
aminotransferases, AGX1 
3.1 8.96E-
06 
IDP2 Cytosolic NADP-specific isocitrate dehydrogenase, 
catalyzes oxidation of isocitrate to alpha-ketoglutarate; 
levels are elevated during growth on non-fermentable 
carbon sources and reduced during growth on glucose, 
IDP2 
3.1 1.51E-
04 
POT1 3-ketoacyl-CoA thiolase with broad chain length 
specificity, cleaves 3-ketoacyl-CoA into acyl-CoA and 
acetyl-CoA during beta-oxidation of fatty acids, POT1 
2.8 5.84E-
04 
URA10 One of two orotate phosphoribosyltransferase isozymes 
(see also URA5) that catalyze the fifth enzymatic step in 
the de novo biosynthesis of pyrimidines, converting 
orotate into orotidine-5'-phosphate, URA10 
2.8 2.39E-
03 
NDE2 Mitochondrial external NADH dehydrogenase, catalyzes 
the oxidation of cytosolic NADH; Nde1p and Nde2p are 
involved in providing the cytosolic NADH to the 
mitochondrial respiratory chain, NDE2 
2.7 9.11E-
06 
GRE2 NADPH-dependent methylglyoxal reductase (D-
lactaldehyde dehydrogenase); stress induced (osmotic, 
ionic, oxidative, heat shock and heavy metals); regulated 
by the HOG pathway, GRE2 
2.2 3.38E-
03 
GTO1 Omega-class glutathione transferase; induced under 
oxidative stress; putative peroxisomal localization, GTO1 
2.2 9.17E-
05 
GND2 6-phosphogluconate dehydrogenase (decarboxylating), 
catalyzes an NADPH regenerating reaction in the pentose 
phosphate pathway; required for growth on D-glucono-
delta-lactone, GND2 
2.1 1.28E-
04 
MHT1 S-methylmethionine-homocysteine methyltransferase, 
functions along with Sam4p in the conversion of S-
adenosylmethionine (AdoMet) to methionine to control 
the methionine/AdoMet ratio, MHT1 
2.0 8.18E-
04 
PDR5 Plasma membrane ATP-binding cassette (ABC) 
transporter, short-lived multidrug transporter actively 
regulated by Pdr1p; also involved in steroid transport, 
cation resistance, and cellular detoxification during 
exponential growth, PDR5 
2.0 3.66E-
03 
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OLE1 Delta(9) fatty acid desaturase, required for 
monounsaturated fatty acid synthesis and for normal 
distribution of mitochondria, OLE1 
1.9 3.32E-
04 
MET8 Bifunctional dehydrogenase and ferrochelatase, involved 
in the biosynthesis of siroheme, a prosthetic group used 
by sulfite reductase; required for sulfate assimilation and 
methionine biosynthesis, MET8 
1.9 4.47E-
04 
GDH3 NADP(+)-dependent glutamate dehydrogenase, 
synthesizes glutamate from ammonia and alpha-
ketoglutarate; rate of alpha-ketoglutarate utilization 
differs from Gdh1p; expression regulated by nitrogen and 
carbon sources, GDH3 
1.8 5.97E-
04 
CAT2 Carnitine acetyl-CoA transferase present in both 
mitochondria and peroxisomes, transfers activated acetyl 
groups to carnitine to form acetylcarnitine which can be 
shuttled across membranes, CAT2 
1.7 1.13E-
04 
YOR1 Plasma membrane ATP-binding cassette (ABC) 
transporter, multidrug transporter mediates export of 
many different organic anions including oligomycin, 
YOR1 
1.7 8.81E-
03 
MET32 Zinc-finger DNA-binding protein, involved in 
transcriptional regulation of the methionine biosynthetic 
genes, similar to Met31p, MET32 
1.6 4.12E-
04 
TRX3 Mitochondrial thioredoxin, highly conserved 
oxidoreductase required to maintain the redox 
homeostasis of the cell, forms the mitochondrial 
thioredoxin system with Trr2p, redox state is maintained 
by both Trr2p and Glr1p, TRX3 
1.6 2.39E-
03 
THI4 Thiazole synthase, catalyzes formation of the thiazole 
moiety of thiamin pyrophosphate; required for thiamine 
biosynthesis and for mitochondrial genome stability, 
THI4 
1.6 1.27E-
04 
MET28 Transcriptional activator in the Cbf1p-Met4p-Met28p 
complex, participates in the regulation of sulfur 
metabolism, MET28 
1.6 1.74E-
04 
UBC8 Ubiquitin-conjugating enzyme that negatively regulates 
gluconeogenesis by mediating the glucose-induced 
ubiquitination of fructose-1,6-bisphosphatase (FBPase); 
cytoplasmic enzyme that catalyzes the ubiquitination of 
histones in vitro, UBC8 
1.6 4.67E-
03 
MET30 F-box protein containing five copies of the WD40 motif, 
controls cell cycle function, sulfur metabolism, and 
methionine biosynthesis as part of the ubiquitin ligase 
complex; interacts with and regulates Met4p, localizes 
within the nucleus, MET30 
1.6 2.18E-
03 
YKL151C Putative protein of unknown function; green fluorescent 
protein (GFP)-fusion protein localizes to the cytoplasm, --
- 
1.6 2.19E-
03 
DAP1 Heme-binding protein involved in regulation of 
cytochrome P450 protein Erg11p; damage response 
1.5 8.74E-
03 
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protein, related to mammalian membrane progesterone 
receptors; mutations lead to defects in telomeres, 
mitochondria, and sterol synthesis, DAP1 
MET2 L-homoserine-O-acetyltransferase, catalyzes the 
conversion of homoserine to O-acetyl homoserine which 
is the first step of the methionine biosynthetic pathway, 
MET2 
1.5 1.79E-
04 
YDL124W NADPH-dependent alpha-keto amide reductase; reduces 
aromatic alpha-keto amides, aliphatic alpha-keto esters, 
and aromatic alpha-keto esters; member of the aldo-keto 
reductase (AKR) family, --- 
1.5 4.20E-
04 
ECM4 Omega class glutathione transferase; not essential; similar 
to Ygr154cp; green fluorescent protein (GFP)-fusion 
protein localizes to the cytoplasm, ECM4 
1.4 2.94E-
04 
GSP2 GTP binding protein (mammalian Ranp homolog) 
involved in the maintenance of nuclear organization, 
RNA processing and transport; interacts with Kap121p, 
Kap123p and Pdr6p (karyophilin betas); Gsp1p homolog 
that is not required for viability, GSP2 
1.4 6.29E-
04 
STF1 Protein involved in regulation of the mitochondrial F1F0-
ATP synthase; Stf1p and Stf2p act as stabilizing factors 
that enhance inhibitory action of the Inh1p protein, STF1 
1.3 1.16E-
03 
GUT2 Mitochondrial glycerol-3-phosphate dehydrogenase; 
expression is repressed by both glucose and cAMP and 
derepressed by non-fermentable carbon sources in a 
Snf1p, Rsf1p, Hap2/3/4/5 complex dependent manner, 
GUT2 
1.3 4.40E-
03 
GSH1 Gamma glutamylcysteine synthetase catalyzes the first 
step in glutathione (GSH) biosynthesis; expression 
induced by oxidants, cadmium, and mercury, GSH1 
1.3 5.85E-
04 
CKI1 Choline kinase, catalyzing the first step in 
phosphatidylcholine synthesis via the CDP-choline 
(Kennedy pathway); exhibits some ethanolamine kinase 
activity contributing to phosphatidylethanolamine 
synthesis via the CDP-ethanolamine pathway, CKI1 
1.3 3.23E-
03 
MCR1 Mitochondrial NADH-cytochrome b5 reductase, involved 
in ergosterol biosynthesis, MCR1 
1.3 1.58E-
03 
GTT2 Glutathione S-transferase capable of homodimerization; 
functional overlap with Gtt2p, Grx1p, and Grx2p, GTT2 
1.2 1.15E-
03 
VHS3 Functionally redundant (see also SIS2) inhibitory subunit 
of Ppz1p, a PP1c-related ser/thr protein phosphatase Z 
isoform; synthetically lethal with sis2; putative 
phosphopantothenoylcysteine decarboxylase involved in 
coenzyme A biosynthesis, VHS3 
1.2 3.03E-
03 
CAT8 Zinc cluster transcriptional activator necessary for 
derepression of a variety of genes under non-fermentative 
growth conditions, active after diauxic shift, binds carbon 
source responsive elements, CAT8 
1.2 7.90E-
03 
PCA1 Cadmium transporting P-type ATPase; may also have a 
role in copper and iron homeostasis; S288C and most 
1.2 7.40E-
03 
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other lab strains contain a G970R mutation which 
eliminates normal cadmium transport function, PCA1 
GDE1 Glycerophosphocholine (GroPCho) phosphodiesterase; 
hydrolyzes GroPCho to choline and glycerolphosphate, 
for use as a phosphate source and as a precursor for 
phosphocholine synthesis; may interact with ribosomes, 
GDE1 
1.2 8.96E-
03 
RNR3 Ribonucleotide-diphosphate reductase (RNR), large 
subunit; the RNR complex catalyzes the rate-limiting step 
in dNTP synthesis and is regulated by DNA replication 
and DNA damage checkpoint pathways via localization of 
the small subunits, RNR3 
1.2 8.96E-
03 
YNL200C Putative protein of unknown function; the authentic, non-
tagged protein is detected in highly purified mitochondria 
in high-throughput studies, --- 
1.2 1.16E-
03 
ACS1 Acetyl-coA synthetase isoform which, along with Acs2p, 
is the nuclear source of acetyl-coA for histone acetlyation; 
expressed during growth on nonfermentable carbon 
sources and under aerobic conditions, ACS1 
1.2 2.15E-
03 
CHO1 Phosphatidylserine synthase, functions in phospholipid 
biosynthesis; catalyzes the reaction CDP-diaclyglycerol + 
L-serine = CMP + L-1-phosphatidylserine, 
transcriptionally repressed by myo-inositol and choline, 
CHO1 
1.1 1.53E-
03 
CHO2 Phosphatidylethanolamine methyltransferase (PEMT), 
catalyzes the first step in the conversion of 
phosphatidylethanolamine to phosphatidylcholine during 
the methylation pathway of phosphatidylcholine 
biosynthesis, CHO2 
1.1 3.97E-
03 
MSB3 GTPase-activating protein for Sec4p and several other 
Rab GTPases, regulates exocytosis via its action on 
Sec4p, also required for proper actin organization; similar 
to Msb4p; both Msb3p and Msb4p localize to sites of 
polarized growth, MSB3 
1.1 2.29E-
03 
GDH2 NAD(+)-dependent glutamate dehydrogenase, degrades 
glutamate to ammonia and alpha-ketoglutarate; expression 
sensitive to nitrogen catabolite repression and intracellular 
ammonia levels, GDH2 
1.1 1.67E-
03 
UGA2 Succinate semialdehyde dehydrogenase involved in the 
utilization of gamma-aminobutyrate (GABA) as a 
nitrogen source; part of the 4-aminobutyrate and 
glutamate degradation pathways; localized to the 
cytoplasm, UGA2 
1.1 5.39E-
03 
FAS2 Alpha subunit of fatty acid synthetase, which catalyzes 
the synthesis of long-chain saturated fatty acids; contains 
beta-ketoacyl reductase and beta-ketoacyl synthase 
activities; phosphorylated, FAS2 
1.1 6.48E-
03 
YNK1 Nucleoside diphosphate kinase, catalyzes the transfer of 
gamma phosphates from nucleoside triphosphates, usually 
ATP, to nucleoside diphosphates by a mechanism that 
1.1 4.62E-
03 
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involves formation of an autophosphorylated enzyme 
intermediate, YNK1 
MET3 ATP sulfurylase, catalyzes the primary step of 
intracellular sulfate activation, essential for assimilatory 
reduction of sulfate to sulfide, involved in methionine 
metabolism, MET3 
1.1 9.38E-
03 
ROM1 GDP/GTP exchange protein (GEP) for Rho1p; mutations 
are synthetically lethal with mutations in rom2, which 
also encodes a GEP, ROM1 
1.0 5.61E-
03 
GTT1 ER associated glutathione S-transferase capable of 
homodimerization; expression induced during the diauxic 
shift and throughout stationary phase; functional overlap 
with Gtt2p, Grx1p, and Grx2p, GTT1 
1.0 9.16E-
03 
HTD2 Mitochondrial 3-hydroxyacyl-thioester dehydratase 
involved in fatty acid biosynthesis, required for 
respiratory growth and for normal mitochondrial 
morphology, HTD2 
1.0 3.55E-
03 
OPI3 Phospholipid methyltransferase (methylene-fatty-acyl-
phospholipid synthase), catalyzes the last two steps in 
phosphatidylcholine biosynthesis, OPI3 
1.0 6.83E-
03 
EHT1 Acyl-coenzymeA:ethanol O-acyltransferase that plays a 
minor role in medium-chain fatty acid ethyl ester 
biosynthesis; contains esterase activity; localizes to lipid 
particles and the mitochondrial outer membrane, EHT1 
0.9 6.13E-
03 
INH1 Protein that inhibits ATP hydrolysis by the F1F0-ATP 
synthase, inhibitory function is enhanced by stabilizing 
proteins Stf1p and Stf2p; has similarity to Stf1p and both 
Inh1p and Stf1p exhibit the potential to form coiled-coil 
structures, INH1 
0.9 8.93E-
03 
SAM2 S-adenosylmethionine synthetase, catalyzes transfer of the 
adenosyl group of ATP to the sulfur atom of methionine; 
one of two differentially regulated isozymes (Sam1p and 
Sam2p), SAM2 
0.9 8.18E-
03 
Stress 
 
  
Multiple stress response   
SPI1 GPI-anchored cell wall protein involved in weak acid 
resistance; basal expression requires Msn2p/Msn4p; 
expression is induced under conditions of stress and 
during the diauxic shift; similar to Sed1p, SPI1 
4.7 8.17E-
04 
PDR15 Plasma membrane ATP binding cassette (ABC) 
transporter, multidrug transporter and general stress 
response factor implicated in cellular detoxification; 
regulated by Pdr1p, Pdr3p and Pdr8p; promoter contains a 
PDR responsive element, PDR15 
3.2 4.08E-
04 
DDR2 Multistress response protein, expression is activated by a 
variety of xenobiotic agents and environmental or 
physiological stresses, DDR2 
2.7 1.11E-
05 
GRE2 NADPH-dependent methylglyoxal reductase (D-
lactaldehyde dehydrogenase); stress induced (osmotic, 
2.2 3.38E-
03 
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ionic, oxidative, heat shock and heavy metals); regulated 
by the HOG pathway, GRE2 
CTT1 Cytosolic catalase T, has a role in protection from 
oxidative damage by hydrogen peroxide,  
2.2 1.98E-
04 
SRL3 Cytoplasmic protein that, when overexpressed, suppresses 
the lethality of a rad53 null mutation; potential Cdc28p 
substrate 
2.0 0.00354
2 
DCS2 Non-essential, stress induced regulatory protein 
containing a HIT (histidine triad) motif; modulates m7G-
oligoribonucleotide metabolism; inhibits Dcs1p; regulated 
by Msn2p, Msn4p, and the Ras-cAMP-cAPK signaling 
pathway, similar to Dcs1p., DCS2 
1.9 6.80E-
04 
FRT2 Tail-anchored endoplasmic reticulum membrane protein, 
interacts with homolog Frt1p but is not a substrate of 
calcineurin (unlike Frt1p), promotes growth in conditions 
of high Na+, alkaline pH, or cell wall stress; potential 
Cdc28p substrate, FRT2 
1.7 3.36E-
03 
RPN4 Transcription factor that stimulates expression of 
proteasome genes; Rpn4p levels are in turn regulated by 
the 26S proteasome in a negative feedback control 
mechanism; RPN4 is transcriptionally regulated by 
various stress responses, RPN4 
1.5 8.18E-
03 
MBR1 Protein involved in mitochondrial functions and stress 
response; overexpression suppresses growth defects of 
hap2, hap3, and hap4 mutants, MBR1 
1.5 7.49E-
03 
UBI4 Ubiquitin, becomes conjugated to proteins, marking them 
for selective degradation via the ubiquitin-26S 
proteasome system; essential for the cellular stress 
response; encoded as a polyubiquitin precursor comprised 
of 5 head-to-tail repeats, UBI4 
1.2 1.98E-
03 
HSP150 O-mannosylated heat shock protein that is secreted and 
covalently attached to the cell wall via beta-1,3-glucan 
and disulfide bridges; required for cell wall stability; 
induced by heat shock, oxidative stress, and nitrogen 
limitation, HSP150 
1.0 6.70E-
03 
NTH1 Neutral trehalase, degrades trehalose; required for 
thermotolerance and may mediate resistance to other 
cellular stresses; may be phosphorylated by Cdc28p, 
NTH1 
1.0 5.36E-
03 
Osmolarity stress   
SIP18 Protein of unknown function whose expression is induced 
by osmotic stress, SIP18 
5.4 5.69E-
08 
STL1 Glycerol proton symporter of the plasma membrane, 
subject to glucose-induced inactivation, strongly but 
transiently induced when cells are subjected to osmotic 
shock, STL1 
3.9 2.35E-
03 
PAI3 Cytop\lasmic proteinase A (Pep4p) inhibitor, dependent 
on Pbs2p and Hog1p protein kinases for osmotic 
induction; intrinsically unstructured, N-terminal half 
3.7 5.86E-
06 
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becomes ordered in the active site of proteinase A upon 
contact, PAI3 
SMP1 Putative transcription factor involved in regulating the 
response to osmotic stress; member of the MADS-box 
family of transcription factors, SMP1 
1.7 2.70E-
03 
GPH1 Non-essential glycogen phosphorylase required for the 
mobilization of glycogen, activity is regulated by cyclic 
AMP-mediated phosphorylation, expression is regulated 
by stress-response elements and by the HOG MAP kinase 
pathway, GPH1 
1.4 2.25E-
03 
SSK22 MAP kinase kinase kinase of the HOG1 mitogen-
activated signaling pathway; functionally redundant with, 
and homologous to, Ssk2p; interacts with and is activated 
by Ssk1p; phosphorylates Pbs2p, SSK22 
1.2 5.15E-
03 
Heat shock 
 
  
HSP26 Small heat shock protein (sHSP) with chaperone activity; 
forms hollow, sphere-shaped oligomers that suppress 
unfolded proteins aggregation; oligomer activation 
requires a heat-induced conformational change; not 
expressed in unstressed cells, HSP26 
4.4 2.95E-
07 
GAC1 Regulatory subunit for Glc7p type-1 protein phosphatase 
(PP1), tethers Glc7p to Gsy2p glycogen synthase, binds 
Hsf1p heat shock transcription factor, required for 
induction of some HSF-regulated genes under heat shock, 
GAC1 
2.2 9.99E-
05 
TIP1 Major cell wall mannoprotein with possible lipase 
activity; transcription is induced by heat- and cold-shock; 
member of the Srp1p/Tip1p family of serine-alanine-rich 
proteins, TIP1 
2.1 1.44E-
04 
HSP12 Plasma membrane localized protein that protects 
membranes from desiccation; induced by heat shock, 
oxidative stress, osmostress, stationary phase entry, 
glucose depletion, oleate and alcohol; regulated by the 
HOG and Ras-Pka pathways, HSP12 
1.9 5.34E-
04 
UBC5 Ubiquitin-conjugating enzyme that mediates selective 
degradation of short-lived and abnormal proteins, central 
component of the cellular stress response; expression is 
heat inducible, UBC5 
1.3 4.99E-
04 
Oxidative stress   
OYE3 Widely conserved NADPH oxidoreductase containing 
flavin mononucleotide (FMN), homologous to Oye2p 
with slight differences in ligand binding and catalytic 
properties; may be involved in sterol metabolism, OYE3 
3.6 9.43E-
05 
GPX1 Phospholipid hydroperoxide glutathione peroxidase 
induced by glucose starvation that protects cells from 
phospholipid hydroperoxides and nonphospholipid 
peroxides during oxidative stress, GPX1 
3.0 8.70E-
03 
GTO1 Omega-class glutathione transferase; induced under 
oxidative stress; putative peroxisomal localization, GTO1 
2.2 9.17E-
05 
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CTT1 Cytosolic catalase T, has a role in protection from 
oxidative damage by hydrogen peroxide,  
2.2 1.98E-
04 
YHB1 Nitric oxide oxidoreductase, flavohemoglobin involved in 
nitric oxide detoxification; plays a role in the oxidative 
and nitrosative stress responses, YHB1 
1.9 4.92E-
03 
MXR1 Peptide methionine sulfoxide reductase, reverses the 
oxidation of methionine residues; involved in oxidative 
damage repair, providing resistance to oxidative stress 
and regulation of lifespan, MXR1 
1.8 1.94E-
03 
gsh1 Gamma glutamylcysteine synthetase catalyzes the first 
step in glutathione (GSH) biosynthesis; expression 
induced by oxidants, cadmium, and mercury, GSH1 
1.3 5.85E-
04 
GTT2 Glutathione S-transferase capable of homodimerization; 
functional overlap with Gtt2p, Grx1p, and Grx2p, GTT2 
1.2 1.15E-
03 
AAD6 Putative aryl-alcohol dehydrogenase with similarity to P. 
chrysosporium aryl-alcohol dehydrogenase, involved in 
the oxidative stress response, AAD6 
1.2 7.73E-
03 
PRX1 Mitochondrial peroxiredoxin (1-Cys Prx) with thioredoxin 
peroxidase activity, has a role in reduction of 
hydroperoxides; induced during respiratory growth and 
under conditions of oxidative stress; phosphorylated, 
PRX1 
1.1 2.76E-
03 
YAP5 Basic leucine zipper (bZIP) transcription factor 1.0 0.00598 
GTT1 ER associated glutathione S-transferase capable of 
homodimerization; expression induced during the diauxic 
shift and throughout stationary phase; functional overlap 
with Gtt2p, Grx1p, and Grx2p, GTT1 
1.0 9.16E-
03 
Cell wall integrity and PKC-pathway  
PIR3 O-glycosylated covalently-bound cell wall protein 
required for cell wall stability; expression is cell cycle 
regulated, peaking in M/G1 and also subject to regulation 
by the cell integrity pathway 
5.0 9.39E-
07 
KDX1(MLP1
) 
Protein kinase implicated in the Slt2p mitogen-activated 
(MAP) kinase signaling pathway; associates with Rlm1p, 
--- 
2.1 1.38E-
03 
BAG7 Rho GTPase activating protein (RhoGAP), stimulates the 
intrinsic GTPase activity of Rho1p, which plays a role in 
actin cytoskeleton organization and control of cell wall 
synthesis; structurally and functionally related to Sac7p 
2.0 0.43253 
HSP12 Plasma membrane localized protein that protects 
membranes from desiccation; induced by heat shock, 
oxidative stress, osmostress, stationary phase entry, 
glucose depletion, oleate and alcohol; regulated by the 
HOG and Ras-Pka pathways, HSP12 
1.9 5.34E-
04 
DCS2 Non-essential, stress induced regulatory protein 
containing a HIT (histidine triad) motif; modulates m7G-
oligoribonucleotide metabolism; inhibits Dcs1p; regulated 
by Msn2p, Msn4p, and the Ras-cAMP-cAPK signaling 
pathway, similar to Dcs1p.  
1.9 6.80E-
04 
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AFR1 Alpha-factor pheromone receptor regulator, negatively 
regulates pheromone receptor signaling; required for 
normal mating projection (shmoo) formation; required for 
Spa2p to recruit Mpk1p to shmoo tip during mating; 
interacts with Cdc12p, AFR1 
1.9 1.81E-
04 
SLT2 Serine/threonine MAP kinase involved in regulating the 
maintenance of cell wall integrity and progression through 
the cell cycle; regulated by the PKC1-mediated signaling 
pathway 
1.9 0.00472
9 
PST1 Cell wall protein that contains a putative GPI-attachment 
site; secreted by regenerating protoplasts; up-regulated by 
activation of the cell integrity pathway, as mediated by 
Rlm1p; upregulated by cell wall damage via disruption of 
FKS1 
1.9 0.00472
9 
GSC2 Catalytic subunit of 1,3-beta-glucan synthase, involved in 
formation of the inner layer of the spore wall; activity 
positively regulated by Rho1p and negatively by Smk1p; 
has similarity to an alternate catalytic subunit, Fks1p 
(Gsc1p), GSC2 
1.6 1.04E-
03 
RLM1 MADS-box transcription factor, component of the protein 
kinase C-mediated MAP kinase pathway involved in the 
maintenance of cell integrity; phosphorylated and 
activated by the MAP-kinase Slt2p, RLM1 
1.2 1.44E-
03 
VHS3 Functionally redundant (see also SIS2) inhibitory subunit 
of Ppz1p, a PP1c-related ser/thr protein phosphatase Z 
isoform; synthetically lethal with sis2; putative 
phosphopantothenoylcysteine decarboxylase involved in 
coenzyme A biosynthesis, VHS3 
1.2 3.03E-
03 
MTL1 Protein with both structural and functional similarity to 
Mid2p, which is a plasma membrane sensor required for 
cell integrity signaling during pheromone-induced 
morphogenesis; suppresses rgd1 null mutations 
1.2 0.50312
4 
ROM1 GDP/GTP exchange protein (GEP) for Rho1p; mutations 
are synthetically lethal with mutations in rom2, which 
also encodes a GEP, ROM1 
1.0 5.61E-
03 
SDP1 Stress-inducible dual-specificity MAP kinase 
phosphatase, negatively regulates Slt2p MAP kinase by 
direct dephosphorylation, diffuse localization under 
normal conditions shifts to punctate localization after heat 
shock 
1.0 0.69519
8 
PTP2 Phosphotyrosine-specific protein phosphatase involved in 
the inactivation of mitogen-activated protein kinase 
(MAPK) during osmolarity sensing; dephosporylates 
Hog1p MAPK and regulates its localization; localized to 
the nucleus,  
1.0 0.02722
4 
SLT2 Serine/threonine MAP kinase involved in regulating the 
maintenance of cell wall integrity and progression through 
the cell cycle; regulated by the PKC1-mediated signaling 
pathway 
0.9 0.05730
8 
BCK2 Protein rich in serine and threonine residues involved in 0.8 0.03723
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protein kinase C signaling pathway, which controls cell 
integrity; overproduction suppresses pkc1 mutations 
1 
WSC3 Partially redundant sensor-transducer of the stress-
activated PKC1-MPK1 signaling pathway involved in 
maintenance of cell wall integrity; involved in the 
response to heat shock and other stressors; regulates 1,3-
beta-glucan synthesis 
0.7 0.11659
8 
PRM5 Pheromone-regulated protein, predicted to have 1 
transmembrane segment; induced during cell integrity 
signaling 
0.7 1 
PKH2 Serine/threonine protein kinase involved in sphingolipid-
mediated signaling pathway that controls endocytosis; 
activates Ypk1p and Ykr2p, components of signaling 
cascade required for maintenance of cell wall integrity; 
redundant with Pkh1p 
0.6 0.60056
9 
PKH3 Protein kinase with similarity to mammalian 
phosphoinositide-dependent kinase 1 (PDK1) and yeast 
Pkh1p and Pkh2p, two redundant upstream activators of 
Pkc1p; identified as a multicopy suppressor of a pkh1 
pkh2 double mutant 
0.6 0.82211
8 
ROM2 GDP/GTP exchange protein (GEP) for Rho1p and Rho2p; 
mutations are synthetically lethal with mutations in rom1, 
which also encodes a GEP 
0.6 1 
GFA1 Glutamine-fructose-6-phosphate amidotransferase, 
catalyzes the formation of glucosamine-6-P and glutamate 
from fructose-6-P and glutamine in the first step of chitin 
biosynthesis 
0.5 1 
MID2 O-glycosylated plasma membrane protein that acts as a 
sensor for cell wall integrity signaling and activates the 
pathway; interacts with Rom2p, a guanine nucleotide 
exchange factor for Rho1p, and with cell integrity 
pathway protein Zeo1p 
0.5 1 
PTP3 Phosphotyrosine-specific protein phosphatase involved in 
the inactivation of mitogen-activated protein kinase 
(MAPK) during osmolarity sensing; dephosporylates 
Hog1p MAPK and regulates its localization; localized to 
the cytoplasm 
0.4 1 
TUS1 Guanine nucleotide exchange factor (GEF) that functions 
to modulate Rho1p activity as part of the cell integrity 
signaling pathway; multicopy suppressor of tor2 mutation 
and ypk1 ypk2 double mutation; potential Cdc28p 
substrate 
0.4 1 
BCK1 Mitogen-activated protein (MAP) kinase kinase kinase 
acting in the protein kinase C signaling pathway, which 
controls cell integrity; upon activation by Pkc1p 
phosphorylates downstream kinases Mkk1p and Mkk2p 
0.3 1 
RHO5 Non-essential small GTPase of the Rho/Rac subfamily of 
Ras-like proteins, likely involved in protein kinase C 
(Pkc1p)-dependent signal transduction pathway that 
controls cell integrity 
0.3 1 
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PKH1 Serine/threonine protein kinase involved in sphingolipid-
mediated signaling pathway that controls endocytosis; 
activates Ypk1p and Ykr2p, components of signaling 
cascade required for maintenance of cell wall integrity; 
redundant with Pkh2p 
0.3 1 
PKC1 Protein serine/threonine kinase essential for cell wall 
remodeling during growth; localized to sites of polarized 
growth and the mother-daughter bud neck; homolog of 
the alpha, beta, and gamma isoforms of mammalian 
protein kinase C (PKC) 
0.3 1 
BNI1 Formin, nucleates the formation of linear actin filaments, 
involved in cell processes such as budding and mitotic 
spindle orientation which require the formation of 
polarized actin cables, functionally redundant with BNR1 
0.3 1 
SWI4 DNA binding component of the SBF complex (Swi4p-
Swi6p), a transcriptional activator that in concert with 
MBF (Mbp1-Swi6p) regulates late G1-specific 
transcription of targets including cyclins and genes 
required for DNA synthesis and repair 
0.2 1 
MKK1 Mitogen-activated kinase kinase involved in protein 
kinase C signaling pathway that controls cell integrity; 
upon activation by Bck1p phosphorylates downstream 
target, Slt2p; functionally redundant with Mkk2p 
0.2 1 
MSG5 Dual-specificity protein phosphatase required for 
maintenance of a low level of signaling through the cell 
integrity pathway; regulates and is regulated by Slt2p; 
dephosphorylates Fus3p; required for adaptive response to 
pheromone 
0.1 1 
SEC3 Non-essential subunit of the exocyst complex (Sec3p, 
Sec5p, Sec6p, Sec8p, Sec10p, Sec15p, Exo70p, Exo84p) 
which mediates targeting of post-Golgi vesicles to sites of 
active exocytosis; Sec3p specifically is a spatial landmark 
for secretion 
0.1 1 
FKS3 Protein involved in spore wall assembly, has similarity to 
1,3-beta-D-glucan synthase catalytic subunits Fks1p and 
Gsc2p; the authentic, non-tagged protein is detected in 
highly purified mitochondria in high-throughput studie 
0.0 1 
SAC7 GTPase activating protein (GAP) for Rho1p, involved in 
signaling to the actin cytoskeleton, null mutations 
suppress tor2 mutations and temperature sensitive 
mutations in actin; potential Cdc28p substrate 
-0.1 1 
BNR1 Formin, nucleates the formation of linear actin filaments, 
involved in cell processes such as budding and mitotic 
spindle orientation which require the formation of 
polarized actin cables, functionally redundant with BNI1 
-0.2 1 
BEM2 Rho GTPase activating protein (RhoGAP) involved in the 
control of cytoskeleton organization and cellular 
morphogenesis; required for bud emergence 
-0.2 1 
SKN7 Nuclear response regulator and transcription factor, part 
of a branched two-component signaling system; required 
-0.3 1 
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for optimal induction of heat-shock genes in response to 
oxidative stress; involved in osmoregulation 
RHO1 GTP-binding protein of the rho subfamily of Ras-like 
proteins, involved in establishment of cell polarity; 
regulates protein kinase C (Pkc1p) and the cell wall 
synthesizing enzyme 1,3-beta-glucan synthase (Fks1p and 
Gsc2p) 
-0.3 1 
SWI6 Transcription cofactor, forms complexes with DNA-
binding proteins Swi4p and Mbp1p to regulate 
transcription at the G1/S transition; involved in meiotic 
gene expression; localization regulated by 
phosphorylation; potential Cdc28p substrate 
-0.5 0.68630
7 
FKS1 Catalytic subunit of 1,3-beta-D-glucan synthase, 
functionally redundant with alternate catalytic subunit 
Gsc2p; binds to regulatory subunit Rho1p; involved in 
cell wall synthesis and maintenance; localizes to sites of 
cell wall remodeling 
-0.6 1 
LRG1 Putative GTPase-activating protein (GAP) involved in the 
Pkc1p-mediated signaling pathway that controls cell wall 
integrity; appears to specifically regulate 1,3-beta-glucan 
synthesis 
-0.8 0.18536
7 
WSC2 Partially redundant sensor-transducer of the stress-
activated PKC1-MPK1 signaling pathway involved in 
maintenance of cell wall integrity and recovery from heat 
shock; secretory pathway Wsc2p is required for the arrest 
of secretion response,  
-1.2 0.45421
4 
Sulfur metabolism   
JLP1 Fe(II)-dependent sulfonate/alpha-ketoglutarate 
dioxygenase, involved in sulfonate catabolism for use as a 
sulfur source, contains sequence that closely resembles a J 
domain (typified by the E. coli DnaJ protein), JLP1 
6.7 1.80E-
05 
AGP3 Low-affinity amino acid permease, may act to supply the 
cell with amino acids as nitrogen source in nitrogen-poor 
conditions; transcription is induced under conditions of 
sulfur limitation, AGP3 
5.1 3.92E-
06 
PDC6 Minor isoform of pyruvate decarboxylase, decarboxylates 
pyruvate to acetaldehyde, involved in amino acid 
catabolism; transcription is glucose- and ethanol-
dependent, and is strongly induced during sulfur 
limitation, PDC6 
4.3 3.70E-
04 
BDS1 Bacterially-derived sulfatase required for use of alkyl- and 
aryl-sulfates as sulfur sources, BDS1 
3.2 7.60E-
05 
GTO1 Omega-class glutathione transferase; induced under 
oxidative stress; putative peroxisomal localization, GTO1 
2.2 9.17E-
05 
MHT1 S-methylmethionine-homocysteine methyltransferase, 
functions along with Sam4p in the conversion of S-
adenosylmethionine (AdoMet) to methionine to control 
the methionine/AdoMet ratio, MHT1 
2.0 8.18E-
04 
MET8 Bifunctional dehydrogenase and ferrochelatase, involved 1.9 4.47E-
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in the biosynthesis of siroheme, a prosthetic group used 
by sulfite reductase; required for sulfate assimilation and 
methionine biosynthesis, MET8 
04 
YLL058W Putative protein of unknown function with similarity to 
Str2p, which is a cystathionine gamma-synthase important 
in sulfur metabolism; YLL058W is not an essential gene, 
--- 
1.8 3.34E-
03 
MET32 Zinc-finger DNA-binding protein, involved in 
transcriptional regulation of the methionine biosynthetic 
genes, similar to Met31p, MET32 
1.6 4.12E-
04 
THI4 Thiazole synthase, catalyzes formation of the thiazole 
moiety of thiamin pyrophosphate; required for thiamine 
biosynthesis and for mitochondrial genome stability, 
THI4 
1.6 1.27E-
04 
MET28 Transcriptional activator in the Cbf1p-Met4p-Met28p 
complex, participates in the regulation of sulfur 
metabolism, MET28 
1.6 1.74E-
04 
MET30 F-box protein containing five copies of the WD40 motif, 
controls cell cycle function, sulfur metabolism, and 
methionine biosynthesis as part of the ubiquitin ligase 
complex; interacts with and regulates Met4p, localizes 
within the nucleus, MET30 
1.6 2.18E-
03 
MET2 L-homoserine-O-acetyltransferase, catalyzes the 
conversion of homoserine to O-acetyl homoserine which 
is the first step of the methionine biosynthetic pathway, 
MET2 
1.5 1.79E-
04 
ECM4 Omega class glutathione transferase; not essential; similar 
to Ygr154cp; green fluorescent protein (GFP)-fusion 
protein localizes to the cytoplasm, ECM4 
1.4 2.94E-
04 
GSH1 Gamma glutamylcysteine synthetase catalyzes the first 
step in glutathione (GSH) biosynthesis; expression 
induced by oxidants, cadmium, and mercury, GSH1 
1.3 5.85E-
04 
GTT2 Glutathione S-transferase capable of homodimerization; 
functional overlap with Gtt2p, Grx1p, and Grx2p, GTT2 
1.2 1.15E-
03 
YHR112C Putative protein of unknown function; green fluorescent 
protein (GFP)-fusion protein localizes to the cytoplasm, --
- 
1.2 1.65E-
03 
MET3 ATP sulfurylase, catalyzes the primary step of 
intracellular sulfate activation, essential for assimilatory 
reduction of sulfate to sulfide, involved in methionine 
metabolism, MET3 
1.1 9.38E-
03 
GTT1 ER associated glutathione S-transferase capable of 
homodimerization; expression induced during the diauxic 
shift and throughout stationary phase; functional overlap 
with Gtt2p, Grx1p, and Grx2p, GTT1 
1.0 9.16E-
03 
SAM2 S-adenosylmethionine synthetase, catalyzes transfer of the 
adenosyl group of ATP to the sulfur atom of methionine; 
one of two differentially regulated isozymes (Sam1p and 
Sam2p), SAM2 
0.9 8.18E-
03 
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Iron ion homeostasis   
HMX1 ER localized, heme-binding peroxidase involved in the 
degradation of heme; does not exhibit heme oxygenase 
activity despite similarity to heme oxygenases; expression 
regulated by AFT1, HMX1 
2.5 9.76E-
03 
SIT1 Ferrioxamine B transporter, member of the ARN family 
of transporters that specifically recognize siderophore-
iron chelates; transcription is induced during iron 
deprivation and diauxic shift; potentially phosphorylated 
by Cdc28p, SIT1 
2.3 1.28E-
03 
FIT2 Mannoprotein that is incorporated into the cell wall via a 
glycosylphosphatidylinositol (GPI) anchor, involved in 
the retention of siderophore-iron in the cell wall, FIT2 
2.0 6.39E-
05 
ARN2 Transporter, member of the ARN family of transporters 
that specifically recognize siderophore-iron chelates; 
responsible for uptake of iron bound to the siderophore 
triacetylfusarinine C, ARN2 
1.9 1.38E-
03 
FIT3 Mannoprotein that is incorporated into the cell wall via a 
glycosylphosphatidylinositol (GPI) anchor, involved in 
the retention of siderophore-iron in the cell wall, FIT3 
1.7 5.54E-
03 
TIS11 mRNA-binding protein expressed during iron starvation; 
binds to a sequence element in the 3'-untranslated regions 
of specific mRNAs to mediate their degradation; involved 
in iron homeostasis, TIS11 
1.4 3.07E-
03 
PCA1 Cadmium transporting P-type ATPase; may also have a 
role in copper and iron homeostasis; S288C and most 
other lab strains contain a G970R mutation which 
eliminates normal cadmium transport function, PCA1 
1.2 7.40E-
03 
FRE6 Putative ferric reductase with similarity to Fre2p; 
expression induced by low iron levels, FRE6 
1.1 7.08E-
03 
ATX1 Cytosolic copper metallochaperone that transports copper 
to the secretory vesicle copper transporter Ccc2p for 
eventual insertion into Fet3p, which is a multicopper 
oxidase required for high-affinity iron uptake, ATX1 
1.1 9.51E-
03 
a The log2 ratio of treated/control. 
b The Bonferroni-corrected p values. 
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 SI Fig 2. Anaerobic vs. aerobic growth curves. 107 mg/L of limonene was added at mid-
exponential phase. Error bars represent one SD above and below the mean for biological 
triplicates.  
 
 
SI Fig 3. GC-MS chromatogram of limonene (RT = 7.9 min) sampled from challenged 
cultures after 6 h incubation at 30°C. The black line is limonene from anaerobic flasks (with 
no limonene oxide formation) and the blue line represents limonene from aerobic cultures 
(limonene oxide compounds at 11.5 min, peak 1 = limonene oxide, cis and peak 2 = limonene 
oxide, trans.). At 12 after inoculation (6 h after limonene addition), 1 mL of isopropyl 
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myristate (IPM) was added to the culture (~ 22 ml), vortexed and harvested (1 min, 4025 rcf). 
The top IPM phase containing limonene was removed and 1 μL was resuspended in 1 mL of 
a 1:4 toluene:hexane solution. The GC-MS analysis was carried out using the setting 
described in the Materials and Methods section with the following changes: 1 μL of sample 
was injected and the oven temperature was set to 70°C, held for 10 min then followed by a 
temperature ramp of 40 °C/min to 300°C and held for 3 min. Detection was achieved in scan 
mode at 9.26 scans/sec from 30-300 amu. 
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SI Fig 4. Transcript levels of genes associated with ergosterol biosynthesis. Numbers in the 
parenthesis represent the log2 fold changes of that particular gene (treated/control). None of 
these genes were differentially expressed (Bonferroni-corrected p < 0.01).  
 
SI Fig 5. Effect of exogenous ergosterol on the growth and viability. Yeast cultures were 
dosed with limonene as described in the Materials and Methods. Cells were harvested and 
washed and diluted on rich medium (YPD) plates as described by Liu, et al (1). (a) YPD and 
(b) YPD + 0.1 mM ergosterol/Tween 80 (0.25% v/v). The top row of each plate is the 
untreated control and rows 2-4 represent biological replicates for limonene-treated cells at 
varying dilutions (10-1-10-6). Image was taken at 24 h. Tween 80 did cause spreading of the 
culture droplet on the surface in the ergosterol supplemented plate causing an increase in the 
diameter. 
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 SI Fig 6. Dose response growth curves in the presence of limonene and limonene + 
surfactant. 107 mg/L of limonene was added at mid-exponential phase. Limonene was 
administered in the presence and absence of Tween 80 (0.2% v/v). Error bars represent one 
SD above and below the mean for biological triplicates. 
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Fig S1. Pulsed-field gel electrophorogram of chromosomes from wild-type (WT) and 
evolved strains. M, yeast chromosome markers. Marker bands are labelled by 
chromosome. 
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Fig S2. Single mutant (tcb3-989) growth during limonene treatment. The method followed 
Brennan et al. exactly 1. At mid-exponential growth (6 h) 107 mg/l of limonene was dosed 
into the culture and growth was monitored. Total RNA was extracted 2 post limonene 
addition. All data was performed in triplicate. 
 
 
 
Table S1. Overall Illumina whole-genome sequencing results and detection of mutations 
Strain Gen 
Total no. 
Mapped 
PE reads 
Genome 
percent 
reference 
coverage 
(%) 
Average 
read 
depth 
Total no. 
mutations 
Total 
no. 
SNPs Coding 
Non-
coding 
Total 
no. 
INDELS Coding 
Non- 
coding 
Limonene 
Recoveryb 
(%) 
TB21 88 56883018 99.02 350.9639 29 11 7 4 18 1 17 106±12 
TB302 120 17106404 96.95 105.5452 39 4 2 2 35 8 27 128±9 
TB405 160 20087733 98.01 123.9398 31 7 2 5 24 6 18 124±20 
TB478 188 54674451 98.97 337.3372 31 10 7 3 21 2 19 138±7 
TB511 200 18685198 98.3 115.2862 31 8 6 2 23 8 15 132±10 
TB516 200 19656432 98.16 121.2787 39 7 2 5 32 7 25 136±7 
TB517 200 18326663 98.12 113.0741 35 5 3 2 30 3 27 115±24 
TB519 200 19444208 98.01 119.9693 42 9 6 3 33 4 29 141±17 
TB23csa 666 18480963 98.21% 114.0261 32 12 3 9 20 2 18 - 
a Strain TB23cs was isolated from a chemostat culture. 
b Recovery was calculated by taking the ratio of the peak area, determined by CG/MS, of limonene from the evolved 
strain to the control after 12 h of fermentation during the relative fitness assay. The control was carried out under 
identical conditions but in the absence of cells. For the WT strain the recovery was 119±5%. All data is in biological 
triplicate ± SD (n = 3).  
 
 
Table S2. Primers used in this work. 
Primer name 5′ to 3′ sequence 
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PDR3aF ATGAAAGTGAAGAAATCAACTAG 
PDR3aR GTATTCTGGGCCTCCATGTCTTCTTTATGGTTAATGAATCCC 
PDR3bF GAATGCTGGTCGCTATACTGTTGTCTCGTTGGGAGTATTATG 
PDR3bR TCATAAGAAGGGATATGAAGTATTG 
amdPF GGGATTCATTAACCATAAAGAAGACATGGAGGCCCAGAATAC 
amdPR CATAATACTCCCAACGAGACAACAGTATAGCGACCAGCATTC 
PDR3KIcheck
F 
CGCACTGAACACTACCTGGG 
PDR3KIcheck
R 
ATGACGAGGACGCCACATTC 
TCB3aF ATGACTGGCATCAAAGCTC 
TCB3aR GTATTCTGGGCCTCCATGTCTAATACAACCAATAGGTTCGC 
TCB3bF GAATGCTGGTCGCTATACTGTTCGATGACAGAATGAATGG 
TCB3bR TTACTGCGTGTATTCTTGAGGAAC 
amdTF GCGAACCTATTGGTTGTATTAGACATGGAGGCCCAGAATAC 
amdTR CCATTCATTCTGTCATCGAACAGTATAGCGACCAGCATTC 
TCB3KIcheck
F 
TCATTCCGTCTTTGCGACCT 
TCB3KIcheck
R 
GCAGTAACAGGAGAGCGTTGA 
 
 
Table S3. Differentially expressed (P < 0.05) gene list for single mutant (tcb3-989) for 
limonene treated vs. untreated cells. 
 
Gene 
name 
Protein 
stable ID 
Gene description log2 FC t adj.P.Val 
Upregulated     
INO1 YJL153C Inositol-3-phosphate synthase, involved in synthesis of inositol 
phosphates and inositol-containing phospholipids; transcription is 
coregulated with other phospholipid biosynthetic genes by Ino2p 
and Ino4p, which bind the UASINO DNA element 
[Source:SGD;Acc:S000003689] 
2.992 6.355 0.01287 
ATF2 YGR177C Alcohol acetyltransferase, may play a role in steroid 
detoxification; forms volatile esters during fermentation, which is 
important for brewing and winemaking 
[Source:SGD;Acc:S000003409] 
1.735 19.381 0.00023 
SIT1 YEL065W Ferrioxamine B transporter, member of the ARN family of 
transporters that specifically recognize siderophore-iron chelates; 
transcription is induced during iron deprivation and diauxic shift; 
potentially phosphorylated by Cdc28p 
[Source:SGD;Acc:S000000791] 
1.695 17.952 0.00027 
YGP1 YNL160W Cell wall-related secretory glycoprotein; induced by nutrient 
deprivation-associated growth arrest and upon entry into 
stationary phase; may be involved in adaptation prior to stationary 
phase entry; has similarity to Sps100p 
[Source:SGD;Acc:S000005104] 
1.586 5.018 0.02646 
AQY2 YLL052C Water channel that mediates the transport of water across cell 
membranes, only expressed in proliferating cells, controlled by 
osmotic signals, may be involved in freeze tolerance; disrupted by 
a stop codon in many S. cerevisiae strains 
[Source:SGD;Acc:S000003975] 
1.545 8.418 0.00474 
PDR15 YDR406W Plasma membrane ATP binding cassette (ABC) transporter, 
multidrug transporter and general stress response factor 
implicated in cellular detoxification; regulated by Pdr1p, Pdr3p 
and Pdr8p; promoter contains a PDR responsive element 
[Source:SGD;Acc:S000002814] 
1.425 5.899 0.01619 
HMX1 YLR205C ER localized heme oxygenase, involved in heme degradation 
during iron starvation and in the oxidative stress response; 
expression is regulated by AFT1 and oxidative stress; relocates to 
the perinuclear region in the presence of oxidants 
[Source:SGD;Acc:S000004195] 
1.367 10.505 0.00201 
YLR346C YLR346C Putative protein of unknown function found in mitochondria; 
expression is regulated by transcription factors involved in 
pleiotropic drug resistance, Pdr1p and Yrr1p; YLR346C is not an 
essential gene [Source:SGD;Acc:S000004338] 
1.358 7.188 0.00847 
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CAR1 YPL111W Arginase, responsible for arginine degradation, expression 
responds to both induction by arginine and nitrogen catabolite 
repression; disruption enhances freeze tolerance 
[Source:SGD;Acc:S000006032] 
1.353 4.835 0.02883 
ARN1 YHL040C Transporter, member of the ARN family of transporters that 
specifically recognize siderophore-iron chelates; responsible for 
uptake of iron bound to ferrirubin, ferrirhodin, and related 
siderophores [Source:SGD;Acc:S000001032] 
1.323 18.501 0.00027 
YLL053C YLL053C Putative protein; in the Sigma 1278B strain background 
YLL053C is contiguous with AQY2 which encodes an aquaporin 
[Source:SGD;Acc:S000003976] 
1.296 7.615 0.00689 
FIT2 YOR382W Mannoprotein that is incorporated into the cell wall via a 
glycosylphosphatidylinositol (GPI) anchor, involved in the 
retention of siderophore-iron in the cell wall 
[Source:SGD;Acc:S000005909] 
1.295 16.543 0.00029 
FRE5 YOR384W Putative ferric reductase with similarity to Fre2p; expression 
induced by low iron levels; the authentic, non-tagged protein is 
detected in highly purified mitochondria in high-throughput 
studies [Source:SGD;Acc:S000005911] 
1.257 17.758 0.00027 
ERG3 YLR056W C-5 sterol desaturase, catalyzes the introduction of a C-5(6) 
double bond into episterol, a precursor in ergosterol biosynthesis; 
mutants are viable, but cannot grow on non-fermentable carbon 
sources [Source:SGD;Acc:S000004046] 
1.161 16.588 0.00029 
RSB1 YOR049C Suppressor of sphingoid long chain base (LCB) sensitivity of an 
LCB-lyase mutation; putative integral membrane transporter or 
flippase that may transport LCBs from the cytoplasmic side 
toward the extracytoplasmic side of the membrane 
[Source:SGD;Acc:S000005575] 
1.138 8.514 0.00467 
YPL277C YPL277C Putative protein of unknown function; localized to the 
membranes; gene expression regulated by copper levels 
[Source:SGD;Acc:S000006198] 
1.126 19.422 0.00023 
ECL1 YGR146C Protein of unknown function, affects chronological lifespan; 
induced by iron homeostasis transcription factor Aft2p; multicopy 
suppressor of temperature sensitive hsf1 mutant; induced by 
treatment with 8-methoxypsoralen and UVA irradiation 
[Source:SGD;Acc:S000003378] 
1.125 9.330 0.00368 
SMP1 YBR182C Putative transcription factor involved in regulating the response to 
osmotic stress; member of the MADS-box family of transcription 
factors [Source:SGD;Acc:S000000386] 
1.117 11.463 0.00145 
PDR3 YBL005W Transcriptional activator of the pleiotropic drug resistance 
network, regulates expression of ATP-binding cassette (ABC) 
transporters through binding to cis-acting sites known as PDREs 
(PDR responsive elements); post-translationally up-regulated in  
/.../lacking a functional mitochondrial genome 
[Source:SGD;Acc:S000000101] 
1.098 27.746 0.00008 
TIS11 YLR136C mRNA-binding protein expressed during iron starvation; binds to 
a sequence element in the 3'-untranslated regions of specific 
mRNAs to mediate their degradation; involved in iron 
homeostasis [Source:SGD;Acc:S000004126] 
1.096 28.455 0.00008 
PRM7 YDL039C Pheromone-regulated protein, predicted to have one 
transmembrane segment; promoter contains Gcn4p binding 
elements [Source:SGD;Acc:S000002197] 
1.064 5.202 0.02350 
TIR2 YOR010C Putative cell wall mannoprotein of the Srp1p/Tip1p family of 
serine-alanine-rich proteins; transcription is induced by cold 
shock and anaerobiosis [Source:SGD;Acc:S000005536] 
1.060 13.656 0.00070 
YOR389W YOR389W Putative protein of unknown function; expression regulated by 
copper levels [Source:SGD;Acc:S000005916] 
1.047 14.909 0.00048 
FIT3 YOR383C Mannoprotein that is incorporated into the cell wall via a 
glycosylphosphatidylinositol (GPI) anchor, involved in the 
retention of siderophore-iron in the cell wall 
[Source:SGD;Acc:S000005910] 
1.022 17.051 0.00027 
Down regulated     
Gene 
name 
Protein 
stable ID 
Gene description logFC t adj.P.Val 
WSC4 YHL028W Endoplasmic reticulum (ER) membrane protein; involved in the 
translocation of soluble secretory proteins and insertion of 
membrane proteins into the ER membrane; may also have a role 
in the stress response but has only partial functional overlap with 
WSC1-3 
-1.105 -4.962 0.027 
DAL5 YJR152W Allantoate permease; ureidosuccinate permease; also transports 
dipeptides, though with lower affinity than for allantoate and 
ureidosuccinate; expression is constitutive but sensitive to 
nitrogen catabolite repression 
-1.260 -8.781 0.004 
 YKR075C Protein of unknown function; similar to Reg1p; expression 
regulated by glucose and Rgt1p; GFP-fusion protein is induced in 
response to the DNA-damaging agent MMS; YKR075C has a 
paralog, YOR062C, that arose from the whole genome 
-1.479 -8.421 0.005 
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Table S4. Differentially expressed (p < 0.05) cell wall protein list for single mutant (tcb3-
989) and WT. 
 
 
Untreated Mut/WT  
Protein log2FC T value adj. p value 
sp|P38616|YGP1_YEAST 0.5967 3.2832 0.00741 
sp|P38248|ECM33_YEAST -0.172 -3.487 0.0037 
sp|P38288|TOS1_YEAST -0.212 -2.82 0.02435 
sp|Q03674|PLB2_YEAST -0.314 -5.376 2.56E-06 
sp|P47001|CIS3_YEAST -0.415 -4.316 0.00029 
sp|P36135|UTH1_YEAST -0.582 -2.73 0.03036 
sp|P39105|PLB1_YEAST -0.624 -3.647 0.00319 
WT +/- limonene treatment  
Protein log2FC T value adj. p value 
sp|P20840|SAG1_YEAST 1.1627 19.267 0 
sp|P38616|YGP1_YEAST 0.8284 5.3917 7.32E-07 
sp|P32329|YPS1_YEAST 0.8216 6.2453 4.42E-09 
sp|Q03180|PIR3_YEAST 0.6543 4.2978 4.32E-05 
sp|P46992|YJR1_YEAST 0.6413 4.5382 1.67E-05 
sp|Q06325|YPS7_YEAST 0.6217 3.0185 0.00554 
sp|Q04951|SCW10_YEAST 0.5038 5.7269 5.65E-08 
sp|Q03178|PIR1_YEAST 0.4887 3.8011 0.0003 
sp|P32478|HS150_YEAST 0.4724 5.5663 1.11E-07 
sp|P53379|MKC7_YEAST 0.4587 4.6785 9.91E-06 
sp|P52911|EXG2_YEAST 0.4142 5.7681 4.95E-08 
sp|Q12355|PST1_YEAST 0.3914 2.2045 0.05032 
sp|P15703|BGL2_YEAST 0.2267 2.202 0.04922 
sp|Q03655|GAS3_YEAST -0.391 -6.355 1.76E-09 
sp|P28319|CWP1_YEAST -0.606 -9.321 0 
sp|P47001|CIS3_YEAST -0.644 -4.671 1.08E-05 
sp|O13547|CCW14_YEAST -0.781 -9.11 0 
sp|P36135|UTH1_YEAST -0.95 -4.401 4.32E-05 
Mutant +/- limonene treatment   
Protein log2FC T value adj. p value 
sp|Q06325|YPS7_YEAST 0.4939 2.4017 0.04365 
sp|P47001|CIS3_YEAST 0.3433 2.9 0.01304 
sp|Q03674|PLB2_YEAST 0.2655 4.4849 5.78E-05 
sp|O13547|CCW14_YEAST 0.2296 2.8364 0.0138 
sp|P38288|TOS1_YEAST -0.245 -3.031 0.00931 
duplication 
 YLR053C Putative protein of unknown function -1.113 -6.384 0.013 
PUT4 YOR348C Proline permease; required for high-affinity transport of proline; 
also transports the toxic proline analog azetidine-2-carboxylate 
(AzC); PUT4 transcription is repressed in ammonia-grown cells 
-1.298 -
13.886 
0.001 
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sp|Q03655|GAS3_YEAST -0.25 -4.055 0.00026 
sp|P28319|CWP1_YEAST -0.293 -5.008 5.72E-06 
sp|Q08193|GAS5_YEAST -0.345 -5.666 3.58E-07 
sp|P46992|YJR1_YEAST -0.379 -2.292 0.05122 
sp|P47033|PRY3_YEAST -0.401 -2.45 0.03981 
sp|P38616|YGP1_YEAST -0.473 -2.254 0.05451 
sp|P53189|SCW11_YEAST -0.645 -3.721 0.00112 
sp|Q12355|PST1_YEAST -1.031 -6.155 3.58E-07 
sp|P38248|ECM33_YEAST -16.73 -4.097 0.00025 
Limonene treatment Mut/WT  
Protein log2FC T value adj. p value 
sp|O13547|CCW14_YEAST 1.0104 11.795 0 
sp|P36135|UTH1_YEAST 0.8171 3.8901 0.0003 
sp|P47001|CIS3_YEAST 0.5726 3.7131 0.00041 
sp|P28319|CWP1_YEAST 0.2186 3.4781 0.00076 
sp|P22146|GAS1_YEAST -0.129 -2.441 0.01914 
sp|Q08193|GAS5_YEAST -0.305 -4.895 3.10E-06 
sp|Q03180|PIR3_YEAST -0.372 -2.543 0.01593 
sp|P15703|BGL2_YEAST -0.387 -3.604 0.00055 
sp|P32478|HS150_YEAST -0.408 -4.621 1.02E-05 
sp|P32623|CRH2_YEAST -0.422 -4.096 9.52E-05 
sp|P39105|PLB1_YEAST -0.426 -2.525 0.01658 
sp|P52911|EXG2_YEAST -0.539 -7.254 3.38E-12 
sp|P38288|TOS1_YEAST -0.539 -6.429 6.62E-10 
sp|P47033|PRY3_YEAST -0.556 -3.576 0.0006 
sp|P53379|MKC7_YEAST -0.627 -6.215 2.54E-09 
sp|P38616|YGP1_YEAST -0.704 -3.789 0.00039 
sp|Q04951|SCW10_YEAST -0.713 -7.928 4.00E-14 
sp|P53189|SCW11_YEAST -0.82 -4.361 4.92E-05 
sp|P20840|SAG1_YEAST -0.89 -14.43 0 
sp|P32329|YPS1_YEAST -1.016 -7.606 5.52E-13 
sp|P46992|YJR1_YEAST -1.249 -8.336 4.44E-15 
sp|P23776|EXG1_YEAST -1.269 -4.822 8.24E-06 
sp|Q12355|PST1_YEAST -1.524 -8.27 6.94E-12 
 
Supplemental Materials and Methods: 
 
GC/MS: After 12 h under limonene challenge (115 µg/l), 1 mL dodecane was added to the 
culture (~ 22 ml), vortexed and harvested (1 min, 4025 rcf). The top dodecane phase 
containing limonene was removed and stored for later analysis at -20°C. For GC/MS 
analysis, the dodecane-limonene mixture was diluted 1:100 in a 1:4 toluene:hexane 
solution. The GC-MS analysis was carried out using the settings described in Brennan et 
al. 1 with the following changes: 3 μL of sample was injected and the oven temperature 
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was set to 70°C, held for 10 min then followed by a temperature ramp of 40 °C/min to 
300°C and held for 3 min. Detection was achieved in SIM acquisition mode for limonene 
using the following ions (m/z): 68.1, 93.1, 136.5 at 26.87 cycles/sec. The retention time for 
limonene was approximately 8 min.  
 
Genomic Reconstruction: The mutant PDR3 ORF was PCR amplified in two overlapping 
parts using primer pairs PDR3aF/PDR3aR and PDR3bF/PDR3bR (all primer sequences 
are listed in Table 1) from strain TB516 genomic DNA. The primers were located such that 
the 3’ end of part ‘a’ contained 200bp of homology to the 5’ end of part ‘b’. The amdSYM 
marker expression cassette was amplified from the pUG-amdSYM plasmid (Euroscarf 2) 
using primer pair amdPF/amdPR. The PCR amplified amdSYM marker was assembled 
between the two PDR3 amplicons (part a and part b) using the Gibson Assembly method 
as in 3. In order to facilitate part assembly the PDR3aR/amdPF and PDR3bF/amdPR 
primers shared 100% homology. The assembly product comprising of PDR3a-amdSYM-
PDR3b was gel purified prior to PCR amplification using PDR3aF and PDR3bR primers. 
The PCR product was transformed into the S288C parent strain using the lithium acetate 
method as previously described 4 such that the native PDR3 ORF was replaced with the 
PDR3a-amdSYM-PDR3b cassette. Transformants were selected on CBS plates with 
0.6g/L acetamide as the sole nitrogen source in place of ammonium sulfate. Transformant 
colonies were screened for correct marker integration using PDR3KIcheckF and 
PDR3KIcheckR primers which anneal outside the knock in locus. Three positive 
transformants were grown in CBS media without acetamide selection to allow for amdSYM 
marker loop-out via recombination between the 200bp of homology shared between PDR3 
part ‘a’ and part ‘b’. After 24 hours of growth, cultures were plated on CBS media 
containing 2.3g/L fluroacetamide for counter-selection of the amdSYM marker. Colonies 
were screened for loss of the amdSYM marker using PCR with primer pair 
PDR3KIcheckF/PDR3KIcheckR. Positive colonies had the full PDR3 ORF sequenced to 
confirm the presence of the desired mutation and the absence of PCR generated errors. 
The TCB3 mutation (frame shift at 989) was reconstructed in the S288C parent strain 
using the same approach as for PDR3, except that the knock in cassette containing the 
amdSYM marker was transformed in two parts (TCB3a-amdSYM and amdSYM-TCB3b). 
This difference arose because the Gibson Assembly product containing the two ORF parts 
and the amdSYM marker could not be obtained. Given that the TCB3a-amdSYM and 
amdSYM-TCB3b products were easily generated, they were co-transformed into the 
parent strain such that the native yeast homologous recombination machinery would 
135
facilitate the completion of the knock-in cassette. Mutant TCB3 DNA was amplified from 
TB516 genomic DNA using primer pairs TCB3aF/TCB3aR and TCB3bF/TCB3bR, while 
the amdSYM marker was amplified using amdTF and amdTR primers. Marker insertion 
and loop-out events were screened for using TCB3KIcheckF and TCB3KIcheckR primers, 
with all plate and growth manipulations carried out as for PDR3. A sequence confirmed 
TCB3 strain (marker removed) was used to reconstruct the double mutant phenotype via 
transformation of the PDR3a-amdSYM-PDR3b knock in cassette and subsequent 
selection and marker removal as described above.  
References 
 
1. Brennan, T.C.R., Krömer, J.O. & Nielsen, L.K. Physiological and Transcriptional 
Responses of Saccharomyces cerevisiae to d-Limonene Show Changes to the Cell 
Wall but Not to the Plasma Membrane. Appl Environ Microbiol 79, 3590-3600 
(2013). 
2. Solis-Escalante D Fau - Kuijpers, N.G.A. et al. amdSYM, a new dominant 
recyclable marker cassette for Saccharomyces cerevisiae. 
3. Gibson, D.G. et al. Enzymatic assembly of DNA molecules up to several hundred 
kilobases. Nat Meth 6, 343-345 (2009). 
4. Daniel Gietz, R. & Woods, R.A. in Methods in Enzymology, Vol. Volume 350. (eds. 
G. Christine & R.F. Gerald) 87-96 (Academic Press, 2002). 
 
 
136
